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 Ion channels are the molecular units that underlie electrical signaling in cells. Many 
physiological processes are dependent upon this signaling mechanism, as dysregulation often 
leads to severe pathophysiological consequences. The intermediate conductance calcium-
activated potassium channel (KCa3.1) functions as heteromeric complexes with calmodulin 
(CaM), which is constitutively bound to the calmodulin-binding domain (CaMBD) of KCa3.1 
located in the C-terminus, just distal to the sixth transmembrane domain (S6). This arrangement 
enables CaM to function as an intracellular Ca2+-sensor, coupling changes in the intracellular 
Ca2+ concentration to the regulation of channel activity. Understanding how channels gate or 
transition from the closed to the open conformation is a fundamental question in the field of ion 
channel biophysics. A chemomechanical gating model was proposed to explain how Ca2+-
binding causes the channel to transition from a non-conducting to a conducting configuration. 
However, this model lacks a specific mechanism explaining how the conformational change in 
the CaMBD is coupled to the activation gate. Therefore, the goal of this dissertation was to 
investigate the role of S6 in the activation mechanism of KCa3.1. Specifically, I tested the 
hypothesis that the non-luminal residues in the C-terminal portion of S6 function as an 
interacting surface to couple CaM to the activation gate. Biochemical perturbation and site 
directed mutagenesis targeting predicted non-luminal residues in S6 act to shift the gating 
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equilibrium toward the open state by increasing the apparent Ca2+ affinity and dramatically 
slowing the deactivation process. Kinetic modeling using a 6-state gating scheme showed these 
perturbations act to slow the transition between the open state back to the closed state. The 
modification in the steady-state and kinetic behavior of the channel in combination with the 
kinetic analysis indicate the shift in gating equilibrium is caused by slowing the closing 
transition, suggesting the non-luminal surface of S6 is allosterically coupled to the activation 
gate. Therefore, in addition to being a structural component of the pore; S6 is also a dynamic 
component of the activation mechanism. Continuing to identify regions of the channel 
participating in the activation mechanism is critical to understand how Ca2+ binding leads to 
channel opening.   
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1.0  INTRODUCTION 
 
1.1 OVERVIEW 
Ion channels are allosteric proteins with at least two conformational states: the open state and the 
closed state. The act of transitioning between these conformational states is a process termed 
gating. One of the most fundamental questions in the field of ion channel biophysics tries to 
understand how ion channels transition between various conformational states. The intermediate 
conductance calcium-activated potassium channel (KCa3.1) is a ligand-gated ion channel that is 
solely activated by the binding of intracellular Ca2+. This channel can be modeled as having three 
separate domains that work in concert to transfer the chemical energy of Ca2+ binding into a 
mechanical force to open the pore. These domains are: the pore-forming domain, the Ca2+-
binding domain, and the coupling domain. As detailed in the introduction, the pore-forming 
domain and the Ca2+-binding domain are well characterized. However, the location and 
mechanism of the coupling domain are poorly understood. The purpose of this dissertation was 
to characterize the role of the sixth transmembrane domain (S6) in the activation mechanism of 
KCa3.1. Specifically, I focused on the non-luminal surface of the C-terminal portion of S6 and 
asked whether this region participates in the activation of KCa3.1. I demonstrate that altering this 
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region influences the steady-state and kinetic behavior of the channel. These data, in addition to 
our kinetic analysis indicate this region is important for the closing transition, suggesting the 
non-luminal surface of the C-terminal portion of S6 is allosterically coupled to the activation 
gate. Therefore, in addition to being a structural component of the pore, S6 is dynamically 
associated with the activation mechanism.  
1.2 LIGAND AND BINDING-SITE INTERACTION 
Proteins are inherently dynamic structures whose function is dictated by interactions with other 
molecules called ligands [1]. The interaction between a ligand and its binding site is relatively 
simple in the case of a single ligand binding to a single site on a protein. However, this 
interaction becomes increasingly more complex when multiple ligands bind to multiple sites. For 
instance, there may be no interaction between binding sites, so that the binding of the initial 
ligand has no affect on the affinity at the other binding sites. On the other hand, there can also be 
cooperativity, so that the binding of the initial ligand increases or decreases the affinity at the 
other binding sites. Cooperativity between binding sites is recognized as a key regulatory 
function of most proteins. Since much effort has been expended to understand how protein-
ligand interactions affect the binding properties of downstream binding sites the term allostery 
was introduced to describe this aspect of protein function [2]. 
Two models were proposed to address cooperativity in allosteric proteins: the Koshland-
Nemethy-Filmer model (KNF) [3] and the Monod-Wyman-Changeux model (MWC) [4]. The 
KNF model is also known as the sequential model, because conformational, and thus affinity 
changes, occur in sequence from one subunit to the next in response to successive ligand binding 
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[3]. This model proposes that the inherent flexibility of proteins allows ligand binding at an 
individual subunit to affect the tertiary conformation of the adjacent subunit, and with that 
increases the affinity for the next ligand to bind. This process continues in sequence until the last 
subunit is bound by ligand (Fig. 1. A). Therefore, the transformation from a ligand free state to a 
fully-ligand bound state is the accumulation of successive conformational changes within the 
subunits. At the opposite extreme is the MWC model, also known as the concerted model (Fig. 1. 
B). Unlike the KNF model, this model proposes that there are two symmetric quaternary 
conformations of the protein structure and ligand binding at one site does not alter the affinities 
of the other sites, but alters the conformational equilibrium between the two quaternary 
conformations of the protein [4]. 
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Figure 1.  Allosteric models.  Illustration of the Koshland-Nemethy-Filmer and Monod-Wyman-Changeux models 
for positive allosteric cooperativity of ligand binding using a hypothetical tetrameric protein. (A) The Koshland-
Nemethy-Filmer (KNF) model proposes that binding of each ligand induces a conformational change in the subunit 
to which it is bound and in the adjacent subunits increasing their affinity for binding of the next ligand. (B) In the 
Monod-Wyman-Changeux (MWC) model there are only two conformational states, tense and relaxed, each having 
intrinsic ligand affinities that are not altered by ligand binding to other subunits. Rather, ligand binding shifts the 
conformation equilibrium from the tense to relaxed state.  
[Reprinted with permission from Ion Channel of Excitable Membranes, 3rd edition, pg. 578. Copyright 2001 by 
Sinauer Associates.] 
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1.2.1 Ion Channels as Allosteric Proteins 
Ion channels are a class of allosteric proteins that have been extensively studied in an effort to 
understand how these proteins transition from one conformational state to another. Ion channels 
are ion permeable pathways through the plasma membrane that have at least two well defined 
conformational states: open and closed [5]. In the open state, the channel acts as a conduit 
through which selected ions flow passively down their electrochemical gradient. The 
electrochemical gradient is defined as the driving force that determines the passive transport of 
ions through a channel. This gradient includes a contribution from the concentration gradient of 
the solute and a second contribution from the electrical potential of charged solutes that exist 
between the inside and outside of the cell [6]. In the second state, the closed state, the ion-
conducting pathway is closed, preventing the flow of ions, regardless of the electrochemical 
gradient. Gating is the process through which the pore transitions between the closed and open 
states. The conformational changes enabling the pore to transition from a non-conducting to a 
conducting state are allosterically coupled to other parts in the protein. Therefore, the allosteric 
property of ion channels allows the free energy of channel opening to be dictated by changes in 
membrane voltage, mechanical force, or ligand binding. 
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1.3 EARLY BIOPHYSICAL APPROACH TO INVESTIGATING ION CHANNEL 
GATING 
The observation that ion channels gate was a monumental achievement that lead to the field of 
ion channel biophysics. The foundation for this field can be traced to the initial work of Hodgkin 
and Huxley, who characterized membrane current in squid giant axons [7-11]. Their initial work 
helped to elicit curiosity in ion channel research. Many discoveries since Hodgkin’s and 
Huxley’s initial work have helped to form our current understanding of gating. Therefore, I 
would like to introduce what I consider to be the most significant of these discoveries since the 
initial contributions of Hodgkin and Huxley. However, no list would be complete without first 
introducing Hodgkin’s and Huxley’s contribution toward the understanding of membrane 
current. 
1.3.1 Elucidating the Components of Membrane Current 
Axon physiology gained momentum with the development of the voltage clamp technique by 
Kenneth Cole [12]. The voltage clamp is an electrical technique for measuring the flow of ions 
across membranes. Unlike conventional methods, where current is applied and the subsequent 
change in membrane potential is measured, the voltage clamp technique holds the membrane 
potential constant while the membrane current is measured [5]. The development of the voltage 
clamp allowed Hodgkin and Huxley to directly measure ion movement across excitable 
membranes. Using the voltage clamp technique, Hodgkin and Huxley set out to characterize 
membrane current and the underlying permeability mechanisms [7-11]. Their experimental 
design relied upon two assumptions: 1) ions tend to move passively down their electrochemical 
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gradient. Therefore, the direction of ion flow could be predicted at a given concentration gradient 
and membrane potential. 2) Permeability changes are insensitive to the concentration of the 
major ions: Na+, K+, and Cl-. Therefore, the movement of one ion can be stopped by replacing 
that ion by an impermeable species with little consequence on the movement of the other ions 
[5]. Incorporating these assumptions into their experimental design, Hodgkin and Huxley 
determined that the membrane current measured from a voltage-clamped squid axon 
(depolarized to 0 mV from the normal resting potential) is composed of four components (Fig. 2) 
[9]. These components can be divided into two major categories: ionic current, which is carried 
by the movement of ions, and the capacitive current, which is a quick transient spike of current 
that is over before the voltage step is completed. The ionic portion of the membrane current 
constitutes the action potential and is made up of two major components: the sodium current 
(INa) and the potassium current (IK) and a minor component termed the leakage current (Ileak). INa 
is the transient inward flow of Na+ ions, IK is the outward flow of K+ ions, and Ileak is the small, 
relatively voltage-independent background conductance (Fig. 2). 
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 Figure 2. Components of membrane current. Membrane current is composed of ionic current and 
capacitive current (Ic). The ionic portion of the current is primarily composed of Na+ current (INa) and K+
current (IK), and a minor component from the leakage current (Ileak). [Reprinted with permission from 
Armstrong C.M., Quarterly Review of Biophysics, vol. 7, issue 2, pg. 182. Copyright 1974 by the 
Cambridge University Press.] 
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While investigating the components of membrane current, Hodgkin and Huxley made the 
first observation that the onset of membrane current is dependent upon membrane potential [7]. 
Thus, the changes in Na+ and K+ conductance, (gNa) and (gK) respectively, are dependent upon 
how the membrane electric field affects the orientation of charged molecules associated with 
these conductances. Therefore, gNa and gK are dependent upon the orientation of these charged 
particles, and only when these particles are in a particular position will membrane current be 
observed [7]. The observation that membrane current is composed of multiple conductances, and 
the activation of these conductances are dependent upon membrane potential directly lead to 
investigations regarding the nature of the charged particles associated with current activation, 
and whether these conductances are separate or share a common pathway.  
1.3.2 Single versus Separate Channel Hypothesis 
The observation that total membrane current consists of multiple conductances directly lead to 
investigations as to whether the Na+ and K+ components of membrane current are combined or 
separate systems. This problem later became know as the single versus separate channel 
hypothesis (Fig. 3) [13, 14]. The experiments that are credited with providing the most insight 
into this problem used a pharmacological approach to specifically target and dissect the 
components of membrane current [15, 16]. The initial evidence suggested that gNa and gK utilize 
separate pathways based upon the specificity of TEA (tetraethylammonium ion) and TTX 
(tetrodotoxin) [15]. When TTX is applied to the outside of an axon it blocks Na+ current without 
affecting the time course or magnitude of the K+ current [17]. Therefore, from this observation it 
was assumed that TTX blocks the Na+ channels leaving the K+ channels unblocked. The 
corollary is that TEA blocks K+ current leaving the Na+ channels unaffected [18-20]. Therefore, 
 9 
the use of TTX and TEA provided strong evidence that gNa and gK are separate systems. 
However, the single channel hypothesis, argued by L. Mullins, states that the channel first 
conducts Na+ ions after which it inactivates, and only then will it conduct K+ ions [21]. Mullins 
argued that TTX simply blocks the Na+ component and TEA the K+ component [13, 14, 21]. 
However, Clay Armstrong and colleagues conducted a series of experiments in support of the 
dual channel mechanism using the proteolytic enzyme pronase [22, 23]. Pronase is rather 
selective for it does not alter K+ or Na+ activation rather it eliminates Na+ inactivation. These 
experiments illustrated that the onset of K+ activation was not affected by eliminating Na+ 
inactivation. Because K+ activation is intact after eliminating Na+ inactivation, this result 
suggested that gNa and gK are separate systems. Thus, Armstrong’s experiments provided the 
strongest evidence in support of the dual channel hypothesis. 
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 Figure 3. Single versus se parate channel hypothesis. (A) Single channel scheme assumes that a 
single voltage-dependent time constant controls the change of the membrane from impermeable to K+
permeable. The Na+ permeable phase is governed by two time constants, and any lengthening of these
time constants, especially (h) will prevent the appearance of the K+ permeable state. (B) The separate 
channel scheme has a Na+ permeable state that can be turned on by the (m) process and turned off
either by (h) or by a voltage change reversing (m). The K+ process is independent from the Na+
channel and is turned on or off by the (n) process. [Adapted from Mullins L.J., 1968. A single channel 
or a dual channel mechanism for nerve excitation. Journal of General Physiology. vol 52, pg. 550.] 
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1.3.3 Ionic Pores versus Carrier Proteins 
Implicit in the work from Hodgkin and Huxley is whether ions use pores or carrier proteins to 
pass through the cell membrane. There is strong evidence that the passive transport of K+ and 
Na+ ions through the membrane occurs through pores. Part of this evidence comes from 
Armstrong’s lab, which postulated a pore mechanism from their characterization of the 
interaction between quaternary ammonium (QA) compounds and K+ channels [16, 18, 24, 25]. 
Specifically, their experiments tested for a pore model and not a carrier model for ion transport. 
The TEA derivative, nonyltriehtylammonium ion (C9), is an effective blocker of K+ channels. 
When C9 is applied to the inside of an axon, K+ current (IK) does not reach a steady-state level 
during the voltage step, but inactivates in a manner similar to Na+ current (INa). The mechanism 
of C9 inactivation can only be explained by a model K+ pore. The model has four states when C9 
is present (Fig. 4. A). (1) At the resting potential the activation gate is closed preventing C9 from 
entering the mouth of the pore. (2) After the depolarization step, the gate is open permitting the 
K+ ion to move through the pore (3) C9 is capable of entering the pore through the inner mouth, 
inactivating the channel. (4) Repolarizing to the resting potential causes the channel to transition 
from the inactivated state to the closed state, trapping the C9 ion in the channel. There are two 
methods to speed recovery that give strong evidence to the ionic pathway being a pore rather 
than a carrier [16, 22]. The first method is to increase external K+ concentration, and the second 
method is to make the membrane potential more negative. Only the pore model can explain the 
mechanism behind each of these results. As illustrated in Fig. 4 (B), the hydrophobic binding of 
C9 prevents the molecule from spontaneously leaving the pore. The presence of a K+ ion at point 
X pushes C9 out of the pore through electrostatic repulsion. Therefore, increasing external K+ 
concentration and making the membrane potential more negative increases the probability of 
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finding a K+ ion at point X. These effects with C9 would be difficult to reconcile using a carrier 
model indicating that ions transverse the cell membrane using pores.   
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A. 
 
B. 
 
Figure 4. Early ion channel model. Models from Clay Armstrong’s C9 experiments illustrating that ions transverse 
the membrane through ion channels rather than carrier proteins. (A) Model illustrating the four hypothetical states of 
a pore when C9 is in the cytoplasm. (B) Model to explain the accelerated removal of C9 from the pore when 
extracellular [K+] is high or when Vm is negative. [Reprinted with permission from Armstrong C.M., Quarterly 
Review of Biophysics, vol. 7, issue 2, pgs. (A) 186 and (B) 189. Copyright 1974 by the Cambridge University Press.] 
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1.3.4 Gating Currents 
“…it seems difficult to escape the conclusion that the changes in ionic permeability 
depend on the movement of some component of the membrane which behaves as though it had a 
large charge or dipole moment.” A.L. Hodgkin and A.F. Huxley 1952 [7]. 
 
Channel gating, as it was originally predicted by Hodgkin and Huxley in 1952, is the 
voltage-dependent opening and closing of pores [7]. Their seminal work characterizing the 
components of membrane current formed the foundation for the field of ion channel biophysics. 
Hodgkin and Huxley made the first prediction that charged particles in the membrane are 
responsible for manipulating the permeability changes that accompany the activation of Na+ and 
K+ channels [7]. Their original hypothesis was responsible for initiating much of the work 
attempting to identify these charged particles, and determining whether they are associated with 
the membrane or exclusively with the channels. In the next section, I will briefly summarize 
some of the original ideas concerning these charged particles and how they are associated with 
channel gating. 
1.3.4.1 Dissolved ions and molecules as gates or sensors 
Originally, it was thought that dissolved ions and molecules functioned as both the voltage 
sensor and the gate for Na+ and K+ channels [26, 27]. The most studied of these ions was Ca2+. It 
was well known that increasing the concentration of free Ca2+ surrounding nerve or muscle 
increased the depolarization level required to reach firing threshold [28]. Gordon and Welsh first 
theorized that Ca2+ ions plug the pores acting as both the voltage sensor and the gate [27]. 
However, many observations from the field did not support this model. For example, 1) Ca2+ can 
pass through an open Na+ channel, 2) excitability is maintained for a prolonged period of time in 
the presence of Ca2+ chelating agents, and 3) Ca2+-free solutions did not alter the voltage-
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dependence of Na+ channel activation [29-32]. In addition to Ca2+, non-physiological ions block 
channels in a voltage-dependent manner, therefore they were also considered to function as the 
voltage sensor and the gate [16]. However, perfusing axons with non-physiological ions does not 
affect the time course of channel opening or closing [33-35]. These results indicated that 
dissolved or non-physiological ions cannot function as the voltage sensor machinery or gate [26]. 
Furthermore, it is unlikely that simply perfusing an axon washes out the components necessary 
for voltage sensing, suggesting the charged particles are an inherent component of the membrane 
[26]. Because these gating particles were now considered to be part of the membrane, it could be 
proposed that the gating process is dependent upon these particles undergoing a conformational 
change within the membrane. 
“Thermodynamically there is no way for channels to continue to open and close millions 
of times without direct input of energy into the sensing-gating process on every cycle. 
Arguments have already been presented against direct contributions from conventional metabolic 
sources or from the ion gradient. The only remaining source of energy is the electric field. The 
field must do electric work on the sensor-gate by moving some charges through the 
intramembrane field. Hence, while work is being done a small membrane current reflecting these 
internal rearrangements will flow.” Bertil Hille 1976 [26]. 
 
The existence of carrier currents, or as they are most often referred, gating currents were 
predicted to exist by Hodgkin and Huxley in 1952 [7]. However, both Hodgkin and Huxley, and 
later Chandler and Meves were unsuccessful in trying to observe gating currents [7, 33]. In both 
cases, the relatively low channel density was to blame for their inability to measure these 
currents. Additionally, as discussed by Hodgkin and Huxley, the magnitude of these currents 
were unknown, but were expected to be a fraction of the maximum current [7]. Therefore, 
Chandler and Meves attempted to reduce the interference of ionic currents by replacement with 
non-permeable cations, although they still failed to resolve gating currents [33]. It wasn’t until 
Armstrong and Francisco Bezanilla first recorded the small transient currents in 1973 [36] that 
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they were shown to exist 21 years after they were first predicted by Hodgkin and Huxley. Like 
Chandler and Meves, Armstrong and Bezanilla reduced ionic currents through ionic replacement 
[36]. In their experiments, they replaced Na+ on the outside with Tris+tris(hydroxymethyl) 
methyl ammonium ion and they replaced K+ with Cs+ on the inside. They also used TTX, which 
does not affect gating currents, to eliminate the remaining current through Na+ channels. The 
problem Chandler and Meves had with the signal to noise, Armstrong and Bezanila rectified with 
signal averaging techniques to increase the signal to noise ratio. There is considerable evidence 
to suggest that gating currents are associated with the activation of Na+ channels [37, 38]. First, 
the time course between INa and the associated gating current is nearly identical. Second, the 
addition of internal Zn2+ eliminates both ionic and gating current, and these currents recover 
together after wash-out of the cation. Third, prolonged depolarization eliminates both INa and the 
gating current, which recovers together when the holding potential is restored. Finally, 
inactivation of the channel temporarily eliminates the gating currents. When the channel is in the 
inactivated state, it prevents the activation gate from closing, and therefore inhibits the gating 
charge from returning to the off position.  
1.4 MOLECULAR APPROACH FOR INVESTIGATING ION CHANNEL GATING 
Up until the early 1970’s, most of our understanding regarding the structures involved in gating 
was derived from the voltage clamp technique (Fig. 5). This method was so effective that it 
biased our approach toward the study of ion channels; no one thought to consider the chemical 
nature of the channel. However, a new era in the study of channel structure began in 1973 when 
the nicotinic acetylcholine receptor (nAChR) and the Na+ channel were first identified as 
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proteins [23, 39]. Since ion channels are proteins, much effort was expended for the development 
and refinement of techniques for solubilizing and purifying membrane proteins without 
destroying their function [5]. For instance, nAChR was isolated from the electric organ plasma 
membranes of the electric ray, Torpedo. Membrane proteins were solubilized with detergents to 
form micelles containing a protein molecule surrounded by detergents and a few lipid molecules. 
Affinity columns bound with α-neurotoxins, such as α-bungarotoxin, were used to separate the 
micelles containing nAChR, which were eluted with a high concentration of cholinergic ligand 
[40-45]. The complete amino acid sequence was determined by a combination of protein 
chemistry and molecular genetics [46-48]. To ensure the sequences were sufficient to express the 
protein in a fully functional form, complementary DNAs (cDNAs) were expressed in 
heterologous expression systems, such as Xenopus oocytes [49, 50]. Heterologously expressed 
channels enabled the functional characteristics of the cloned protein to be compared with the 
endogenous channel [51]. Therefore, the study of ion channels took on an interdisciplinary 
approach in the 1980’s, as methods in molecular biology and protein chemistry enabled us to 
investigate the chemical structure of ion channels. 
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Figure 5. 1970's model of a voltage-gated ion channel. The channel is drawn as a 
transmembrane protein with a lumen down the center. The components are labeled with terms 
used in 1975. [Figure is based upon Hille B., Progress in Biophysics and Molecular Biology, 
vol. 21, pgs. 1-32, 1970. Reprinted in Hille Handbook of Physiology. The Nervous System, 
vol. 1, pt. 1, 1977. Reprinted with permission from the American Physiological Society, 
copyright 1977.]  
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1.4.1 Cloning of the K+ Channel 
Initial attempts in K+ channel protein chemistry proved to be difficult [5, 52-54]. Unlike the 
nAChR, Na+ and Ca2+ channels, high affinity ligands were not available for K+ channels during 
this time period [5]. Therefore, the biochemical approach used to determine the primary 
sequence of nAChR and Na+ channels could not be utilized. Another approach needed to be 
taken, and this approach benefitted from a behavioral mutant, Shaker, from Drosophila 
melanogaster [53]. This mutation caused ether-anesthetized flies to shake uncontrollably [5]. 
The abnormalities causing this behavior were traced to a disruption in action potential firing, 
suggesting that a gene within the Shaker locus encoded for a K+ channel [55, 56]. This mutation 
enabled the sequence to be obtained by positional cloning [5]. The goal in positional cloning is to 
identify fragments of chromosomal DNA from the coding region of the gene rather than to look 
for derived RNA messages. One starts by locating the position of the chromosomal mutation. 
Next, the gene is identified through a process known as chromosome walking by using a clone of 
an already known piece of genomic DNA located as near as possible to the suspected gene [5]. 
Subsequent investigations determined that the Shaker gene encodes for an α-subunit, which 
corresponds to a single copy of the six transmembrane (6 TM) domain that is repeated four times 
in voltage-gated Na+ and Ca2+ channels [57-61]. This makes sense in evolutionary terms because 
voltage-gated Na+ and Ca2+ channels are thought to have evolved from K+ channels. It is likely 
that the precursor channel that gave rise to Na+ and Ca2+ channels arose from a single-domain 
channel through two rounds of gene duplication. The first round consisted of converting the 
single-domain channel into a two-domain channel, which was duplicated again to form the four-
domain precursor channel [62]. Therefore, K+ channels are evolutionary older than Na+ and Ca2+ 
channel, and as suggested by the structure of these channels, the fully assembled K+ channel is 
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expected to be a complex of four subunits assembled into a tetramer around a centrally located 
pore. Roderick Mackinnon later provided the first experimental confirmation that the subunits of 
the Shaker K+ channel assemble as a tetramer [63]. 
1.4.2 The Cloned K+ Channel 
The cloning of the Shaker K+ channel provided the means for discovering a diverse family of K+ 
channels [63-66]. Cloning projects have revealed over 80 related mammalian genes for α-
subunits of K+ channels that come in many different architectural forms [5]. K+ channels can be 
recognized by the K+ channel signature sequence, (-TXXTXGYGD-), contained in the pore-
lining P-loops [67]. K+ channel architecture varies from the simplest 2TM channels such as Kir 
and KcsA, to the 4TM 2-pore channels such as TWIK, to the 6TM architecture of the voltage-
gated K+ channels (Kv), to the largest 7TM architecture of large conductance Ca2+-activated K+ 
(BK) channels (KCa1.x), see Fig. (6). Also included in the 6TM family of ion channels is the SK 
subfamily, which includes the small (KCa2.1, KCa2.2, and KCa2.3) and intermediate 
conductance (KCa3.1) Ca2+-activated K+ channels, which are the subject of this dissertation. 
These channels share little sequence similarity with the BK channels; rather these channels are 
more closely related to the Kv family of K+ channels. This can be explained through the 
hypothetical phylogeny of voltage-gated ion channels [62]. The earliest known structures are the 
1-domain 2TM channels, and through the subsequent addition of 4TMs gave rise to the 1-domain 
6TM channels, which encompasses the voltage-gated K+ channels and the ligand gated ions 
channels [62]. This would explain why KCa3.1 and KCa2.x are more closely related to the Kv 
channels than the BK channels. Furthermore, through two rounds of gene duplication, the 1-
domain 6TM channels gave rise to the 4-domain 6TM of the voltage-gated Na+ and Ca2+ 
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channels. 
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Figure 6. Ramification of K + channels in higher animals. Known K-channel genes are sorted by similarity of 
amino acid sequence. The coarsest grouping separates them by membrane topology (2TM, 4TM, 6TM). This 
diagram was made by aligning 89 channel sequences, mostly from mammals, using just 47-49 amino acids including 
their P-regions and extending into the subsequent hydrophobic domain. A dendrogram was made with the Clustal 
algorithm and then converted into a cladogram using the MacClade program. Finally, the full tree was simplified by 
retaining only one representative member of each subfamily and discarding the other small branches. Branch lengths 
do not represent time, but the branching is expected to preserve evolutionary relationships. The HCN channels are 
relatives that also pass Na+ ions; the akt and pak channels are from plants and Paramecium, respectively. [The figure 
was prepared by W.J. Joiner and A.M. Quin. Reprinted with permission from W.J. Joiner.] 
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1.5 STRUCTURE-FUNCTION APPROACH FOR INVESTIGATING ION CHANNEL 
GATING 
Heterologous expression of K+ channels combined with site-directed mutagenesis elicited the 
development of hypotheses regarding the regions of the channel responsible for permeation and 
gating [5]. The mutated channels were expressed in Xenopus oocytes or other heterologous 
expression systems (e.g., HEK (human embryonic kidney), CHO (Chinese hamster ovary) or 
COS (monkey kidney) cells) and channel function was examined and compared to the WT-
channel [49, 50]. This experimental approach used structure-function logic to indirectly 
investigate channel structure. When interpreting these results it is typically assumed that the 
mutated region of the channel is associated directly with the structure that corresponds to the 
manipulated function. For instance, a mutation in a region that alters permeation or single 
channel conductance, is thought to be associated with the permeation pathway. Therefore, in an 
ideal situation, the structural perturbations caused by the mutation are local, enabling a direct 
link with channel function. However, mutations can disrupt channel structure indirectly at a 
second site or globally, complicating the interpretation of how a mutated region is associated 
with channel function. Therefore, when interpreting experiments from mutagenesis it is helpful 
to have converging lines of evidence obtained from multiple experimental approaches. 
Mutagenesis is often combined with chemical modification or some form of structural 
determination to ensure that the effects are specific for one function, rather than disturbing 
multiple functions of the channel [5]. One such method is the substituted cysteine accessibility 
method (SCAM) [68-70]. SCAM will be defined and discussed later as this method was used 
extensively to understand the architecture of S6 in KCa3.1. 
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As mentioned previously, the cloning of Shaker, and subsequent K+ channels enabled the 
indirect examination of channel architecture through structure-function studies. Furthermore, 
much of our current understanding regarding pore structure is the culmination of many 
investigations from the early 80’s through the middle to late 90’s. I would like to briefly 
highlight the methodologies used in several investigations, which were credited for defining the 
regions of the channel that are associated with the pore and the gate. 
1.5.1 The Pore 
Investigations into the K+ channel pore used several experimental approaches to isolate regions 
of the channel associated with the pore. One of the methods involved swapping regions between 
K+ channels with known functional differences associated with permeation and block, as a means 
to isolate the sequence involved in formation of the pore [71-74]. If the transplanted region is 
associated with the pore, then the chimeric channel should adopt the biophysical properties of the 
donor channel. Hartmen et al., [71] used this technique to investigate whether the P-loop is 
associated with the pore. The 21 amino acid segment linking S5 to S6 was transplanted from the 
voltage-activated NGK2 K+ channel to DRK1, a K+ channel differing in single channel 
conductance and sensitivity to both external and internal TEA. Supporting their hypothesis, the 
chimera exhibited characteristic, such as single channel conductance and block by external and 
internal TEA, similar to the donor NGK2 channel. This result suggests that the 21 amino acid 
segment linking S5 to S6 controls many of the essential biophysical properties of the pore in 
addition to forming part of the permeation pathway. Utilizing the same approach Lopez et al., 
[74] transplanted S6 of NGK2 into the Shaker K+ channel as a means to investigate whether S6 
is associated with the pore. The chimeric channel adopted the single channel conductance and 
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sensitivity to internal TEA and barium of the donor channel, suggesting that in addition to the P-
loop, S6 is associated with the pore. The second method utilized structure-function studies of 
pore blockers such as TEA and CTX [75-81]. The basis for many of these structure-function 
studies came from the initial observation that CTX blocks the BK channel by binding to the 
external surface of the mouth of the pore [77]. By analogy, it was assumed that CTX also blocks 
the Shaker K+ channel in a similar manner [79]. Many of these investigations came from the lab 
of Roderick Mackinnon, whose lab used site-directed mutagenesis to isolate the residues 
required for CTX block, thereby indirectly mapping the external surface of the pore [79, 81, 82]. 
The results from a series of investigations determined that the lateral segment of the P-loop, 
between S5 and S6, forms the external mouth of the pore [60, 61]. It was also observed that the 
P-loop residues required for CTX block also function as the binding site for externally applied 
TEA [80]. Therefore, in a separate investigation, Yool et al., [73] determined the residues in the 
middle of the P-loop that are important for internal TEA block. Furthermore, mutation of these 
residues also altered the permeation properties to K+, Rb+, and NH4, suggesting these residues 
contribute to both the internal TEA binding site as well as forming part of the permeation 
pathway. 
1.5.2 The Gate 
Structure-function studies were also instrumental in providing insight into the regions of the 
channel forming the gate [5, 83]. The gate was thought to be a structure that physically blocks 
the pore to prevent ion diffusion [84]. The gate is in the open configuration when the channel is 
activated, enabling ions to flow down their electrochemical gradient. Upon dissociation of ligand 
or reversal in membrane potential, the channel transitions directly to the closed state. Ion 
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diffusion is blocked as the gate returns to the original position. This type of mechanism is 
referred to as activation-deactivation gating. However, in the continued presence of ligand or 
depolarizing membrane potentials, some channels block ion diffusion by entering into an 
intermediate inactive state. In this state, the channel is open, but ion diffusion is blocked through 
either collapse of the selectivity filter, termed C-type inactivation [85-90] or an auto-inhibitory 
part of the channel protein, termed N-type inactivation [91-96]. This mechanism is referred to as 
activation-inactivation gating; the channel must transition from the inactivate state to the open 
state before entering into the closed state. Thus, gating involves large conformational changes in 
protein structure, which have been difficult to understand without direct knowledge of channel 
structure. A clue for the location of the gate came from experiments showing that fast 
inactivation [84, 97] of Na+ and K+ channels may result from a cytoplasmic gate such as the 
amino terminal peptide of the Shaker B K+ (ShB) channel blocking the permeation pathway [93, 
96]. Isacoff et al. [83] reported that the intracellular loop between transmembrane segments S4 
and S5 most likely forms part of the receptor for the inactivation gate. Their results indicated that 
the glutamate at position 395 might be the counter-charge for the positively charges residues of 
the inactivation ball. Their investigation showed that mutation of position 395 affected the 
stability of the inactivated state as well as single channel conductance. However, mutations at 
other positions in the S4-S5 linker also produced alterations in the rates of the N-type 
inactivation [98]. Furthermore, the activation gating of the Shaker channel is also very sensitive 
to mutations in this region [99], and it is known that binding of the inactivation ball and other 
blockers is dependent on the activation state of the channel. Therefore, mutations in this region 
might change the apparent affinity for the ball by a direct change in the binding site, or indirectly 
by changing gating [100]. Holmgren et al. [98] used the method of cysteine substitution and 
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subsequent chemical modification to help distinguish direct and indirect effects, with the goal of 
identifying residues that directly interact with the inactivation gate. Their investigation showed a 
particularly strong effect of charge modification at position 391, consistent with a direct 
electrostatic interaction. At this position, chemical modification altered the kinetics of ball 
peptide binding without altering other biophysical properties of the channel. Results with 
reagents that attach different charged groups at 391C suggest that there are both electrostatic and 
steric interactions between this site and the ball peptide. These findings identify this site to be in 
or near the receptor site for the inactivation ball. Four lines of evidence support this idea. First, 
inactivation only occurs after the voltage-dependent gate opens, suggesting the open 
conformation of the pore exposes a receptor for the gate [96]. Second, inactivation is produced 
by the binding of only one gate to a single pore opening [101, 102]. Third, high concentrations of 
extracellular K+ reduce inactivation, most likely by pushing the gate from its intracellular side 
[92]. Fourth, inactivation mimics the action of quaternary amines, which are thought to be pore 
blockers [25, 91]. In a subsequent investigation, Zhou et al., [103] showed that the central cavity 
and inner pore of the K+ channel form the receptor site for both the inactivation gate and small-
molecule inhibitors. They propose that inactivation occurs by a sequential reaction in which the 
gate binds initially to the cytoplasmic channel surface and then enters the pore as an extended 
peptide. Therefore, combining mutagenesis with permeation and block structure-function studies 
provided insight into the regions of the K+ channel that form the pore and the gate.  
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1.6 SUBSTITUTED CYSTEINE ACCESSIBILITY METHOD 
As previously mentioned, combining chemical modification with site-directed mutagenesis is an 
effective way to determine whether the observed phenotype caused by a mutation is the result of 
a local or global change in channel structure [5]. Chemical modification using membrane 
impermeant reagents applied to the extracellular or intracellular aspect of transmembrane 
proteins has been useful in determining residues that are accessible from the outside and inside 
of the membrane, respectively [104]. However, structural mapping greatly improved with the 
development of site directed mutagenesis, and the cloning of ion channels. SCAM or substituted 
cysteine accessibility method combines site-directed mutagenesis and chemical modification 
with thiol specific regents to assess the accessibility of introduced cysteines [68-70, 105, 106]. 
Typically, as a test of cysteine accessibility, a biochemical test is used to measure the extent to 
which the thiol reagent is incorporated into the protein [104]. The development of reagents that 
react quickly under physiological conditions has allowed this technique to be applied to the study 
of ion channel structure [106-108]. 
1.6.1 SCAM and Ion Channels 
Ion channels provide a distinct advantage over other proteins when trying to assess the extent of 
chemical modification and hence cysteine accessibility. Channel function is easily measured 
through patch clamping, allowing for real-time functional measurements to take the place of 
conventional biochemical tests. If the modified cysteine is located in a gating sensitive region, 
modification of this residue will alter channel gating, which can be assessed through patch 
clamping [104]. Cysteine residues are classified as either exposed or buried based upon the 
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extent of modification. SCAM neglects fluctuation in protein structure. Therefore, no cysteine is 
considered unreactive due to the possibility that the buried cysteines may react slowly. To gauge 
the extent of modification, it is useful to determine the time course, modification rate, and state 
dependence of the modified cysteine. However, reactivity is not simply based upon accessibility 
to the reagent, as reactivity can also be affected by acid dissociation of the Cys-SH, steric 
constraints on the formation of an activated complex, and for charged reagents, the electric field 
along the path to the residue. Although adding to the difficulty in interpreting the results, these 
factors can be dissected out by comparing the reaction rates for reagents that differ in charge or 
size [69]. The most common approach is to compare accessibility between the different 
methanethiosulfonate (MTS) reagents. Arthur Karlin and colleagues designed a set of water-
soluble reagents based on the MTS moiety [106, 107]. The MTS reagents readily transfer a 
hydrophilic moiety to the target sulfhydryl by forming an -SS- bridge [5]. The regents [2-
(trimethylammonium) ethyl] methanethiosulfonate bromide (MTSET) and sodium (2-
sulfanoethyl) methanethiosulfonate (MTSES) are the same size (10 Å x 5.8 Å) but differ in their 
charge, with MTSET being positively and MTSES being negatively charged [5, 109]. The third 
commonly used MTS reagent, 2-aminoethyl methanethiosulfonate hydrobromide (MTSEA) is 
the smallest (diameter of 4.6 Å) but is charged only at acidic pH and crosses membranes slowly 
[5, 109]. Therefore, extra caution is required when using this compound. 
1.6.1.1 Experimental Assumptions 
SCAM has been credited in helping to identify residues that line the channel, determining the 
size of the channel, differences in the channel structure during different functional states, 
location of the selectivity filter, and mapping the electrostatic potential profile of the channel [45, 
110-113]. As with any method, certain experimental assumptions are taken when interpreting the 
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data. 1) When studying membrane-embedded channel proteins, the first objective is to ensure 
that the WT-channel is not irreversibly altered by the addition of the MTS reagent. 2) While 
substituting cysteines along the channel it is assumed that no previously buried WT-cysteines are 
exposed through mutation. 3) The sulfhydryl group of natural or engineered cysteines is in one of 
three environments: water accessible, lipid accessible, or in the protein interior [69]. 4) The 
channel lining is considered to be part of the water accessible surface, and hydrophilic charged 
reagents react faster with sulfhydryls in a water accessible surface than in a lipid accessible 
surface [69]. 5) An irreversible change in channel function is assumed to mean modification of a 
substituted cysteine and that this cysteine is exposed to the water filled lumen. 6) The position of 
the substituted cysteine side-chain is nearly the same as that of the WT-side-chain. Therefore, 
SCAM is used to indirectly determine the orientation of the WT side-chain [69]. Although this 
method is useful for understanding protein structure, the interpretation of negative results can be 
difficult. A negative result could mean that the cysteine is inaccessible to the reagent, or the 
cysteine reacts with the reagent but modification has no effect on protein function [69]. In the 
section on KCa3.1, I will discuss how this method was used to probe the architecture of S6. 
1.7 CURRENT VIEW OF ION CHANNEL GATING AND THE STRUCTURE OF 
THE PROTEIN 
The initial characterization of membrane current, and the related investigations that followed 
helped to fuel the next 40 years of ion channel research. During this time period it became 
accepted that ion channels enable ions to move down their electrochemical gradient due to the 
formation of an ion conducting pathway, a selectivity filter, and a gate. The movement of ions is 
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regulated by the opening and closing of the ion conduction pathway, a process referred to as 
gating. Gating is controlled by sensor domains that when activated increase the pore’s 
probability to be in the open conformation. Ion channels that open in response to changes in 
membrane potential are called voltage-gated ion channels and those that open in response to 
ligand binding are called ligand-gated ion channels. The basic function of these sensing domains 
is to perform mechanical work on the ion conduction pore to alter its conformation between a 
non-conducting and a conducting conformation. Therefore, a voltage-sensor converts electrical 
energy into a mechanical force whereas a ligand-binding domain converts chemical energy into 
mechanical force to open the pore. Thus, ion channel gating is the result of electromechanical or 
chemomechanical coupling between a sensor domain and the pore, enabling the channel to 
transition from the closed to the open conformation. Although much progress has been made 
toward understanding the mechanism of ion channel gating, the fundamental goal still remains to 
obtain a structure to complement the vast amounts of biophysical data.  
Prior to 1998, the majority of our understanding about structure came through a 
combination of techniques based in the areas of electrophysiology and molecular biology. 
Although these techniques provided invaluable insight on the gating mechanism, these 
approaches are only capable of indirectly gathering information about channel structure (Fig. 7). 
Therefore, another approach was needed to launch ion channel research to the next level. This 
breakthrough came in 1998 when the laboratory of Rod MacKinnon developed the first crystal 
structure of a bacterial K+ channel homolog, KcsA [67]. The x-ray structure opened new avenues 
of investigation, while at the same time grounding 40 years of ion channel biophysics within a 
structural framework (Fig. 8).  
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 Figure 7. 1990 's model of a voltage-gated ion channel. Comparing this model to Fig. 5 shows the 
progression from a simple macromolecule with a rudimentary gate, voltage sensors, and selectivity filter to
a more detailed model. During the period after the drawing of Fig. 5, the field learned that the channel is 
composed of four α-helical segments with positively charged residues functioning as voltage sensors;
channels are heavily glycosylated and tied to other intracellular proteins. [Reprinted with permission from
Ion Channel of Excitable Membranes, 3rd edition, pg. 86. Copyright 2001 by Sinauer Associates.] 
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Figure 8. Premonitions of ion channel gating. The 1998 publication of the KcsA crystal structure 
grounded the preceding 30 years of biophysical experimentation into a structural framework. Thanks to the 
contributions of many investigators, the key ion channel land marks were predicted as early as the 1970’s; 
without the aid of any real structural data. As shown by the 1971 Armstrong gating model, it was accepted 
that channels consist of a pore, which transverses the membrane enabling a high rates of ion transport while 
maintaining a high degree of selectivity with a selectivity filter. The selectivity filter is sandwiched by non-
selective vestibules, into which molecules can enter and inhibit permeation by blocking the pore. Pore 
blocker such as quaternary ammonium (QA) were essential in predicting the location of the activation gate, 
and illustrated that gating involved a change in the access to the intracellular mouth of the pore. Although 
the K+ channel crystal structure simply confirmed what was already known about the basic K+ channel 
architecture, it was essential for providing structural detail not attainable by combining techniques in 
molecular biology and electrophysiology. Furthermore, the structure helped to eliminate the guess-work 
involved in structure-function studies necessary for further refining the regions involved in the gating 
mechanism.  
[Reprinted with permission from Yellen G., Nature Structural Biology, vol. 5, number 6, pg. 421. 
Copyright 1998 by the Nature Publishing Group.] 
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Therefore, much of our understanding related to ion channel structure can be credited to 
the solved crystal structures. Structures have been obtained for channels having different types of 
sensing domains, in addition to obtaining structures in different conformational states. Making 
comparisons between the different channel types have helped to reinforce our understanding of 
the pore and the structures involved in gating. For instance, from the x-ray structure of the 
ligand-gated ion channel, MthK, we know the pore domain is separate from the Ca2+-binding 
domain [114, 115]. Two separate domains means the conformational change occurring in the 
Ca2+-binding domain must be coupled via a physical linkage or coupling domain to the activation 
gate enabling the pore to transition from the closed to open conformation. The idea that the 
sensing domain is separate from pore domain holds true for every structure solved to date, and is 
likely true for all ion channels. Since this dissertation is about the ligand-gated ion channel, 
KCa3.1, we will consider how ligand-gated ion channels are modeled in terms of their domains 
and how they function in concert to allosterically couple ligand binding to channel gating. 
Ligand-gated ion channels are structurally modeled as having three domains: the pore-forming 
domain, the ligand-binding domain, and the coupling domain [116]. The pore-forming domain, 
as alluded to previously, contains the permeation pathway and activation gate, which is 
responsible for controlling the flow of ions down their electrochemical gradient. The ligand-
binding domain contains the ligand binding sites, and the coupling domain links the ligand-
binding domain to the activation gate. 
The next section will summarize the structural and mechanistic insight gained by 
examining the KcsA, KirBac1.1, and MthK atomic structures. These channels will be discussed 
in terms of the structural features that comprise the ion selective permeation pathway, the 
activation gate, and where it applies, the ligand-binding domain. Comparing channel structures 
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in two different conformational states is useful for developing hypotheses regarding the gating 
mechanism. Therefore, I will present a possible mechanism to explain how ion channels 
transition from the closed to the open conformation by comparing the closed conformation of 
KcsA to the open conformation of MthK.  
1.8 STRUCTURAL APPROACH FOR INVESTIGATING ION CHANNEL GATING 
1.8.1 Permeation Pathway and Selectivity Filter: KcsA X-Ray Structure [67] 
The K+ channel from Streptomyces lividans is an integral membrane protein with sequence 
similarity to all known K+ channels, particularly within the pore region [67, 117]. The channel is 
a tetramer composed of four identical subunits, each having two membrane spanning 
transmembrane domains (TM1 and TM2). The subunit is oriented so that the inner helix (TM2) 
faces the central pore and the outer helix (TM1) faces the lipid membrane (Fig 9). The pore takes 
the shape of an inverted tee-pee with the selectivity filter being at the base of the inverted tee-pee 
facing the extracellular side of the membrane [67]. The structure of the selectivity filter provides 
a mechanism for how K+ channels obtain a high degree of selectivity while maintaining a high 
throughput rate.  
The selectivity filter maintains high throughput and selectivity by incorporating structural 
features that serve to ensure K+ ions move small distances from one binding site to the next; all 
the while maintaining proper pore diameter [67]. Ensuring that K+ ions diffuse small distances 
from one binding site to the next in the selectivity filter allows for electrostatic repulsion 
between two K+ ions, creating the high throughput rates, up to 108 ions per second, observed in 
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ion channels [67]. Creating, and maintaining proper pore diameter ensures selectivity [5, 16, 67]. 
When an ion enters the selectivity filter it dehydrates, and to compensate for the energetic cost of 
dehydration the carbonyl oxygen atoms from the channel protein take the place of the water [5, 
16, 67]. The specific diameter of a K+ channel pore allows only K+ ions to pass through, 
preventing the movement of ions with different diameters. Ions larger than K+ ions (2.66 Å) are 
sterically excluded from the pore, whereas ions smaller than K+, such as Na+ (1.9 Å), are 
excluded because they do not interact favorably with the rigid oxygen atoms of the pore wall [5, 
16, 67]. The inability of Na+ to interact with the carbonyl oxygen atoms results in the potential 
energy of the atom being higher in the pore compared to water such that entry of the Na+ atom 
into a K+ channel pore is an event of low probability [5, 16, 67].  
In addition to providing insight into the structure of the selectivity filter, KcsA also 
provided investigators with insight into the gate, as the bundle crossing, at the cytoplasmic ends 
of the inner helices, is proposed to function as the activation gate [67]. However, the structure of 
KirBac1.1 gives a better representation for the location and function of the activation gate as 
discussed below. 
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Figure 9. X-ray structure of KcsA illustrating the selectivity filter. Two of the four 
subunits are shown for clarity. The outer helix (TM1), equivalent to S5 in 6TM K+ channels, 
and the P-helix are shown in blue. The inner helix (TM2), equivalent to S6 and the selectivity 
filter, are shown in green. The residues along the selectivity filter are illustrated in CPK
format. The oxygen atoms are colored red, the carbon atoms are cyan, and the nitrogen atoms
are blue. As illustrated in the figure, the oxygen atoms are aligned toward the lumen of the 
pore forming a rigid filter that surrounds the extracellular entrance to the pore. The specific
diameter of the filter permits favorable interactions with dehydrated K+ ions allowing for 
movement through the pore (PDB 1BL8). 
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1.8.2 Gate: KirBac 1.1 Crystal Structure [118] 
The KirBac1.1 channel belongs to the inward-rectifier family of K+ channels [5]. The channel is 
a homotetramer with four identical subunits, each containing two transmembrane domains (Fig. 
10). The structure is believed to be in the closed state, providing a model for the location of the 
activation gate and the structural elements involved in gating [118]. The closed state of a channel 
is characterized as the inability of ions to move through the ion conduction pathway. The gate is 
proposed to sterically block the movement of ions [5, 16, 83, 119-121]. The structure of 
KirBac1.1 provides evidence that the four hydrophobic side-chains of Phe146, located at the 
cytoplasmic portion of the pore, completely block the ion conduction pathway [118]. Therefore, 
as the channel transitions into the closed conformation it is thought that the side-chains from 
these residues rotate into the center of the ion-conduction pathway to sterically blocking ion flow 
[118]. The fact that hydrophobic residues are used as an activation gate implies that controlling 
the flow of water indirectly regulates ion movement [122, 123]. Therefore, if water is blocked, 
this immobilizes any ions that are in the water filled cavity. This idea was tested using molecular 
dynamics simulations looking at the movement of water in a model channel [124]. Consistent 
with the hypothesis, blocking the flow of water indirectly blocked the movement of ions [125].  
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Figure 10. Crystal structure of KirBac1.1 illustrating the location of the potential activation gate 
Phe146. Two of the four subunits are shown for clarity. The outer helix (TM1), equivalent to S5 in
6TM K+ channels, and the P-helix are shown in blue. The inner helix (TM2), equivalent to S6, and the
selectivity filter are shown in green. Phe146 is represented in CPK format, and the oxygen atoms are 
colored red, the carbon atoms are cyan, and the nitrogen atoms are blue. As illustrated by this figure, 
the side-chain of Phe146 is oriented toward the pore lumen in the closed conformation. This orientation
would suggest that as the channel transitions from the open to the closed conformation, Phe146 rotates 
into the ion conduction pathway blocking ion diffusion (PDB 1P7B).  
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1.8.3 Sensor Domain: MthK X-Ray Structure 
As mentioned previously, controlling the conformation of the gate is critical for the operational 
state of the channel and hence, controlling downstream signaling processes. Although not as 
extensively studied as voltage-gated ion channels, the sensor mechanism in ligand-gated ion 
channels is better understood due to both its inherent simplicity and an x-ray structure of the 
MthK channel. MthK, a bacterial channel from Methanobacterium thermoautotrophicum, is a 
tetrameric two transmembrane channel that is activated by the binding of intracellular Ca2+ to a 
C-terminal ligand-binding domain [114, 115, 126]. The ligand-binding domain in this channel is 
termed a regulator of K+ conductance (RCK) domain. MthK is composed of eight RCK domains, 
one from each of the four pore forming subunits and four from the intracellular solution; possibly 
arising from a separate gene encoding for an RCK domain [126]. A tight and static dimer 
interface connects each channel domain to the corresponding soluble domains. These four dimers 
form a gating ring at the most intracellular portion of the channel. A second flexible interface 
forms between adjacent dimers, and this interface constitutes the Ca2+ binding cleft. In order for 
the channel to open, the gating ring must convert the chemical energy of Ca2+ binding into a 
mechanical force to open the pore [114]. The structure of the gating ring provides a possible 
mechanism to account for Ca2+-dependent activation (Fig. 11). Ca2+-binding reshapes the cleft 
resulting in the flexible interface undergoing a conformational change that causes the rigid units 
at the fixed interface to tilt, thereby expanding the diameter of the gating ring pulling open the 
pore’s inner helices [126]. This conformational change allows the pore to transition from a non-
conducting to a conducting configuration. Even though the crystal structure of MthK provided 
insight into the Ca2+-dependent activation mechanism, very little is understood about how the 
chemical energy of Ca2+ binding is transduced into a mechanical force to gate the channel. 
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Figure 11. Gating mechanism of a Ca 2+-dependent K + channel, MthK. (A) Crystal structure of the 
MthK channel in the open conformation. RCK domains forming a fixed interface are the same color. The 
flexible interface contains the Ca2+ binding cleft, which is located between the main lobes of two adjacent
RCK domains; shown here with Ca2+ ions as yellow spheres. (B) Hypothetical model of MthK in the closed
conformation. (C) Model of the conformational changes associated with gating. A single dimer is shown in
red. The release of Ca2+ results in a large conformational change in the RCK domain, causing the pore to
transition from the open to the closed conformation. [Reprinted with permission from Jiang Y., Nature, vol. 
417, pg. 520. Copyright 2002 by the Nature Publishing Group.] 
 
 
 
 
 
 
 42 
1.8.4 The Coupling Mechanism 
Unlike the previous domains, the location and mechanism of the coupling domain cannot be 
definitively determined from static crystal structures. The coupling mechanism can be a direct 
linker between the sensing domain and the activation gate. However, the mechanism can also be 
indirect, making it difficult to locate a specific region of the protein responsible for this function. 
Several hypotheses have been proposed to explain the coupling mechanism. The first hypothesis 
states that the linker between transmembrane domains functions to couple the movement of the 
sensing domain to the pore [127, 128]. The region of the C-terminus between the cytoplasmic 
end of S6 and the Ca2+-binding domain in BK [129] and the cyclic nucleotide-binding domain in 
CNG channels [130-133] has been implicated as a region that couples the energy of ligand 
binding to channel opening. The second hypothesis states that coupling occurs at the interaction 
surface between transmembrane domains [127, 128]. Thus, the movement of one domain would 
influence the movement of an adjacent domain. The S5-S6 interaction has been implicated as an 
important interaction surface mediating the transition between the closed and open states of the 
channel [127, 134, 135]. 
1.8.4.1 Potential method to assess coupling 
As previously mentioned, our understanding of the structures associated with the coupling 
mechanism are lacking compared to our knowledge of the channel regions associated with the 
pore and the sensing domain. However, recent progress has been made utilizing an experimental 
approach that immobilizes moving parts of the channel to isolate the critical regions involved in 
the coupling mechanism. This technique, introduced by Horn et al., [136] involves using a 
bifunctional cysteine reagent (benzophenone-4-carboxamidocysteine methanethiosulfonate) to 
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covalently bind introduced cysteines. Exposing the reagent to ultraviolet light causes the ketone 
group on the benzophenone to insert into adjacent C-H bonds, as a way to inhibit the relative 
movement between secondary structural regions of the channel. If the relative movement 
between these domains is critical to the function of the channel, then immobilizing these 
structures will have an observable effect on the biophysical properties of the channel. 
Systematically immobilizing different regions of the channel may potentially provide a method 
to map the regions of the channel involved in the coupling mechanism. However, in the words of 
Richard Horn, “The ultimate scientific fantasy in the minds of many channelologists is to have a 
detailed motion picture (in Technicolor, of course!) of channels exposed to their favorite stimuli 
and opening and closing in response to them [127].” 
1.8.5 Potential Gating Mechanism 
Solving the crystal structure of K+ channels has provided structural and mechanistic insight not 
possible using methods based in electrophysiology and molecular biology. Nevertheless, one of 
the main questions in the area of ion channel biophysics remains understanding how the channel 
transitions from the closed to the open conformation. Since crystal structures are static 
representations of inherently dynamic molecules, the mechanism of conformational change is 
incompletely understood. Solving channel structures in different conformations has allowed for 
the development of hypotheses to further understand the gating mechanism. Comparing KcsA 
(“closed state”) and MthK (“open state”) has allowed for the question of conformational change 
to be addressed. These structures together provided valuable insight into the conformational 
changes that accompany channel gating. Comparing the pore structure of KcsA to that of MthK 
shows that there are large structural differences along the inner helices. In KcsA the inner helix 
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is straight, whereas in MthK the inner helices are bent and splayed open. Further examination of 
the MthK inner helix reveals that the bend occurs at a hinge point located at the level of a glycine 
residue, located just below the selectivity filter. Glycine, because of its small side-chain permits 
freedom of rotation about the φ and ψ dihedral angles, which enables backbone conformations to 
be adopted that are not sterically tolerated by other amino acids [2]. Therefore, glycines confer 
flexibility to protein structure and make an ideal candidate for a hinge point or gating hinge. The 
location and function of the glycine residue explains the different conformations apparent 
between the inner helices of KcsA and MthK. Therefore, a possible mechanism to explain the 
conformational change occurring as the channel transitions from the closed to the open 
conformation would involve the ligand-binding domains exerting an outward lateral force on the 
C-terminal portion of the inner helices [114]. This force creates a torque at the gating hinge 
causing the inner helices to go from a straight conformation to a splayed open conformation, 
which is predicted to represent the open conformation of the pore [126]. This model represents 
one of a number of gating hypotheses to explain the conformational changes in the pore as the 
channel transitions from the closed to the open conformation. For instance, the conserved glycine 
in Kv channels is not predicted to function as a gating hinge. Rather, a PVP motif located in the 
C-terminal portion of the transmembrane domain is predicted to function in a similar capacity 
[137]. Thus, even within the family of K+ channels multiple mechanisms might exist to transfer 
the activation energy from the sensor domain to the activation gate.   
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1.9 THE INTERMEDIATE CONDUCTANCE CALCIUM ACTIVATED 
POTASSIUM CHANNEL – KCa3.1 
The intermediate conductance Ca2+-activated K+ channel (KCa3.1) is a Ca2+ dependent K+ 
channel, which shares 40% homology with the small conductance family of K+ channels 
(KCa2.1, KCa2.2, and KCa2.3). KCa3.1, originally cloned in 1997 from human pancreas [138] 
and placenta [139], is a tetramer composed of four identical subunits, each having six 
transmembrane domains (S1-S6) with the pore composed of S5, the P-helix, and S6. 
Macroscopic and single channel recordings display inward rectification in symmetric K+ with a 
chord conductance of 39 pS in the inward direction and 10 pS in the outward direction [138, 
139]. KCa3.1 currents are reversibly blocked by charybdotoxin (CTX) (Ki = 2.5 nM) and 
clotrimazole (CLT) (Ki = 24.8 nM) [138], and activated by DC-EBIO (K0.5 = 84 uM) [140, 141].  
1.9.1 KCa3.1 in Physiology 
KCa3.1 is expressed in the cells of non-excitable tissues, such as cells of the hematopoetic 
system where it is utilized to mediate volume regulation in lymphocytes and erythrocytes [138, 
139, 142-144]. Furthermore, KCa3.1 is expressed in low levels in resting T lymphocytes, but is 
up regulated during activation by mitogens [145]. Activation of this channel causes 
hyperpolarization of the membrane potential, which functions to maintain the intracellular Ca2+ 
concentration required for mitogen activation [146, 147]. KCa3.1 is also expressed in organs 
involved in salt and fluid transport including the colon, lung, placenta, and salivary glands [138, 
139, 142-144, 148]. In the colon, KCa3.1 is important in Ca2+-mediated transepithelial Cl- 
secretion. That is, Ca2+-mediated Cl- secretion is dependent upon the opening of a CTX-sensitive, 
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Ca2+-activated basolateral membrane K+ conductance in the absence of any change in apical 
membrane Cl- conductance [149]. Therefore, activation of a K+ conductance hyperpolarizes the 
apical and basolateral membrane potentials, increasing the electrochemical driving force for Cl- 
exit through constitutively active apical membrane Cl- channels [150-154]. Examination of the 
single channel properties of these KCa channels from T84 cells indicates they are of intermediate 
conductance, and display all of the biophysical and pharmacological properties of the cloned 
KCa3.1 channel [155]. Finally, these channels are also expressed in endothelial cells, reflecting 
their role in the regulation of smooth muscle vascular tone [156, 157]. 
1.9.2 Regulation of Vascular Tone through Activation of the EDHF Response 
Regulating smooth muscle tone in arterioles is an important mechanism for adjusting the 
perfusion pressure of a particular tissue or capillary bed [6]. Smooth muscle tone can be 
regulated systemically or through local factors such as mechanical stimuli, and the release of 
chemical and humoral factors [158]. The endothelium is an important source of local chemical 
factors released in response to the binding of substances in the blood that activate specific 
receptors in the endothelium [159-164].  
The endothelium is a simple squamous epithelial layer that covers the luminal surface of 
all blood vessels, and helps to regulate the balance between vasoconstriction and vasorelaxation. 
The inability of the endothelium to adapt to changes in blood flow is referred to as endothelial 
dysfunction and is often associated with many cardiovascular diseases such as hypertension, 
atherosclerosis and heart failure [159, 165-167]. The endothelial dependent regulation of 
vascular tone is generally attributed to the release of nitric oxide and prostacyclin through the 
activation of nitric oxide synthase and cyclooxygenase pathways, respectively. These pathways 
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function to produce relaxation in vascular smooth muscle cells (VSMCs) by causing VSMCs 
hyperpolarization and subsequent relaxation [160, 161, 164, 168, 169]. However, several studies 
have presented evidence for the existence of a third pathway that is independent of both 
cyclooxygenase and NO synthase and is also associated with the hyperpolarization of VSMCs 
[162, 169-172]. This third pathway is mediated through the release of a diffusible substance or 
the spread of an electrical signal that is generated by the endothelium, resulting in 
hyperpolarization of the adjacent VSMCs and subsequent relaxation [162, 169]. Therefore, this 
pathway is referred to as the endothelial derived hyperpolarizing factor (EDHF).  
The EDHF pathway is most prominent in resistance-sized arteries [160, 161, 164, 173]. 
Therefore, the contribution of this pathway to the regulation of vascular tone increases as vessel 
size decreases. EDHF is activated through agonist stimulating G protein-coupled receptors as 
well the calcium ionophore A 23187, thapsigargin, and cyclopiazonic acid [169]. These 
compounds function to increase endothelial [Ca2+]i resulting in hyperpolarization of the 
endothelial cells, and in some blood vessels eliciting endothelium dependent hyperpolarization of 
VSMCs. EDHF is also characterized as being insensitive to block by specific blockers of BK 
channels, but being sensitive to the block of KCa3.1 and KCa2.3 channels [174]. Furthermore, 
the addition of DC-EBIO, which activates both KCa3.1 and KCa2.3, causes endothelial cell 
hyperpolarization and subsequent hyperpolarization of VSMCs [165, 166]. KCa3.1 and KCa2.3 
are expressed in the endothelium of freshly isolated arteries but are not found in the associated 
VSMCs [175-178]. The addition of substance-P and bradykinin, both of which initiate the EDHF 
mediated response in the porcine coronary arteries, activate an outward current sensitive to the 
block of either KCa3.1 or KCa2.3 [179, 180]. Therefore, these results suggest that KCa3.1 and 
KCa2.3 are associated with the activation of the EDHF pathway.  
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Although the factors associated with this pathway are still unresolved, it is thought that 
an agonist induced increase in [Ca2+]i activates KCa3.1 and KCa2.3 and the activation of these 
channels results in endothelial hyperpolarization, and the initiation of the EDHF response [172]. 
Although, activation of KCa3.1 and KCa2.2 are required for initiation of the EDHF response, the 
mechanism for the spread of hyperpolarization from the endothelial cells to the VSMCs is still 
unknown. However, two possible mechanisms have been proposed. The first mechanism, states 
that endothelial hyperpolarization spreads directly to the VSMCs through gap junctions [171]. 
Gap junctions link VSMCs with other VSMCs and endothelial cells with other endothelial cells, 
and as indicated below, endothelial cells with smooth muscle cells. The gap junction proteins, Cx 
37, 40, and 43, are the predominant forms expressed in the vascular wall, and in the rodent Cx 37 
and Cx 40 are involved in myoendothelial gap-junction communication [181-183]. In rat 
mesenteric arteries, antibodies directed against Cx 40 block the EDHF-mediated response when 
loaded in endothelial cells [182]. In the second mechanism, activation of KCa3.1 and KCa2.3 
results in the accumulation of K+ ions in the intracellular cleft [171]. The increase in [K+] ion 
hyperpolarizes the VSMCs by activating either the inward rectifying K+ channels or the Na+/K+ 
pump expressed in these cells [184, 185]. The hyperpolarization caused by an increase in 
extracellular K+ is counterintuitive because the Nerst equation would predict depolarization and 
subsequent contraction [171]. However, the activation of inward rectifying K+ channels and the 
Na+/K+ pump would offset any depolarization resulting from an increase in extracellular K+ ions 
[186]. Whether the hyperpolarization spreads through gap junctions or is the result of activating 
Kir and Na+/K+ pump the net result of each of these pathways is smooth muscle 
hyperpolarization causing the voltage-dependent Ca2+ channel in the VSMCs to close, decreasing 
intracellular [Ca2+]i and subsequent smooth muscle relaxation. 
 49 
1.9.3 Contribution of KCa3.1 to the EDHF Response 
Although KCa3.1 and KCa2.3 have been implicated as being important for the initiation of the 
EDHF pathway, their precise contribution to this pathway is unknown. The role of these 
channels toward the initiation of this pathway has been proposed mainly on the basis of isolated 
vessels and pharmacological methods to illustrate that these channels are associated with this 
response [165]. Several investigations have reported the contribution of a single channel to blood 
pressure regulation mediated through the EDHF signaling mechanism. For instance, it has been 
reported that KCa3.1 deficient mice (IK1-/-) exhibited a partial defect in EDHF signaling and 
moderately elevated blood pressure [166].  
Genetic manipulation of KCa2.3 has also been shown to alter blood pressure [167]. 
However, unlike the mice deficient in KCa3.1, the levels of KCa2.3 are manipulated by site-
specific insertion of a tetracycline-based genetic switch (KCa2.3T/T) [187]. Thus, dietary 
doxycycline treatments decrease KCa2.3 expression, whereas in untreated mice the channel is 
over expressed 3-fold. Although these investigations provided valuable insight into the EDHF 
signaling mechanism, it is unknown whether the phenotype observed in the KCa3.1-/- or 
KCa2.3T/T mice was due to modulating the EDHF signaling mechanism. A recent study 
investigated the contribution of both KCa3.1 and KCa2.3 to the acetylcholine-induced EDHF-
mediated smooth muscle hyperpolarization by generating mice deficient for both channels 
(KCa3.1-/- and KCa2.3T/T) [165]. This approach also enabled the rescuing effects of KCa2.3 over 
expression and pharmacological manipulation of KCa3.1 to be examined on mice lacking the 
other channel. This study illustrates that, as expected, both channels contribute equally to the 
generation of endothelial KCa currents. However, KCa3.1 is more important to the acetylcholine-
induced EDHF-mediated smooth muscle hyperpolarization. The absence of KCa3.1 impairs 
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smooth muscle hyperpolarization more than the loss of KCa2.3 alone. Over expression of 
KCa2.3 in KCa3.1-/-/KCa2.3T/T mice restored the acetylcholine induced smooth muscle 
hyperpolarization to near WT-levels. However, potentiation of KCa3.1, by the channel activator 
SKA-31, strongly enhanced hyperpolarization in KCa3.1 expressing and KCa2.3 deficient mice 
to above WT-levels. Therefore, converging lines of evidence suggest that KCa3.1 makes a larger 
contribution to the acetylcholine induced smooth muscle hyperpolarization. The different roles 
for KCa3.1 and KCa2.3 in the EDHF signaling mechanism also became apparent when 
examining the EDHF dilator response. The loss of KCa3.1 alone resulted in a large effect at 
intermediate acetylcholine concentrations, which is in direct contrast to the suppression of 
KCa2.3 alone, which had no effect. Furthermore, over expression of KCa2.3 in KCa3.1 deficient 
mice enhanced dilation but not to WT-levels. As expected, potentiation of KCa3.1 in KCa2.3 
deficient mice enhanced the EDHF response, suggesting that KCa2.3 is only important for the 
EDHF dilator response in the absence of KCa3.1. Therefore, this study illustrates that KCa3.1 
plays a key role in mediating acetylcholine-induced smooth muscle hyperpolarization and the 
EDHF dilation in response to acetylcholine.  
1.9.4 Structure of KCa3.1 
Activation of the EDHF pathway and subsequent regulation of vascular tone is dependent upon 
the ability of KCa3.1 to sense and respond to changes in intracellular Ca2+ concentration. This 
mechanism is mediated through calmodulin (CaM), which, as explained below, allows the 
channel to function as an intracellular Ca2+-sensor, enabling channel activity to correspond to 
changes in intracellular Ca2+ concentration. KCa3.1 contains positively charged residues along 
S4, similar to the Kv channels, but the channel is entirely voltage independent and gated solely 
 51 
by the binding of intracellular Ca2+. Channel activation is mediated through a Ca2+-dependent 
gating mechanism, which is dependent upon the co-assembly of channel α-subunit with CaM. 
KCa3.1 functions as a heteromeric complex with CaM, a Ca2+-binding protein, that is 
constitutively bound to the channel’s calmodulin-binding domain (CaMBD) located in the C-
terminus, just distal to S6 [138, 188, 189]. Additionally, CaM has been shown to constitutively 
bind to the channel even in the absence of Ca2+, an important point to keep in mind for the 
discussion below [188, 190, 191]. Upon binding of Ca2+ to CaM, the CaM/CaMBD undergoes a 
conformational change, which is coupled to the pore, enabling the channel to transition from a 
non-conducting to a conducting configuration [189, 192, 193]. This association allows CaM to 
behave as an intracellular Ca2+-sensor, coupling changes in intracellular Ca2+ concentration 
[Ca2+]i to the regulation of channel activity. 
1.9.5 Ca2+-dependent Regulation of KCa3.1 
CaM, is expressed in all eukaryotic cells, and mediates many Ca2+-dependent signaling 
processes. Structurally, CaM contains N- and C-terminal globular domains, each possessing two 
high affinity Ca2+ binding E-F hand motifs; E-F 1 and 2 in the N-terminus and E-F 3 and 4 in the 
C-terminus [194]. The interaction between CaM and the channel α-subunit has been extensively 
studied in KCa2.2 [188-193, 195, 196]. Since there is a high degree of homology in the 
CaM/CaMBD between KCa3.1 and KCa2.2, the mechanism proposed for the interaction 
between CaM/CaMBD and KCa2.2 is also expected to apply for KCa3.1. The original 
investigation proposed a modular design for the interaction between CaM and KCa2.2. Keen et 
al., [188] proposed that the N-terminal E-F hands are responsible for the Ca2+-dependent 
interactions, whereas the C-terminal E-F hands dictate the Ca2+-independent interactions. This 
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hypothesis was investigated through amino acid substitutions that systematically reduce or 
eliminate Ca2+ binding to E-F hands 1-4. The results from their investigation indicated that E-F 
hands 3 and 4 do not affect Ca2+-dependent gating, but mutations to E-F hands 1 or 2 result in 
shifts in apparent Ca2+ affinity, suggesting that E-F hands 1 and 2 are necessary and sufficient for 
Ca2+ gating. However, a more recent investigation calls into question the modular design 
hypothesis [190]. Rather than suggesting that a single functional E-F hand 1 or 2 is sufficient to 
gate the channel, albeit with a lower apparent Ca2+ affinity, this investigation illustrates that 
when one N-lobe E-F hand loses its Ca2+ binding capacity, CaM can no longer associate with the 
channel [190]. Therefore, the modular design hypothesis needs to be revised to express that the 
E-F hands in the N-lobe, in addition to their role in Ca2+-dependent interactions, are also 
involved in the Ca2+-independent interaction between CaM and the channel α-subunit. 
1.9.6 Chemomechanical Gating Model 
A chemomechanical gating model has been proposed to describe the gating of the closely related 
channel KCa2.2 [192, 193]. This model is based on the premise that the CaMBD of KCa2.2 is 
associated with the C-terminal region of S6 through the C-terminal linker, so that the 
conformational changes occurring in the CaM/CaMBD are directly transmitted to the pore to 
elicit gating. Furthermore, since Ca2+ binding to CaM/CaMBD drives channel opening, there 
must be a large conformational change in the CaMBD to elicit opening of the activation gate. 
Crystal structures of the KCa2.2 apoCaM/CaMBD and Ca2+/CaM/CaMBD were solved and 
utilized to develop a mechanism to explain Ca2+-dependent activation subsequent to Ca2+ binding 
[192, 193]. Comparison of the apoCaM/CaMBD structure to the Ca/CaM/CaMBD structure 
allows a mechanism to be proposed in which Ca2+ binding to each CaM N-lobe would expose a 
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hydrophobic patch, thereby allowing the N-lobe to interact with an adjacent CaMBD monomer. 
As each N-lobe grabs the C-terminal region of the corresponding CaMBD, the events associated 
with this reorientation cause a >90 degree rotation in CaM/CaMBD. Since the CaMBD is 
directly attached to the C-terminal portion of S6, the large conformational change is directly 
transmitted to S6 through a yet unknown mechanism, enabling the pore to transition from a non-
conducting to a conducting configuration. Therefore, in this model two CaMBD dimers serve as 
levers to drive opening of the pore. 
1.9.7 The Current State of KCa3.1 
Although little is understood regarding the coupling mechanism in KCa3.1, the C-terminal 
portion of S6 is thought to transform the activation energy from the CaM/CaMBD into a 
mechanical force to alter the conformational state of the pore. The first investigation examining 
the pore architecture of KCa3.1 used SCAM to identify two regions (Val275-Val282 and Ala283-
Ala286) along S6 that display functional differences to [2-(trimethylammonium)ethyl] 
methanethiosulfonate bromide (MTSET) binding [113]. The addition of MTSET caused 
inhibition at positions Val275, Thr278, and Val282, and activation at positions Ala283 and Ala286. 
Understanding the structural differences between these regions is key for understanding how S6 
contributes to the activation process. Within the Val275-Val282 region, only residues Val275, 
Thr278, and Val282 were accessible to MTSET, implying these residues line the lumen of the pore. 
This was later confirmed when it was observed with single channel recordings that MTSET 
causes inhibition by reducing channel conductance [113]. A homology model of the closed state 
of KCa3.1 based on the x-ray structure of KcsA predicted that Cys276, Cys277, and Leu281 are 
oriented away from the pore. The non-luminal orientation of these residues would explain why 
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they are protected from MTSET modification. Ala279 is predicted to face the lumen, but this 
orientation is not supported by the SCAM experiments. The L280C mutation results in a non-
functional channel, therefore the contribution of Leu280 to the structure of S6 could not be 
assessed. Modification of Val275, Thr278, and Val282 is dependent on the open state, indicating the 
closed state blocks MTSET from accessing these positions. The 283-286 region is very 
distinctive because all residues are accessible to MTSET in the open configuration, suggesting 
this region is not embedded in the membrane [113]. MTSET-dependent activation is state-
independent for A283 and A286 suggesting that in the closed state these residues are still 
accessible to hydrophilic reagents. However, in the closed conformation V284 and V285 showed 
a reduced MTSET accessibility, suggesting the 283-286 region undergoes important structural 
changes during gating. In total, the results from the scan of S6 indicates that 275-282 possess 
features that correspond to the inner cavity region of KcsA and 283-286 actively participate in 
coupling the conformational changes in CaM/CaMBD to opening of the pore.  
The location of the gate, in the closed conformation of KCa3.1, cannot be accounted for 
by the bundle crossing formed by the C-terminal ends of S6 [111], as represented by KcsA [67]. 
Comparison of the modifications rates of MTSEA (diameter 4.6 Å) for a residue located in the 
central cavity (275C) to a residue located at the C-terminal end of S6 (286C) for the closed 
configuration were found to differ by less than 7-fold, whereas experiments performed with the 
larger MTSET reagent (diameter 5.8 Å) resulted in a modification rate 103-104 faster for the 
cysteine located in the C-terminal end compared to the cysteine in the central cavity [111]. In 
addition, modification rates for 275C using Et-Hg+, which is smaller than MTSET with 
dimensions corresponding to a sphere with a diameter of 4.1 Å, and Ag+ (2.55 Å) were shown to 
be state independent. Finally, modification rates for MTSET were 103 times faster for the open 
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compared to the closed state [111]. These results would argue that the closed KCa3.1 structure 
cannot have a restrictive barrier at the C-terminal end of S6, rather it would suggest that the 
closed structure is better represented by a narrow passage way centered at V282, which connects 
the inner cavity to the cystolic medium. As illustrated by the modification rates, this passage 
would not be restrictive to the diffusion of small reagents similar in size to the K+ ion, suggesting 
that the C-terminal end of S6 does not form an obstructive barrier for the diffusion of K+ ions in 
the closed configuration. These results are similar to investigations localizing the activation gate 
in KCa2.2 at or near to the selectivity filter [197, 198], suggesting that the C-terminal end of S6 
cannot function as the activation gate. Therefore, these results would suggest that S6 acts as a 
transducer conveying the structural changes occurring in the C-terminal section of the helix to 
the selectivity filter, enabling the pore to transition from a non-conducting to a conducting 
configuration. 
1.10 STATEMENT OF THE PROBLEM 
These investigations provided insight into the architecture of S6, and specifically how the 
luminal residues participate in the activation mechanism. However, we still do not fully 
understand how ligand binding is coupled to opening of the pore. Furthermore, with the 
exception of the luminal residues on the C-terminal portion of S6, we do not know if additional 
sites function to allosterically couple the conformational changes in CaM/CaMBD to the 
activation gate. Therefore, to obtain a better understanding of the coupling mechanism, it is 
important to isolate regions of the channel that are involved in this process. KCa3.1 has four 
endogenous cysteines residues along S6, and of those four residues, Cys269, Cys276, and Cys277 
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are predicted to have a non-luminal orientation [113]. The addition of parachloromercuribenze 
sulfonate (PCMBS) to the intracellular side of an excised membrane patch expressing KCa3.1 
increases steady-state current. This compound was shown to modify the behavior of the Shaker 
K+ channel by modifying cysteine(s) not accessible using MTS reagents [199-201]. The 
increased sensitivity for partially buried cysteines was explained by the unique geometry and 
chemistry of this compound [200]. Therefore, we hypothesized that the increase in KCa3.1 
steady-state current with PCMBS is due to modification of an endogenous cysteine(s) in S6. 
Since these residues are predicted to have a non-luminal orientation, we characterized the 
functional effect of PCMBS on KCa3.1 to assess the role of these residues in the activation 
mechanism.  
1.10.1 Goals of this Dissertation 
The goal of this dissertation was to characterize the role of S6 in the activation mechanism of 
KCa3.1. S6 was investigated by characterizing the effect of PCMBS and tryptophan substitutions 
on the gating of KCa3.1. Specifically, I tested the hypothesis that the non-luminal residues along 
the C-terminal portion of S6 participate in the activation mechanism. Based on this hypothesis 
the following questions were addressed: 1) How does PCMBS activate the WT-channel? 2) 
Which cysteine is responsible for conferring PCMBS-sensitivity? 3) What is the potential 
molecular mechanism for the function of PCMBS?  
Presently, there are no methods to directly assess the conformational changes associated 
with channel gating. However, characterizing the mechanism underlying the functional effect of 
PCMBS will give insight into the regions associated with the activation mechanism. 
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Furthermore, understanding how PCMBS disrupts gating will indirectly provide a mechanism for 
the conformational changes associated with the activation mechanism of KCa3.1. 
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2.0  CHARACTERIZATION OF THE PCMBS-DEPENDENT MODIFICATION OF 
KCa3.1 CHANNEL GATING 
© Mark A. Bailey, Michael Grabe, Daniel C. Devor 2010. Originally published in the Journal of 
General Physiology VOL: 136: 367-387. The Rockerfeller University Press. 
2.1 ABSTRACT 
Intermediate conductance, calcium-activated potassium channels (KCa3.1) are gated by the 
binding of intracellular Ca2+ to calmodulin (CaM), a Ca2+ binding protein that is constitutively 
associated with the C-terminus of the channel. Although previous studies indicated that the pore-
lining residues along the C-terminal portion of S6 contribute to the activation mechanism, little is 
known about whether the non-luminal face of S6 contributes to this process. Here we 
demonstrate that the sulfhydral reagent, parachloromercuribenze sulfonate (PCMBS), modifies 
an endogenous cysteine residue predicted to have a non-luminal orientation (Cys276) along the 
sixth transmembrane segment (S6). Modification of Cys276 manipulates the steady-state and 
kinetic behavior of the channel by shifting the gating equilibrium toward the open state, resulting 
in a left-shift in apparent Ca2+-affinity and a slowing in the deactivation process. Utilizing a 6-
state gating scheme, our analysis shows that PCMBS slows the transition between the open state 
back to the third closed state. Interpreting this result in the context of the steady-state and kinetic 
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data suggests that PCMBS functions to shift the gating equilibrium toward the open state by 
disrupting channel closing. In an attempt to understand whether the non-luminal face of S6 
participates in the activation mechanism, we conducted a partial tryptophan scan of this region. 
Substituting a tryptophan for Leu281 recapitulated the affect on the steady-state and kinetic 
behavior observed with PCMBS. Considering the predicted non-luminal orientation of Cys276 
and Leu281, a simple physical interpretation of these results is that the non-luminal face of S6 
forms a critical interaction surface mediating the transition into the closed conformation, 
suggesting the non-luminal C-terminal portion of S6 is allosterically coupled to the activation 
gate.  
2.2 INTRODUCTION 
Proteins are inherently dynamic structures. Regulating the transition between conformational 
states is critical for proper function and, on a larger scale, maintaining control of a multitude of 
physiological processes. Ion channels are one class of protein that exemplifies this connection 
between structure and function, since switching between open and closed states controls a whole 
host of physiological responses. In this study, we probe the nature of these transitions and how 
they are controlled by external factors in the Ca2+-activated potassium channel, KCa3.1 [138, 
139]. KCa3.1 is composed of four subunits, each having six transmembrane domains (S1-S6) 
with a pore domain located between S5 and S6. Channel activation is mediated through a Ca2+-
dependent gating mechanism, which is dependent upon the co-assembly of channel α-subunit 
with calmodulin (CaM)[189]. CaM, a Ca2+-binding protein, is constitutively bound to the 
channel’s calmodulin-binding domain (CaMBD) located in the C-terminus, just distal to S6. 
 60 
Upon binding of Ca2+ to CaM, the CaM/CaMBD undergoes a conformational change, which is 
coupled to the pore, enabling the channel to transition from a non-conducting to a conducting 
configuration [188, 190]. This association allows CaM to behave as an intracellular Ca2+-sensor, 
coupling changes in intracellular Ca2+ concentration to the regulation of channel activity. The 
unique association with CaM allows this channel to regulate the molecular signaling mechanisms 
underlying the control of vascular tone [172]. In vascular endothelium, cell stimulation initiates 
an increase in intracellular Ca2+ (Ca2+i). Increasing Ca2+i activates KCa3.1, resulting in 
endothelial cell hyperpolarization, a requirement for the initiation of the endothelial derived 
hyperpolarizing factor (EDHF) response [202]. The activation of this EDHF pathway ultimately 
results in the hyperpolarization of adjacent vascular smooth muscle cells (VSMCs), which 
enables subsequent arteriolar dilation and decrease in vascular tone [168, 169].  
Activation of the EDHF pathway and subsequent regulation of vascular tone is dependent 
upon tight regulation of KCa3.1 channel activity. Although little is understood regarding the 
coupling mechanism in these channels, the C-terminal portion of S6 is thought to transform the 
activation energy from the CaM/CaMBD into a mechanical force to alter the conformational 
state of the pore [110, 111, 113, 192, 193]. The first investigation examining the pore 
architecture of KCa3.1 used the substituted cysteine accessibility method (SCAM) to identify a 
region within S6 that is expected to contribute to the lumen (V275-V282) and a second region 
expected to participate in the activation mechanism (A283-A286) [113]. Additionally, it has been 
suggested that in the closed conformation, the cytoplasmic ends of S6 do not function as a barrier 
to the movement of K+ ions [111] as it does in KcsA [67]. Rather, the activation gate is 
suggested to be located at or near the selectivity filter, with the C-terminal portion of S6 (V282-
A286) participating in the activation mechanism [110, 111, 113]. However, in contrast to the 
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previous investigations, which determined the role of cysteines engineered along the luminal 
face of S6, we observe that the non-luminal face of S6 also participates in the activation 
mechanism. Cys276 and Leu281 are predicted to have a non-luminal orientation, and our results 
suggest that perturbations at these positions, using either parachloromercuribenze sulfonate 
(PCMBS) (Cys276) or tryptophan substitution (Trp281), shifts the gating equilibrium toward the 
open conformation. Activation and deactivation kinetics, as measured by Ca2+-jump 
experiments, are markedly slowed, suggesting that perturbing these positions disrupts a transition 
that is allosterically coupled to the activation gate. Therefore, our results indicate the transition of 
KCa3.1 to the closed conformation is dependent on the interaction surface formed by the non-
luminal face of S6, specifically the C-terminal portion of the helix. Results from our kinetic 
analysis indicate that PCMBS and L281W disrupt channel behavior through a common 
mechanism by manipulating the transition from the open state back to the third and final closed 
state. Our results, together with previous investigations, lead us conclude that the luminal and 
non-luminal faces of the C-terminal portion of S6 actively function to couple the conformational 
changes in the CaM/CaMBD to the pore, thus permitting the channel to transition from a non-
conducting to a conducting conformation.  
2.3 MATERIALS AND METHODS 
Molecular Biology. KCa3.1 (hIK1) cDNA was kindly provided by J.P. Adelman (Vollum 
Institute, Oregon Health Sciences University). The cDNA was subcloned into pcDNA3.1(+) 
(Invitrogen, Carlsbad, CA) using the EcoRI and XhoI restriction sites. All mutations were 
generated using the Stratagene QuikChange™ site-directed mutagenesis strategy (Stratagene, La 
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Jolla, CA). The fidelity of all constructs utilized in this study, were confirmed by sequencing 
(ABI PRISM 377 automated sequencer, University of Pittsburgh) and subsequent sequence 
alignment (NCBI BLAST) using GenBankTM accession number AF022150.  
Cell culture. Human embryonic kidney (HEK293) cells were obtained from the American Type 
Culture Collection (Manassas, VA) and cultured in Dulbecco’s modified Eagle’s medium 
(DMEM; Invitrogen) supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin 
in a humidified 5% CO2/95% O2 incubator at 37 oC. Cells were transfected using 
LipofectAMINE 2000 (Invitrogen) following the manufacturer’s instructions. Stable cell lines 
were generated for all constructs by subjecting cells to antibiotic selection (1mg/ml G418). Note 
that clonal cell lines were not subsequently selected from this stable population in order to avoid 
clonal variation. 
Electrophysiology. The effects of PCMBS on KCa3.1 were assessed with inside-out patch-clamp 
experiments as a functional assay. Currents were recorded using an Axopatch 200B amplifer 
(Axon Instruments, Inc.). During patch-clamp experiments, the bath solution contained 145 mM 
K-gluconate, 5 mM KCl, 1.3 mM MgCl2, 10 mM HEPES, 1 mM EGTA, and 300 μM ATP (pH 
adjusted to 7.2 with KOH). Sufficient CaCl2 was added to obtain the desired free Ca2+ 
concentration (program kindly provided by Dr. Dave Dawson, Oregon Health Sciences 
University) and applied to the intracellular surface of the patch through a rapid solution 
exchanger (RSC-160; Biologic). To obtain a Ca2+-free bath solution EGTA (1 mM) was added 
without CaCl2 (estimated free Ca2+ <10 nM). Electrodes were fabricated from thin-walled 
borosilicate glass (World Precision Instruments, Sarasota, FL), pulled on a vertical puller 
(Narishige, Long Island, NY), fire-polished, and had a resistance of 1-5 MΩ. The pipette 
solution was 140 mM K-gluconate, 5 mM KCl, 1 mM MgCl2, 10 mM HEPES and 1 mM CaCl2 
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(pH adjusted to 7.2 with KOH). All experiments were performed at room temperature. All 
patches were held at a holding potential of –100 mV. The voltage is referenced to the 
extracellular compartment, as is the standard method for membrane potentials. Inward currents 
are defined as the movement of positive charge from the extracellular compartment to the 
intracellular compartment and are presented as downward deflections from the baseline in all 
recordings. Ionic currents were low-pass filtered at 2 kHz by using an AxoPatch 200B amplifier 
and digitized at 5 kHz using a Digidata 1322A interfaced with a PC computer running pCLAMP 
9.2 software (all instruments including software; Axon Instruments). Currents were analyzed 
using Clampfit 9.2 (Axon Instruments) and Biopatch software (version 3.3, Bio-logic).  
Variance analysis. Macroscopic membrane patches were excised into 10 μM Ca2+, after which a 
complete Ca2+-concentration response experiment was performed (see figure for specific details). 
At the end of the Ca2+-concentration response experiment, PCMBS (500 μM) was added to the 
10 μM Ca2+ concentration, and the experiment continued until the current reached a second 
steady-state PCMBS-mediated maximum current level. The total current record, to be used for 
variance analysis, was divided into 250 episodes and mean current <I> and variance (σ2) were 
calculated for each episode using Channelab Software (Synaptosoft Inc., Decatur, GA, USA). 
The increase in channel open probability (Po), mediated through PCMBS, was estimated by 
determining the difference between the Po(max) value in the presence and absence of PCMBS. 
Furthermore, the number of channels (N) in the patch and single channel amplitude (i) are 
obtained by fitting the σ2 against <I> distribution to Equation 1:
 
 
    (1) 
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The Po(max) can then be calculated using Equation 2: 
 
iN
IPo maxmax =     (2) 
 
Where, Imax is the maximum current observed and i and N are the mean values for single channel 
amplitude and number of channels calculated from Equation 1. The product of i and N would 
give the theoretical current at Po = 1, hence, channel Po can be calculated at any given current as 
a proportion of Po(max) [203].  
Ca2+ jump experiments. Macroscopic membrane patches expressing KCa3.1 were excised from 
HEK293 cells and intracellular solution was quickly switched using a rapid solution exchanger 
(RSC-160; Biologic). In order to estimate the kinetics of activation and deactivation, the protocol 
requires that the internal solution be alternated between a Ca2+-free solution for 3 seconds and a 
series of Ca2+-containing solutions (concentrations reported in the results section) for 1.5 seconds 
with a 5 ms interval between switches. Activation and deactivation currents were recorded, 
superimposed, and averaged using Clampfit 9.2 (Axon Instruments) software. Time constants 
describing channel activation and deactivation kinetics were determined by fitting the activation 
and deactivation current records with a standard single exponential function. The deactivation 
kinetics were well described using a single exponential. However, the activation kinetics were 
sigmodial in shape, due to the delay in channel activation, and not well described with a single 
exponential function. This delayed response in channel activation can be explained through two 
factors. The first factor is based upon the volume of solution that must be exchanged between the 
surface of the patch and the tip of the patch pipette. The larger the volume, the longer it takes for 
a complete solution exchange, thus increasing the duration of the delay in channel activation. 
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Because this factor is dictated by the size and positioning of the membrane relative to the tip of 
the pipette, this will vary between patches and for these purposes is considered rate-limiting. The 
second factor contributing to the delay in channel activation is the multiple (2 or more) 
transitions the channel must pass through before entering the open state [204]. Assuming the 
number of conformational transitions along the activation pathway are equal between channels, 
this factor can be considered constant across all experiments. Therefore, these two factors 
summed together manifest as the delay in channel activation. However, we failed to notice a 
correlation between the duration of delay in channel activation verses Ca2+-concentration and 
thus no further effort was made to analyze this component in the context of channel activation 
kinetics. Therefore, when fitting the current record to estimate activation kinetics the delay in 
channel activation was disregarded, which left the remaining portion of the current recording that 
is well described by a single exponential function [205].  
Modeling. The 6-state kinetic model illustrated in Fig. 10 (A) was solved numerically to quantify 
how PCMBS perturbs the gating of KCa3.1 and to understand the overall contribution of S6 to 
the Ca2+-dependent gating mechanism. Forward and reverse rate constants are labeled according 
to the channel state such that kij is the rate of going from state i to state j. Thus, the model has 10 
rate constants k12, k23, k34, k35, and k46 are the forward rate constants and k21, k32, k43, k53, and k64 
are the reverse rate constants. The Ca2+-dependent transitions are represented by the forward rate 
constants k12, k23, and k34, and all other transitions are assumed to be Ca2+-independent. We 
explored two version of the model with regard to the Ca2+-dependence of these rate constants. 
First, we constructed a model in which the rate of Ca2+ binding varied linearly with Ca2+ 
concentration, k=A⋅[Ca], where A is a constant as proposed for KCa2.3 [206]. Second, we 
constructed a model in which the rate of Ca2+ binding varied nonlinearly with Ca2+ 
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concentration, k=A⋅[Ca]/(B+[Ca]), where A and B are constants. The second rate takes the form 
of a Michaelis-Menten equation in which the rate of binding saturates at high Ca2+i as further 
discussed in the results section. We used an 11th independent variable, N, to scale the single 
channel current resulting from the model to match macroscopic experimental currents. Thus, N 
represents the number of active channels in the patch. For a particular set of rate constants, we 
solved the system of equations corresponding to Fig. 10 (A) using a stiff solver routine in Matlab 
(7.6). We then calculated the root mean square difference (RMSD) between the simulated 
channel current and the experimentally recorded trace. Next, we used a Nelder-Mead search 
algorithm to search through parameter space in an attempt to minimize the RMSD [207]. A 
typical search involved solving the model 50,000 times for each Ca2+ concentration. 
Furthermore, the search algorithm was rerun on each data set several times in an attempt to 
thoroughly explore parameter space for the best fit. This entire procedure was carried out for data 
sets recorded in the absence or presence of PCMBS in order to identify the transitions modulated 
by this compound.  
The 6-state scheme was also used to predict the apparent Ca2+ affinity and shift in 
apparent affinity observed with PCMBS. Channel Po was calculated from the model over the 
range of experimentally measured Ca2+ concentrations, and the corresponding EC50 was 
extracted from the resulting curve. We determined channel Po at each Ca2+i concentration by 
running the model to steady state and dividing the probability of being in the open state (states 5 
and 6) by the total probability (sum of states 1 through 6). 
Sensitivity analysis. To determine which parameters were most critical for fitting the data, we 
varied each rate constant by ±10%, reran the model, and calculated the percent change in the 
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error. This analysis was only carried out on the final set of parameter values that produced the 
best fit for any given condition. 
Structural modeling. We constructed a homology model of the pore domain of KCa3.1 with 
Modeller 9v7 [208] using Kv1.2 (PBD ID 2A79) and KcsA (PDB ID 1BL8) as a template 
structure.  
Hill equation. Ca2+ concentration response experiments were plotted as normalized current 
(I/Imax) against the corresponding Ca2+ concentration p[Ca2+],M and were fit with the following 
version of the Hill equation: I=Imin+(Imax-Imin)/(1+10((LogEC50-X)*HillSlope)). Fitting was performed 
using Prizm (GraphPad Software, Inc.). 
Chemicals. All chemicals were obtained from Sigma-Aldrich (St. Louis, MO), unless otherwise 
stated. Adenosine-5’-triphosphate obtained from Roche Diagnostics and parachloromercuribenze 
sulfonate (PCMBS) purchased from Toronto Research Chemicals Inc., (ON, Canada) were 
freshly made on the day of the experiment and added directly to the bath solution prior to the 
experiment.  
Online Supplemental Material. The results from the sensitivity analysis are included as an 
individual table for each data set. 
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2.4 RESULTS 
2.4.1 PCMBS can be used as a Probe to Modulate KCa3.1 Gating 
It was previously demonstrated that MTSET only transiently inhibits WT-KCa3.1 steady-state 
behavior [113]. Therefore, we wanted to determine whether PCMBS could alter steady-state 
current in excised membrane patches expressing KCa3.1. As shown in Fig. 12 (A-C), addition of 
PCMBS (500 μM) to the membrane patch increased channel activity at 0.3 μM (A), 0.6 μM (B), 
and 10 μM (defined as saturating) Ca2+i concentrations. Furthermore, the effect of PCMBS could 
not be reversed upon washout, suggesting a covalent interaction between channel cysteine(s) and 
the sulfhydryl-reactive compound. To address whether PCMBS could activate KCa3.1 in the 
absence of Ca2+i, experiments were performed in which PCMBS (500 μM) was added following 
the addition of a Ca2+ free bath solution. As shown in Fig. 12 (D), PCMBS is unable to activate 
KCa3.1 in the absence of Ca2+i, demonstrating that the compound potentiates channel current 
rather than directly activating the channel. Only after the addition of Ca2+i can PCMBS increase 
steady-state current, suggesting the closed conformation prevents PCMBS from accessing the 
endogenous cysteine residue(s). Our results illustrate that PCMBS can covalently bind to 
endogenous cysteine residue(s), and these residue(s) must reside within a gating sensitive region 
of the channel.    
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Figure 12. PCMBS increases KCa3.1 steady-state current. Macroscopic current records from KCa3.1 channels 
heterologously expressed in HEK cells to determine sensitivity to PCMBS. PCMBS (500 μM) was added to inside-
out patches excised in 0.3 (A), 0.6 (B), and 10 μM (C) Ca2+i following the establishment of steady-state current 
level. PCMBS washout lasted at least 1 minute to ensure channel activation was due to covalent binding, rather than 
an indirect interaction between channel and compound. (D) KCa3.1 current record demonstrating that PCMBS 
cannot activate the channel in the absence of Ca2+i. PCMBS can only increase current when the channel is in the 
open state. The patch was initially excised in 10 μM Ca2+i, followed by the addition of a Ca2+i-free solution, than a 
Ca2+i-free solution+PCMBS (500 μM) was added to the bath solution. PCMBS+Ca2+i-free solution was washed out 
with 10 μM Ca2+i to reactivate the channel. After reaching a steady-state current level, PCMBS (500 μM) was 
reapplied to the patch resulting in channel activation.  
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2.4.2 Characterization of Potentiation by PCMBS 
To gain insight into the mechanism by which PCMBS activates KCa3.1, we determined whether 
PCMBS increases steady-state current through an increase in N, Po, or i using variance analysis, 
as described in the materials and methods section. Fig. 13 (A) depicts a representative current 
record in which a series of Ca2+i concentrations were applied to the intracellular face of an 
inside-out patch expressing KCa3.1 channels, and following establishment of steady-state current 
in 10 μM Ca2+i, PCMBS (500 μM) was added to the bath. This current record was utilized to 
calculate σ2 both in the absence (portion of the record excluding PCMBS) and presence (entire 
record) of PCMBS. Plotting σ2 against <I> and fitting this relationship with Eq. 1 gave estimates 
of N, Po, and i (Fig. 13 B-C). Analysis of these data indicate that potentiation results from a 50% 
increase in Po(max) (from 0.61 to 0.91 in PCMBS) rather than changes to N (1071 versus 1078 in 
PCMBS) or i (3.5 pA versus 3.4 pA in PCMBS). Analysis of multiple experiments (n=12) 
revealed that PCMBS increases Po(max) from 0.65±0.03 to 0.93±0.02 without an increase in N or i 
(3.3±0.03 pA versus 3.3±0.03 pA in PCMBS). Given the variability of N across patches, its 
average was not calculated. These data suggest that PCMBS acts through a Ca2+-independent 
pathway to increase steady-state current through an increase in Po(max).  
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 Figure 13. P CMBS increases steady-state P o(max). Variance analysis of KCa3.1 channel current was utilized to 
estimate Po(max), N, and i in the absence and presence of PCMBS. (A) Representative Ca2+ concentration response 
experiment recorded from inside-out macropatches expressing KCa3.1 channels. Patches were initially excised in 10 
μM Ca2+i, followed by a series of Ca2+i concentrations (0, 0.1, 0.15, 0.2, 0.25, 0.3, 0.6, 1.0, and 10 μM) applied for 
10 s intervals using a fast solution exchanger. After establishing steady-state current in 10 μM Ca2+i PCMBS (500 
μM) was added to the bath solution until reaching a second, steady-state, current level. (B) Variance analysis to 
determine Po(max), N, and i in the absence of PCMBS. Plot of variance (σ2), which was calculated from the portion of 
the record excluding the time when PCMBS was added, against mean current <I> as fit with Eq. 1 (solid line) and 
Po(max) was calculated using Eq. 2: Po(max) = 0.61, N=1071, and i=3.5 pA. (C) Variance analysis to determine Po(max), 
N, and i in the presence of PCMBS. Plot of σ2, which was calculated from the entire record against <I> was fit with 
Eq. 1 (solid line) and Po(max) was calculated using Eq. 2: Po(max) = 0.91, N=1078, and i=3.4 pA. 
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Importantly, the steady-state current increase observed in saturating Ca2+ would mask any 
increase in channel activation occurring through a Ca2+-dependent pathway. Therefore, to 
determine whether PCMBS also affects the Ca2+-dependent pathway, we measured the apparent 
Ca2+ affinity in the absence and presence of PCMBS as shown in Fig. 14 (A). This figure 
illustrates that PCMBS induced a significant current potentiation between 0.3 and 0.6 μM Ca2+i 
compared to the equivalent current increase in the absence of the compound. These data were fit 
to a version of the Hill equation, Fig. 14 (B), demonstrating a PCMBS-dependent shift in the 
EC50 from 508±13 nM (n=57) to 235±17 nM (n=6) without altering the Hill coefficient (2.0±0.2 
and 2.5±0.2). These results indicate that PCMBS increases channel activation through both Ca2+-
independent and -dependent pathways, reflected by an increase in Po(max) and a shift in apparent 
Ca2+ affinity, respectively. 
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Figure 14. PCMBS shifts apparent Ca2+ affinity. Complete Ca2+ concentration response experiments were 
performed to estimate EC50 and the Hill coefficient (h) in the absence and presence of PCMBS. (A) Representative
macroscopic current record from an inside-out patch expressing KCa3.1 channels. The patch was excised in 10 μM 
Ca2+i followed by a series of Ca2+i concentrations beginning with 0, 0.1, 0.3, 0.6, 1.0, 3.0, and 10 μM Ca2+i, all 
applied in 10 s intervals using a rapid solution exchanger. After the current reached a steady-state level, PCMBS 
(500 μM) was added and a 2nd Ca2+i concentration response experiment was performed using the above Ca2+i
concentrations in the presence of PCMBS. (B) Plot of normalized <I> current against the corresponding Ca2+i for 
KCa3.1 (?) and KCa3.1+PCMBS (?) fit with a variation of the Hill equation (see methods). This analysis gave 
estimates for KCa3.1 (solid line, n=57) EC50=508±13 nM and h=2.0±0.2 and KCa3.1+PCMBS (dashed line, n=6) 
EC50=235±17 nM and h=2.5±0.2. All experiments were done in pairs, but an alternate set of Ca2+i concentrations 
(0.1, 0.15, 0.2, 0.25, 0.3, 0.6, 1.0 and 10 μM) were used when estimating EC50 and h for KCa3.1+PCMBS. Error 
bars represent standard error of the mean (SEM). The error bars for KCa3.1 are smaller than the symbols (?).  
 
 
 74 
Our results suggest that PCMBS shifts the gating equilibrium toward the open state, 
which we expect to be manifested as a change in the activation or deactivation kinetics of the 
channel. To determine which of these kinetic steps is being modified, we measured the kinetics 
of channel activation and deactivation in the absence and presence of PCMBS. The patch was 
excised in 10 μM Ca2+i, after which Ca2+i was rapidly switched between a Ca2+-free solution and 
a Ca2+i solution, as depicted in the inset of Fig. 15. After 5-10 complete cycles (1 cycle consists 
of taking measurements using 0.5 (A), 0.7 (B), 1.0 (C), and 10 (D) μM Ca2+i), PCMBS was 
added to the bath solution and the protocol was repeated. Since PCMBS increases current at all 
Ca2+-concentrations, current recordings were normalized to the maximum current level to 
compare channel kinetics in the absence and presence of PCMBS. Additionally, current records 
for each Ca2+i -concentration were superimposed and averaged to produce the representative 
current records shown in Fig. 15 (A-D). Time constants (τ) for channel activation and 
deactivation were determined from fits of the data to a single-exponential and reported in Fig. 15 
(E-F), see also Table (1). As shown, the data demonstrates that the activation kinetics are Ca2+-
dependent, becoming faster with increased Ca2+i-concentration, whereas the deactivation kinetics 
are Ca2+-independent, being insensitive to changes in Ca2+i-concentration. The addition of 
PCMBS, Fig. 15 (A-D), results in a 6-fold increase in the time-constant for deactivation (Fig. 15 
F) with only moderate effects on the time course for activation (Fig. 15 E, see also Table 1).  
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 Figure 15. PCMBS modulates channel kinetics.  Activation and deactivation kinetics were estimated with Ca2+-
jump experiments in the absence and presence of PCMBS. A rapid solution exchanger was utilized to quickly 
alternate between a Ca2+i-free solution and 1 of 4 Ca2+i solutions: (A) 0.5, (B) 0.7, (C) 1.0, and (D) 10 μM Ca2+i 
following the protocol illustrating one complete Ca2+ cycle shown in the inset of this figure. 5-10 complete Ca2+ 
cycles were recorded from a single patch in the absence and presence of PCMBS (500 μM). Activation and 
deactivation sweeps in the absence of PCMBS (black trace) were collected and averaged according to their 
respective Ca2+-concentration, and superimposed against the corresponding PCMBS sweep (red trace). Current 
traces were normalized to the max current level, facilitating comparison of time courses between KCa3.1 and 
KCa3.1+PCMBS. Activation (E) and deactivation (F) rates were estimated by fitting activation and deactivation 
records with an exponential function and reported as a time constant (τ-on and τ-off) in the absence (?) and 
presence (?) of PCMBS, see also Table (1). 
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Table 1. Exponential fits comparing the  activation and deactivation kinetics of KCa3.1. Time constants (τ) 
from single exponential fits to channel activation or deactivation records from the four [Ca2+]i concentrations 
examined. 
            PCMBS 
Channel [Ca2+]i on  off  n on  off  n 
  μM (ms)  (ms)   (ms)  (ms) 
______________________________________________________________________________ 
KCa3.1 0.5 224±22 61±5  13 337±29 402±31 13 
(paired) 0.7 185±11 60±5  13 250±14 414±30 13 
 1.0 147±9  65±4  13 224±12 428±30 13 
 10 123±11 59±4  13 206±13 411±34 13 
____________________________________________________________________________ 
KCa3.1   
C276A 0.5 211±20 48±4  7 191±12 60±8  7 
  0.7 186±15 46±4  7 154±13 57±6  7 
 1.0 142±15 56±3  7 134±12 61±6  7 
  10 120±11 43±3  7 103±6  59±6  7 
______________________________________________________________________________ 
 KCa3.1  
 C277A  0.5 244±10 54±6  6 318±20 377±45 5 
 0.7 186±9  59±6  6 262±18 336±46 5 
 1.0 152±8  59±5  6 223±19 365±44 5 
  10 129±12 59±7  6 194±14 332±39 5 
______________________________________________________________________________ 
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KCa3.1 0.5 209±9  57±2  51 
 0.7 170±5  57±2  51 
 1.0 141±5  59±2  51 
 10 114±5  56±2  51 
______________________________________________________________________________ 
KCa3.1  
L281W 0.5 149±12 186±11 23 175±20 267±20 8 
  0.7 130±9  202±11 23 142±17 278±24 8 
  1.0 119±10 198±9  23 119±13 293±27 8 
  10 92±7  197±9  23 100±10 288±27 8 
____________________________________________________________________________ 
KCa3.1  
V282W 0.5 161±11 59±3  13 
  0.7 131±8  59±2  13 
  1.0 113±8  59±3  13 
  10 84±5  58±3  13 
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 2.4.3 Cysteine 276 Confers PCMBS-sensitivity to KCa3.1 Potentiation 
Potentiation by PCMBS is the result of cysteine modification, and KCa3.1 contains 9 
endogenous cysteines residues. Fig. 16 (A) illustrates a model of the pore region for the open 
state of KCa3.1 obtained by homology modeling using the rKv1.2 channel structure [209]. This 
model shows that the four endogenous cysteine residues (267, 269, 276, and 277) are located 
along S6, making these residues likely candidates for conferring PCMBS-sensitivity. To isolate 
the residue(s) responsible for the PCMBS-mediated potentiation, each cysteine was mutated to 
an alanine and the effect of PCMBS determined. However, C267A and C269A failed to produce 
macroscopic currents, preventing their assessment in PCMBS-mediated channel potentiation. 
Therefore, we tested whether PCMBS (500 μM) could potentiate current in the C276A and 
C277A constructs. A representative Ca2+ concentration response experiment for C277A is shown 
in Fig. 17 (A). PCMBS increases steady-state current in 10 μM Ca2+i (left panel), in addition to 
causing a left shift in apparent Ca2+ affinity (right panel). Furthermore, washout of PCMBS does 
not reverse the increase in current (unpublished data), demonstrating that PCMBS still covalently 
binds to the channel. We confirm through variance analysis (Fig. 17 B-C) that the steady-state 
current increase in saturating Ca2+i is the result of an increase in Po(max) (see figure legend for 
details). Additionally, the C277A mutation did not alter the apparent Ca2+ affinity or the Po(max) 
relative to the WT-channel, suggesting the increase in C277A activation is due to the binding of 
PCMBS and not to the mutation having an indirect effect on channel gating. In total, these results 
demonstrate the PCMBS-mediated channel activation does not require Cys277.  
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Figure 16. Homology model  of the pore region for the open state of KCa3.1 using the rKv1.2 structure . (A) 
Representation of the S5- P-helix -S6 region viewed as a profile illustrating the predicted orientation of Cys267, 
Cys269, Cys277 (all in gray) Cys276 (yellow), and Leu281 (red). Only two of the four subunits are shown for clarity. (B) 
Representation of the S5- P-helix -S6 region from the extracellular entrance showing the predicted non-luminal 
orientation of Cys276 (yellow) and Leu281 (red). The S5 and P-helix are colored green and the S6 helix is colored 
blue. All residues are illustrated in VDW format. (C) Sequence alignment used for the homology model of KCa3.1 
in the open state (rKv1.2) and the closed state (KcsA model illustrated in Fig. 26). Bold font represents homologous 
amino acids used as a guide to align sequences.  
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Figure 17. PCMBS increases channel activation for KCa3.1 C277A.  Ca2+-concentration response experiments 
and variance analysis were undertaken to determine whether PCMBS increases C277A channel activation in the 
same manner observed for the WT channel. (A, left panel) Representative macroscopic current record from an 
inside-out patch expressing KCa3.1 C277A channels. All experiments were performed utilizing the Ca2+-
concentraiton response protocol described in Fig. 14. (A, right panel) Plot of normalized <I> current against the 
corresponding [Ca2+]i for KCa3.1 C277A (?) and KCa3.1 C277A+PCMBS (?). All analysis was performed 
following the protocol described in Fig. 14 to give averages: KCa3.1 C277A (solid line, n=15) EC50=566±24 nM 
and h=1.9±0.1 and KCa3.1 C277A+PCMBS (dashed line, n=7) EC50=220±14 nM and h=1.7±0.2. Error bars 
represent standard error of the mean (SEM). (B) Variance analysis as described in Fig. 13 to determine Po(max), N, 
and i in the absence of PCMBS: Po(max) = 0.51, N=954, and i=3.5 pA. (C) Variance analysis as described in Fig. 13 to 
determine Po(max), N, and i in the presence of PCMBS Po(max) = 0.70, N=849, and i=3.5 pA. Analysis of multiple 
patches (n=6) indicates that PCMBS increase Po(max) from 0.55±0.02 to 0.84±0.03 without increasing N or i (3.8±0.1 
pA versus 3.9±0.1 in PCMBS). 
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In contrast to the C277A mutation, C276A (Fig. 18 A) completely eliminated both the 
shift in apparent affinity (Fig. 18 B) and the increase of steady-state current in saturating Ca2+i 
(Fig. 18 C, see figure legend for details). Additionally, the C276A mutation did not alter the 
apparent Ca2+ affinity or the Po(max) relative to the WT-channel, suggesting the absence of 
channel potentiation is due to removing Cys276, rather than the mutation having an indirect effect 
on channel gating. In total, these results indicate that channel potentiation is the result of PCMBS 
binding to Cys276. 
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Figure 18. C276A prevents the PCMBS-mediated increase in channel activation. Ca2+-concentration response 
experiments and variance analysis were undertaken to determine whether PCMBS increases C276A channel 
activation in the same manner observed for the WT channel. (A) Representative macroscopic current record from an 
inside-out patch expressing KCa3.1 C276A channels. All experiments were performed utilizing the Ca2+-
concentraiton response protocol described in Fig. 14. (B) Plot of normalized <I> current against the corresponding 
Ca2+i for KCa3.1 C276A (?) and KCa3.1 C276A+PCMBS (?). All analyses were performed following the 
protocol described in Fig. 14 to give averages: KCa3.1 C276A (solid line, n=18) EC50=460±27 nM and h=1.7±0.04 
and KCa3.1 C276A+PCMBS (dashed line, n=9) EC50=485±68 nM and h=1.6±0.04. Error bars represent standard 
error of the mean (SEM). (C) Variance analysis as described in Fig. 13 to determine Po(max), N, and i in the absence 
of PCMBS: Po(max) = 0.67, N=488, and i=3.3 pA. PCMBS did not increase steady-state current in KCa3.1 C276A 
therefore, in order to obtain an estimate of Po(PCMBS), Po had to be extrapolated using the Eq. where Po=Po(max)(I/I(max)) 
and Po(PCMBS)=0.63. Analysis of multiple patches (n=6) indicates that PCMBS did not increase Po(max) (0.68±0.05 in 
the absence of PCMBS and 0.59±0.05 in PCMBS).   
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PCMBS modulated the kinetic as well as steady-state behavior of the WT-channel. 
Therefore, we also determined whether Cys276 or Cys277 played a role in PCMBS related changes 
to channel activation and deactivation. As depicted in Fig. 19 (A-D), C277A activation and 
deactivation records were similar to the WT-channel, both in the absence and presence of 
PCMBS. The average activation and deactivation time constants (τ) are plotted in Fig. 19 E and 
F, respectively, as well as being reported in Table (1). These results further demonstrate that 
Cys277 does not mediate the PCMBS-dependent potentiation of KCa3.1. However, as expected, 
Cys276 eliminated the PCMBS-dependent changes in the kinetic behavior of the channel (Fig. 20 
A-D). The elimination of the PCMBS effect on kinetic behavior cannot be explained through an 
indirect effect of the Cys276 mutation, because the time course of activation and deactivation 
kinetics (in the absence of PCMBS) closely describe the values observed in the WT-channel 
(Table 1). Therefore, these results suggest that modification of the kinetic behavior is the result 
of PCMBS binding to Cys276.  
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Figure 19. PCMBS modulates C277A channel kinetics in a manner similar to the WT-channel. Activation and 
deactivation kinetics were estimated with Ca2+-jump experiments using Ca2+i concentrations 0.5, (A) 0.7, (B) 1.0, 
(C) and 10 μM (D) in the absence (black trace) and presence (red trace) of PCMBS as described in Fig. 15. 
Activation (E) and deactivation (F) rates were estimated by fitting activation and deactivation records with an 
exponential function and reported as a time constant (τ-on and τ-off) in the absence (?) and presence (?) of 
PCMBS, see also Table (1). 
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Figure 20. C276A prevents the PCMBS-mediated modulation in channel kinetics. Activation and deactivation 
kinetics were estimated with Ca2+-jump experiments using Ca2+i concentrations 0.5, (A) 0.7, (B) 1.0, (C) and 10 μM 
(D) in the absence (black trace) and presence (red trace) of PCMBS as described in Fig. 15. Activation (E) and 
deactivation (F) rates were estimated by fitting activation and deactivation records with an exponential function and 
reported as a time constant (τ-on and τ-off) in the absence (?) and presence (?) of PCMBS, see also Table (1). 
 
 
 
 
 
 
 
 
 
 86 
2.4.4 Gating of KCa3.1 can be described with a 4-State Model 
Our results demonstrate that PCMBS disrupts the steady-state and kinetic behavior of KCa3.1 by 
modifying Cys276. Addressing the mechanism behind PCMBS modification is necessary for 
understanding how the molecular interactions surrounding position 276 contribute to the gating 
mechanism. To this end, we developed a kinetic model, which would enable us to identify the 
transitions along the activation or deactivation pathway altered by PCMBS. A previous 
investigation established that the gating of KCa2.2 (SK2) can be described by a 6-state gating 
scheme consisting of 4 closed states and 2 open states, with forward transitions between closed 
states being Ca2+ dependent [206]. Therefore, we determined if this model (Fig. 21 A) could be 
used to describe the activation and deactivation kinetics of the closely related channel, KCa3.1. 
Activation and deactivation current records were fit with the 6-state model as described in the 
Materials and Methods section. The solid lines in Fig. 21 (B) represent the fit to the activation 
and deactivation records assuming the Ca2+-dependent rate constants have a linear dependence 
on Ca2+-concentration, as proposed for KCa2.2 [206]. This model gave an accurate description of 
all data sets, except for the activation rate in saturating Ca2+i, where the model predicted 
activation rates that were faster than those observed experimentally. To obtain a more accurate 
description of the activation rate in saturating Ca2+i, we assumed that the Ca2+-dependent steps 
depended nonlinearly on the Ca2+-concentration. This modification allowed for the Ca2+-binding 
rate constants to saturate in high Ca2+i, giving a better description of the activation rates in 10 
μM Ca2+i (dashed lines Fig. 21 B), and therefore, was used for all further analysis. Sensitivity 
analysis was used to evaluate the importance of each parameter to the goodness of the fits for 
both variations of the model (Appendix Table A.7). This analysis showed that the final C-C and 
C-O transitions (box outline Fig. 21 A) were not required to fit the 4 sets of activation and 
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deactivation records (Table 2). Rather, these data were well described with a simpler 4-state 
model comprised of 3 closed states and 1 open state, and the best fit is achieved when the Ca2+-
dependent rate constants saturate in high Ca2+.  
 We went on to further validate our kinetic scheme by predicting the apparent Ca2+ 
affinity and the shift in apparent Ca2+ affinity mediated by PCMBS. Fig. 21 (C) illustrates the 
simulated Ca2+-concentration response curves in the absence (solid line) and presence (dashed 
line) of PCMBS plotted against the corresponding experimental data. The model accurately 
predicts the apparent Ca2+ affinity as well as the shift induced by PCMBS. The success of the 
model is not entirely unexpected, since it was initially fit to the kinetic data, which encompasses 
the steady-state response. Nonetheless, the consistency between the model and the experimental 
data is reassuring. 
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Figure 21. A 4-state model can be used to fit the activation and deactivation kinetics for K Ca3.1. (A) Gating 
scheme used to describe the activation and deactivation kinetics of KCa3.1. The 6-state model is comprised of 4 
closed states and 2 open states, with forward transitions between closed states being Ca2+-dependent and all other 
transitions being Ca2+-independent. The box outline represents the states that are not necessary to fit the activation 
and deactivation kinetics as determined through sensitivity analysis (appendix). (B) Representative activation and 
deactivation records fit with two variations of the model shown in (A). Activation and deactivation currents were 
recorded and fit following the protocol described in the methods sections. The colors refer to the different Ca2+ 
concentrations, with red representing (0.5), blue (0.7), green (1.0), and black (10 μM) Ca2+. The solid line represents 
the fit assuming Ca2+-dependent rate constants have a linear dependence on Ca2+-concentration, k= A⋅[Ca]. The 
dashed line represents the fit assuming Ca2+-dependent rate constants have a non-linear dependence on Ca2+-
concentration, k= A⋅[Ca]/(B+[Ca]). Rate constants derived from the fit are summarized in Table (2) (C) The model 
can be used to predict the shift in apparent Ca2+ affinity with PCMBS. Plot of normalized <I> current against the 
corresponding Ca2+i for KCa3.1 and KCa3.1+PCMBS. The symbols represent the experimental data (KCa3.1 υ) and 
(KCa3.1+PCMBS ν)., which is plotted against the predicted apparent Ca2+ affinity (KCa3.1 solid line) and 
(KCa3.1+PCMBS dashed line). Model prediction: KCa3.1 EC50 540 nM and KCa3.1+PCMBS EC50 280 nM. 
Experimental observation: KCa3.1 EC50 508 nM and KCa3.1+PCMBS EC50 235 nM. 
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Table 2. Summary of the 6-State model used to describe the kinetic behavior of KCa3.1±PCMBS. 
Rate constants derived from fitting the model to KCa3.1 activation and deactivation records. (A) Rates constants 
derived using the model with all free parameters: KCa3.1, KCa3.1+PCMBS, and KCa3.1 L281W. (B) Rates 
constants derived using the k53 model: KCa3.1+PCMBS and KCa3.1 L281W. (C) Rates constants derived using the 
k12 k23 and k53 model: KCa3.1+PCMBS. 
 
 KCa3.1            KCa3.1+PCMBS                                          Units                     
 (A)   (A)   (B)    (C)                                
 n=2   n=1   n=1  n=1  
______________________________________________________________________________ 
12 27±3   10      27       20                              μM-1 s-1  
21 34±8   76   34     34                      s-1 
23 5425±2725  2911   5425     2820             μM-1 s-1  
32 190±40  2978   190     190           s-1 
34 -   -   -      -             - 
43 -   -   -      -             - 
35 34±7   291   34     34           s-1 
53 20±5   3   3     3           s-1 
46 -   -   -     -             - 
64 -   -   -     -             - 
error 38   45   42     43       
bold: fixed to kKCa3.1(-PCMBS) 
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        KCa3.1 L281W      KCa3.1 L281W                                                     Units   
 (A)   (B)    
  n=1   n=1       
______________________________________________________________________________ 
12 11   27                                                                                           μM-1 s-1  
21 76   34                                                                                           s-1 
23 12380   5425                                                                        μM-1 s-1  
32 192   190                                                            s-1 
34 -   -                                                              - 
43 -   -                                        - 
35 53   34                           s-1 
53 5   4                                      s-1 
46 -   -                                        - 
64 -   -                                                   - 
error 8   13  
bold face: fixed to kKCa3.1(-PCMBS)         
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2.4.5 PCMBS slows the k53 Transition 
Previous studies on K+ channels have shown that mutations along S6 perturb a concerted 
transition that occurs late in the activation pathway prior to opening [210]. Since our data 
suggests that PCMBS binds to a S6 residue (Cys276) we determined whether the PCMBS-induced 
perturbation could also be traced to a late opening transition. To answer this, we analyzed 
activation and deactivation kinetics in the presence of 500 μM PCMBS, in terms of the scheme 
discussed above, and compared the rate constants with those obtained in the absence of the 
compound. Fig. 22 (A, dashed line) shows the fit of the model to a representative Ca2+-jump 
experiment performed in the presence of PCMBS. As summarized in Table (2), initial modeling 
showed that PCMBS has complex effects on channel kinetics by altering multiple transitions 
along the activation and deactivation pathway. The largest changes occur for the k32 (15-fold 
faster), k35 (8-fold faster), and k53 (7-fold slower) transitions, which made it difficult to interpret 
our results. However, due to the large parameter space in the kinetic model, it is impossible to 
prove that the fitted parameters are indeed the best fit. Additionally, it is impossible to know if 
there are different parameter sets with quantitatively similar goodness of fits. In an effort to 
account for this uncertainty, we started from the parameter values determined in the absence of 
PCMBS (k-PCMBS), and we only allowed a few parameters to be fit at a time while holding all 
other values constant. In doing this, we isolated one parameter that is critical for describing the 
kinetic changes to the channel upon the application of PCMBS – k53, the transition rate from the 
first open state back to the third closed state (Table 2). Simply modifying k53 alone (solid line) 
results in a goodness of fit that is nearly identical to our first attempt (dashed line) indicating that 
an ~7-fold slowing of transition k53 can account for our experimental observations (see Fig. 21 A 
and Table 2). After extensive parameter searches, we believe these results provide the most 
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parsimonious description of how PCMBS affects the channel; however, more complex 
interactions involving multiple rates cannot be ruled out. Our results demonstrate that PCMBS 
slows the first transition along the deactivation pathway, rather than altering a concerted 
transition late in the activation pathway. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 93 
  
 
 
 94 
Figure 22. P CMBS sl ows transition k 53, as determined through the constrained version of the model.  (A) 
Representative activation and deactivation records fit with two variations of the model. The dashed line represents 
the variation that allowed parameters k12, k21, k23, k32, k35, and k53 to be free, and the solid line represents the 
variation that held parameters k12, k21, k23, k32, and k35 to k(-PCMBS) values, k53 is the only free parameter, see results 
for details. As noted in the previous figure, the Ca2+-dependent rate constants were assumed to have a non-linear 
dependence on Ca2+-concentration, k= A⋅[Ca]/(B+[Ca]). The colors refer to the different Ca2+ concentrations, with 
red representing (0.5), blue (0.7), green (1.0), and black (10) μM Ca2+. (B) Gating scheme detailing that parameter 
k53 is modulated by PCMBS, as determined through the constrained version of the model.  
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2.4.6 L281W replicates the PCMBS phenotype 
Our results suggest that Cys276 is located within a gating sensitive region of the channel, since 
disrupting this site with PCMBS shifts the gating equilibrium toward the open state. Since 
PCMBS converts cysteine into a mercuriphenyl-sulphonate conjugate [200], we attempted to 
mimic the influence of PCMBS by placing a bulky tryptophan residue at position 276. However, 
as illustrated in Fig. 23 (A), the C276W mutation had no effect on apparent Ca2+ affinity, EC50 = 
558±50 nM and h = 1.8±0.1 (n=7), when compared to the WT-channel EC50 = 508±13 nM and h 
= 2.0±0.1 (n=57). This result demonstrates that Trp276 does not reproduce the shift in apparent 
Ca2+ affinity associated with the PCMBS-dependent channel potentiation. It should be noted that 
PCMBS is negatively charged at pH 7.2. However, experiments to determine whether PCMBS 
electrostatically disrupts channel structure could not be conducted because we were unable to 
record macroscopic current from the C276D mutation. 
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 Figure 23. Trp281 and Trp282 recapitulate the PCMBS-mediated shift in apparent Ca2+ affinity. Complete Ca2+ 
concentration response experiments were performed to estimate EC50 and Hill coefficients (h) for those constructs 
expressing macroscopic currents, as described in Fig. 14. (A) Plot of normalized <I> current against the 
corresponding Ca2+i for KCa3.1 C276W (?) and C277W (?). KCa3.1 (?) and KCa3.1+PCMBS (?) are included 
for comparison. KCa3.1 C276W (n=7) EC50=558±50 nM and h=1.8±0.1, KCa3.1 C277W (n=6) EC50=748±54 nM 
and h=1.5±0.1, KCa3.1 (n=57) EC50=508±13 nM and h=2.0±0.2 and KCa3.1+PCMBS (n=6) EC50=235±17 nM and 
h=2.5±0.2. (B) Plot of normalized <I> current against the corresponding [Ca2+]i for KCa3.1 L281W (?), KCa3.1 
L281W+PCMBS (?), and KCa3.1 V282W (?). KCa3.1 (?) and KCa3.1+PCMBS (?) are included for 
comparison. KCa3.1 L281W (n=12) EC50=54±6.4 nM and h=3.3±0.2, KCa3.1 L281W+PCMBS (n=3) EC50=43±1.2 
nM and h=3.6±0.5, KCa3.1 V282W (n=12) EC50=296±14 nM and h=1.6±0.1, KCa3.1 (n=57) EC50=508±13 nM and 
h=2.0±0.2, and KCa3.1+PCMBS (n=6) EC50=235±17 nM and h=2.5±0.2. Error bars represent standard error of the 
mean (SEM). Error bars smaller than the symbols are not visible in the graph. 
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While Trp276 does not manipulate apparent Ca2+ affinity, PCMBS is a larger molecule, 
and it may exert its influence at a position distant from the Cys276 anchoring point. To examine 
this possibility, we performed a partial tryptophan scan of S6, from Gly274 to Val282, and assessed 
whether these mutations recapitulated any characteristics of the PCMBS phenotype. Mutations 
G274W, V275W, T278W, A279W, and L280W all failed to produce macroscopic currents, thus 
preventing their assessment. As shown in Fig. 23 (A-B) C277W causes a right shift in apparent 
Ca2+ affinity, while both L281W and V282W produced left shifts similar to PCMBS. 
Remarkably, Trp281 mediates a large shift in apparent Ca2+ affinity, an ~10-fold increase over the 
WT (-PCMBS) channel and an ~4-fold increase over the WT (+PCMBS) channel. To determine 
whether Trp281 and Trp282 also recapitulate the changes in kinetic behavior, Ca2+-jump 
experiments were performed. As shown in Fig. 24, the Trp281 mutation mimics the deactivation 
process, resulting in an ~3-fold slowing relative to the WT-channel. However, the mutation had 
no effect on the activation process. Furthermore, Trp282 had no effect on channel activation or 
deactivation (Fig. 24 E-F). Since Trp281 mimics the PCMBS phenotype, we wanted to assess 
whether the mutation prevented further modulation with PCMBS. PCMBS did not alter the 
apparent Ca2+ affinity (Fig. 23 B) or activation kinetics of the Trp281 mutation (Fig 24 E-F). 
However, the addition of PCMBS to the mutant channel further slowed channel deactivation by 
roughly 40% over the four Ca2+i concentrations examined (Fig. 24 E-F), suggesting this 
compound can still bind Cys276, but does not potentiate channel behavior. 
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 Figure 24. Trp281 recapitulates the PCMBS-mediated modulation in deactivation kinetics. Activation and 
deactivation kinetics were estimated with Ca2+-jump experiments as described in Fig. (4) using Ca2+i concentrations 
0.5, (A) 0.7, (B) 1.0, (C) and 10 μM (D) for L281W (blue trace) and KCa3.1 in the absence (black trace) and 
presence (red trace) of PCMBS were included for comparison. Activation (E) and deactivation (F) rates were 
estimated by fitting activation and deactivation records with an exponential function and reported as a time constant 
(τ-on and τ-off) for KCa3.1 (?), KCa3.1 PCMBS (?), L281W (?), L281W PCMBS (?), and V282W (?), see 
also Table (1). 
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We also assessed whether the 4-state model can accurately describe L281W activation 
and deactivation records from the Ca2+-jump experiments. As illustrated in Fig. 25 (A), the 4-
state model accurately describes the 4-sets of activation and deactivation time courses. Fig. 25 
(B) provides an enhanced depiction of the fit outlined by the dashed box in Fig. 25 (A). The rate 
constants derived from the fit are presented in Table 2. As shown in the table, the values for k12, 
k21, and k53 are very similar to those values obtained from the initial analysis of 
KCa3.1+PCMBS. This surprising result suggests that L281W has many kinetic characteristics in 
common with the PCMBS modulated channel. Therefore, we asked whether the phenotype 
displayed by this construct could be explained by only modifying transition k53. As shown in 
Table 2, the parameters from the KCa3.1 model (kKCa3.1-PCMBS) were adequate to describe L281W 
activation and deactivation time courses. This result indicates that slowing of the deactivation 
process can be explained by slowing of transition k53 for both the PCMBS modulated channel 
and the L281W construct. As discussed with PCMBS, we cannot rule out that the phenotype 
present in L281W is the result of complex interactions involving multiple rates. However, it is 
interesting that parameters from the KCa3.1 data can reproduce the fits for both PCMBS and the 
L281W Ca2+-jump experiments. In total, these results indicate that sterically disrupting Cys276 is 
not adequate to recapitulate the PCMBS phenotype. The results from the tryptophan scan suggest 
that Leu281and Val282 are located within a mechanically sensitive region of the channel. More 
importantly, L281W disrupts steady-state and kinetic behavior in a manner that is similar to 
PCMBS, suggesting that L281W and PCMBS may disrupt gating through a common 
mechanism. 
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 Figure 25 . A 4-s tate model can be used to fit the activation and deactivation kinetics f or KCa3.1 L 281W. 
Representative activation and deactivation records fit with the model shown in Fig. 21 (A). Activation and 
deactivation currents were recorded and fit following the protocol described in the methods sections. The colors 
refer to the different Ca2+ concentrations, with red representing (0.5), blue (0.7), green (1.0), and black (10 μM) 
Ca2+. The dashed line represents the fit assuming Ca2+-dependent rate constants have a non-linear dependence on 
Ca2+-concentration, k= A⋅[Ca]/(B+[Ca]). Rate constants derived from the fit are summarized in Table (2). (B) 
Enhanced depiction of the fit outlined by the box in part (A). 
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2.5 DISCUSSION 
Ligand-gated ion channels undergo a series of conformational changes in response to ligand 
binding, enabling the pore to tran g to a conducting configuration [5]. 
A chemo-mechanical gating model has been proposed to explain the Ca2+-dependent gating 
Ca i
lts 
ulate gating. There are several possible explanations for this 
difference, but the simplest is related to the chemical difference between PCMBS and MTSET. 
sition from a non-conductin
mechanism of K  channels [192, 193]. This model states that the binding of Ca2+  to CaM 
initiates a cascade of conformational changes within CaM/CaMBD. These conformational 
changes are then coupled, via the S6 transmembrane helix, to the pore enabling the channel to 
gate [188, 189, 192, 193]. Here we showed that PCMBS potentiates channel activation by 
manipulating steady-state and kinetic behavior through modification of Cys276. A tryptophan 
scan of S6 revealed that L281W mimics modification by PCMBS suggesting that both may act 
through a common mechanism. Perturbations at each of these sites disrupt channel closing, 
supporting the notion that the non-luminal surface of this portion of S6 is allosterically coupled 
to the activation gate. Therefore, the Ca2+-dependent activation mechanism utilizes the non-
luminal surface along S6 to transition into the closed conformation.  
2.5.1 Differences in Chemistries of the Compounds may explain discrepancy regarding 
the effect on the WT-Channel 
It is interesting that MTSET fails to modulate WT-channel gating [111, 113], despite our resu
showing that PCMBS can mod
This conclusion is consistent with previous investigations showing that PCMBS, with a 
peripherally located cysteine reactive moiety, could access cysteines not accessible to MTSET’s 
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more centrally located moiety [199-201]. Additionally, the larger size of PCMBS conjugated to 
cysteine was more likely to irreversibly modify behavior rather than transiently effect behavior 
as observed using MTSET [199-201]. Thus, the unique chemistry of PCMBS enables this 
compound to potentiate the WT-channel by modifying Cys276. 
Since Cys276 is located within a region of the channel (V275-V282) inhibited by MTSET, 
why does PCMBS not inhibit the channel? The discrepancy in modulation can be explained by 
the orientation of Cys276 relative to the lumen of the pore. Val275 is known to line the pore from 
studies
e 
vation, rather than directly opening the gate. Cys276 is only accessible 
in the open conformation (Fig. 12 D), suggesting that the closed conformation either blocks 
 localizing the binding site of clotrimazole and arachidonic acid [211, 212]. Results from a 
SCAM analysis confirmed the orientation of this residue, and indicated a similar orientation for 
Thr278 and Val282 [113]. These results are in agreement with sequence alignments (Table A.1) 
that indicate Val275, Thr278, and Val282 correspond to residues that are known to line the pore in 
KcsA [67, 213], and Shaker [214]. The luminal location of Val275, Thr278, and Val282 indirectly 
argues for Cys276 and Leu281 to be oriented away from the pore. Thus, the non-luminal 
orientation of Cys276 prevents PCMBS from modification induced channel block. 
2.5.2 PCMBS potentiates Channel activation by shifting the Gating Equilibrium toward 
the Open Conformation 
PCMBS cannot activate the channel in the absence of Ca2+i, (Fig. 12 D) suggesting th
compound potentiates acti
PCMBS from accessing Cys276, or the orientation of Cys276 may be inaccessible. A previous 
investigation indicated that once in the closed state, a constriction develops at the level of Thr278-
Ala282 [111]. It is possible that this constriction blocks PCMBS from gaining access to Cys276.  
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PCMBS influences both steady-state and kinetic behavior of the channel. The changes to 
the steady-state behavior occur in sub-saturating Ca2+i as well as saturating Ca2+i concentrations. 
These changes could occur independently through two separate pathways: a Ca2+-dependent 
pathwa
etics of activation, deactivation, or a 
combin
y that shifts the apparent Ca2+ affinity and Ca2+-independent pathway that increases 
Po(max). Thus, the shift in apparent affinity can be explained by either a change in the initial 
binding of Ca2+ to CaM or modification of a conformational change subsequent to Ca2+ binding. 
However, we observed that PCMBS increases Po(max), suggesting that modulation along the Ca2+-
dependent pathway cannot simply be explained by stabilizing the Ca2+/CaM interaction. Rather, 
it suggests that PCMBS functions to shift the gating equilibrium toward the open conformation. 
Shifting the gating equilibrium toward the open conformation would explain both the increase in 
Po(max) and through a mass action effect the shift in apparent affinity. Therefore, the changes in 
steady-state behavior cannot occur through two independent pathways, but are related and a 
consequence of shifting the equilibrium toward the open conformation. These results are similar 
to a previous investigation, which characterized potentiation by Ni2+ on cyclic nucleotide-
activated channels (CNG) from rod photoreceptors [215]. 
We know from the change in steady-state behavior that PCMBS alters the energy 
difference between the closed and open conformations to favor channel opening. What we 
cannot infer from these experiments is whether the energ
ation of the two are altered. Based on channel kinetics, PCMBS slows both channel 
activation and deactivation (Table 1). Although the slowing of channel activation is not 
congruent with our steady-state data, slowing of channel deactivation is the predominant effect 
and corresponds well with our steady-state results. Therefore, the primary manner in which 
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PCMBS shifts the gating equilibrium toward the open conformation is by disrupting the 
energetics of channel deactivation.  
We demonstrated that a 4-state gating scheme describes the activation and deactivation 
records of KCa3.1. However, the rates describing the Ca2+-dependent transitions must have a 
nonline
orted k12 ≈ k23 we tested the model 
where 
Ca2+-dependent Gating of KCa3.1 
The results from the initial kinetic analysis showed that good fits to the data can be obtained by 
modulating all transitions rates in the presence of PCMBS. However, more careful reanalysis 
revealed that only one rate constant, k53, had to be changed to explain the influence of PCMBS 
ar rather than a linear dependence to fit the activation record in saturating Ca2+i. This 
need for nonlinear coefficients is not an artifact of the experimental system, since we were able 
to describe the full range of kinetic behavior for the closely related channel, KCa2.3 
(unpublished data). The discrepancy may be related to channel behavior in saturating Ca2+i, as 
elevated Ca2+i has been reported to block the channel [216].  
As illustrated in Table (2), k23 is substantially higher than the other rate constants, 
particularly k12. Since the analysis from Hirschberg et al., rep
k12 = k23 to ensure that our results were not biased by k23. However, forcing k12 = k23 
results in the model predicting faster activation time courses compared to the rates observed 
experimentally (unpublished data). Therefore, this analysis suggests k23 must be higher than the 
other rates constants to accurately describe the activation time courses from the 4 sets of Ca2+ 
concentrations. The discrepancy may exist because we simultaneously fit activation and 
deactivation records from 4 sets of Ca2+ concentrations, where as the other investigation fit a 
single concentration. 
2.5.3 Modeling the 
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(Table 2). Reducing k53 ~7-fold gives excellent fits to the activation and deactivation records, 
and further substantiates that PCMBS shifts the gating equilibrium toward the open conformation 
d change in τ-off 
(Table 
by disrupting channel closing. Assuming k53 is the only transition effected by PCMBS may be an 
over simplification. As depicted in Table (2), PCMBS affects both channel activation and 
deactivation. Therefore, to address this question we reanalyzed the data allowing transitions k12, 
k23, and k53 to change. Our subsequent analysis showed a slowing of the rate constants k12 and 
k23, which correlates well with the observed slowing of channel activation (Table 2). However, 
there was no improvement in the fit when compared to the k53 model (Table 2). Therefore, the 
modest effect of PCMBS on channel activation does not require a substantial change in k12 or 
k23. The predominant effect on kinetic behavior is completely accounted for by the change in 
transition k53, which accurately describes the slowing in channel deactivation.  
In contrast to the WT-channel, the L281W mutation affects channel deactivation without 
affecting channel activation. Therefore, this made for an ideal model to confirm whether the 
change in the deactivation process can be completely explained by the change in transition k53. 
The initial kinetic analysis showed that the change in channel deactivation can be explained by 
an ~4-fold slowing of transition k53, which corresponds well with the observe
1). As predicted, we were able to reproduce the fit from the initial kinetic analysis by 
modifying only transition k53 (Table 2). This result argues that the slowing of channel 
deactivation observed with PCMBS and L281W can be explained by slowing of transition k53. 
The results from the kinetic analysis correspond well with the observed phenotype for both the 
PCMBS modulated channel and the L281W mutation. This correspondence would suggest that 
PCMBS and the L281W mutation disrupt channel behavior through a common mechanism, 
which will be discussed further in the following section. Although our data are consistent with 
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PCMBS and L281W stabilizing the open conformation, based upon our analysis of macroscopic 
currents we cannot eliminate the possibility that the observed effects are the result of 
destabilizing the closed conformation [210]. Therefore, a physical interpretation of the 
manipulation by PCMBS and L281W are that both perturbations disrupt channel closing, 
suggesting that Cys276 and Leu281 are located in a region of S6 that is allosterically coupled to the 
activation gate. 
2.5.4 Potential Mechanism of PCMBS 
Our results are consistent with PCMBS binding to Cys276; however, we cannot recreate this 
effect by sterically perturbing position 276 with a tryptophan substitution. Furthermore, mutation 
ioned Ala276 and Asp276 (no expression) also failed to 
alter the apparent Ca2+ affinity (unpublished data). Although many scenarios may account for 
to Gly276, Phe276, Tyr276, and the aforement
this result, the simplest explanation is that Cys276 is not coupled to the activation gate. 
Furthermore, mutation of the adjacent amino acid, C277W had only modest effects on apparent 
Ca2+ affinity, also suggesting that Cys277 is not coupled to the activation gate. These results are in 
agreement with a previous investigation, which predicted that the channel cavity extends from 
Val272 to Thr278 [111, 113]. Modeling of the open (computer derived structure) and closed state 
using the KcsA structure, indicates that the major conformational change occurs along S6 
between Thr278 and Val282 [113]. Gating sensitive residues are found in regions of the channel 
where amino acid packing rearranges as the channel transitions from one conformational state to 
another [210]. Therefore, interpreting our results in the context of previous investigations suggest 
that mutations at Cys276 and Cys277 do not modulate gating because this region is predicted to 
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undergo little movement, whereas Leu281 and Val282 are thought to modulate gating because 
these positions are predicted to undergo major conformational change [113].  
 Mutating Leu281 or Val282 to tryptophan shifts the gating equilibrium toward the open 
state, demonstrating this region rearranges as the channel transitions between conformational 
states. More importantly, the Trp281 mutation has the additional effect of slowing the deactivation 
process. The similarity between modification by PCMBS and L281W supports the notion that 
these two perturbations are disrupting the channel through a common mechanism. Thus, PCMBS 
and L281W may function to shift the gating equilibrium toward the open conformation by either 
stabilizing the open state or destabilizing the closed state [210]. Our data cannot eliminate either 
of these possibilities. Therefore, we propose two hypotheses to describe how PCMBS and the 
L281W mutation disrupt the gating of KCa3.1. To attempt to visualize rearrangements that occur 
in this region during gating, we constructed a closed state model of KCa3.1 based on the KcsA 
x-ray structure and an open state model based on Kv1.2 (Fig. 26). The open state model predicts 
that Leu281 is oriented toward S5 (inset Fig. 26). Our kinetic modeling predicts that PCMBS and 
L281W slow transition k53. Therefore, our first hypothesis is that these perturbations hinder the 
possible rotational movement of S6 that was shown to accompany the closed to open transition 
in the KcsA K+ channel [217]. The increase in side-chain volume with the L281W mutation 
could sterically hinder the rotation of S6 by disrupting a potential S5-S6 interaction. 
Additionally, Ackerman et al., characterized the binding mechanism of PCMBS to Charcot-
Leyden crystal protein, and determined that PCMBS binds to Cys57, but results in downstream 
perturbation at the Arg60 side-chain [218]. Therefore, PCMBS may interact with neighboring 
residues in the open state to disrupt the conformational change in S6. This model supports our 
data well because these interactions could energetically stabilize the open conformation. 
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However, we cannot rule out the possibility that PCMBS and L281W shift the gating equilibrium 
toward the open conformation by destabilizing the closed conformation of the channel. Along 
these lines, the open and closed state models of KCa3.1 predict that Cys276 and Leu281 sterically 
clash in the closed state but not in the open state. Therefore, an alternate hypothesis is that when 
PCMBS is conjugated to Cys276 it disrupts the closing transition by sterically clashing with 
Leu281. The L281W mutation would work through a similar mechanism, except this mutation 
would disrupt the closing transition by sterically clashing with Cys276. Although there is an 
agreement between the length of PCMBS and the distance between the β-carbons of the 
corresponding residues from KcsA and KirBac1.1 (Fig. 26), the steric clash predicted by this 
model could lead to an energetic destabilization of the closed state. This conclusion is 
inconsistent with our kinetic modeling. Furthermore, the KcsA structure cannot account for the 
closed conformation of KCa3.1, as the region in KCa3.1, corresponding to the bundle crossing in 
KcsA, does not function as an activation gate [110, 111]. Thus, while this is an interesting model 
that predicts an intersubunit interaction, it is an unlikely representation for the molecular function 
of PCMBS. 
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 Figure 26. Homology model of the pore region for the open and closed state of KCa3.1.  (left panel) 
Representation of the S5- P-helix -S6 region viewed as a profile illustrating the predicted orientation of Cys276 
(yellow), and the L281W mutation (red) in the closed state using the KcsA structure. (Inset) Structure of PCMBS 
adapted from the crystal structure of PCMBS in complex with the Charcot-Leyden crystal protein (Ackermen et al., 
2002). PCMBS is 6.5 Å in length and 9.0 Å in length when the thiol group is included. The color red represents 
oxygen molecules, yellow (sulfur), cyan (carbon), and white (mercury). (right panel) Representation of the S5- P-
helix -S6 region viewed as a profile illustrating the predicted orientation of Cys276 (yellow), and the L281W 
mutation (red) in the open state based upon the structure of rKv1.2. Sequence alignments used for homology 
modeling can be found in Fig. 5 (C). (Inset) Representation of S5 and S6 viewed from the intercellular aspect of the 
pore to illustrate that Leu281 (L281W) is oriented toward S5. Cys276 and L281W from the adjacent subunit are the 
only residues illustrated to compare the predicted orientation in the closed and open state. The S5 and P-helix are 
colored green and the S6 helix is colored blue. All residues are illustrated in VDW format. The C-terminal portion of 
the S5 helix was removed to prevent obscuring the view of L281W.  
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3.0  DISCUSSION AND FUTURE DIRECTIONS 
One of the most fundamental questions in the field of ion channel biophysics concerns the 
conformational changes that are required to transition from the closed to the open conformation. 
In answering this question, it is convenient to think of ligand-gated ion channels, in this case 
KCa3.1, as having three separate domains: 1) the pore-forming domain, 2) the ligand-binding 
domain, and 3) the coupling domain. The pore domain, as introduced previously, contains the ion 
permeation pathway, the selectivity filter, and the activation gate. The ligand-binding domain 
contains the ligand binding sites; the coupling domain is the machinery that links the ligand-
binding domain to the activation gate. The coupling domain is critical for the functioning of the 
channel as it enables the chemical energy of Ca2+ binding to be transduced into a mechanical 
force to open the pore. Although much progress has been made toward understanding how 
channels gate, large gaps still exist in our knowledge. Specifically, these gaps are related to the 
coupling mechanism and the regions of the channel that actively participate in this process. 
During the past 12 years, ion channel crystal structures have provided direct structural evidence 
for the regions associated with the gating mechanism. These atomic structures have provided 
great insight into the mechanism of the pore-forming and ligand-binding domains. For example, 
the crystal structures of CaM/CaMBD and apoCaM/CaMBD of KCa2.2 have provided a 
potential mechanism for Ca2+ binding and the subsequent conformational changes occurring in 
the CaMBD [192, 193]. However, little progress has been made toward understanding what 
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movements are critical in the coupling of Ca2+ binding to gate opening. The difficulty lies in the 
fact that the coupling mechanism might not rely on a direct physical linkage between domains. 
As discussed previously, the linkage may be indirect making it difficult to resolve the 
mechanism by simply examining static structures. Although results from site-directed 
mutagenesis can at times be difficult to interpret, it is a powerful tool for locating gating 
sensitive residues. The sensitivity of gating to mutations provides valuable information about the 
energetics and mechanism of pore opening. Transitioning between different conformational 
states causes amino acids to pack differently. If the conformation of a particular amino acid is 
critical for the pore to transition from one conformational state to another, altering that amino 
acid through site-directed mutagenesis will change the energetics of channel gating. Therefore, 
characterizing how mutations alter gating energetics is a valuable method to gain insight into the 
gating mechanism.  
The significance of S6 in the gating mechanism is demonstrated from observations that 
mutations along the pore affect a late concerted non-voltage-dependent opening step in Kv 
channels [210]. This is not surprising since S6 forms part of the pore, and it is widely accepted 
that this transmembrane domain contributes significantly to the activation process in all K+ 
channels. The contribution of S6 to the gating of KCa3.1 has been investigated using SCAM 
[113]. In this series of investigations, it was concluded that the C-terminal region of S6 
participates in the activation mechanism. Furthermore, based upon the state-dependent 
modification of positions Val284 and Val285, it is predicted that the Ala283-Ala286 region undergoes 
significant conformational change [111, 113]. However, the hydrophilic MTS reagents (MTSET 
and MTSEA) used in their investigation cannot access residues orientated opposite to the lumen. 
Therefore, this approach could not assess whether the non-luminal residues are involved in the 
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gating mechanism. Since this region of the channel is predicted to participate in the activation 
mechanism, it would be informative to determine whether the non-luminal residues are also 
incorporated into this process. The goal of this dissertation was to investigate the role of S6 in 
the activation mechanism of KCa3.1, particularly whether the non-luminal residues in the C-
terminal portion of S6 are required for the closed to open transition. 
KCa3.1 contains nine endogenous cysteines residues, and four of these residues are 
located in S6. Three out of the four residues are predicted to have a non-luminal orientation 
(Cys269, Cys276 and Cys277), based on homology modeling with KcsA and Kv1.2. The 
arrangement of these cysteines served as a convenient tool to assess whether the non-luminal 
face of S6 participates in the activation mechanism. The mercurial based sulfhydryl reagent 
PCMBS has been shown in previous investigations to have the ability to access residues not 
accessible using any of the various MTS reagents [199-201]. Utilizing this compound, we made 
the observation that PCMBS irreversibly increases current when added to the intracellular side of 
an excised membrane patch expressing KCa3.1 (Fig. 12). We proposed that PCMBS increases 
channel activation through modification of an endogenous cysteine residue(s) in S6. Therefore, 
characterizing the mechanism of PCMBS activation enabled us to test the hypothesis that the 
non-luminal residues in the C-terminal portion of S6 are important in the activation mechanism 
of KCa3.1. 
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3.1 MERCURIAL BASED SULFHYDRYL REAGENTS AS PROBES FOR NON-
LUMINAL CYSTEINE RESIDUES 
As discussed previously, PCMBS binds to Cys276 thereby influencing both the steady-state and 
the kinetic behavior of the channel (Figs. 20, 12, 14-15). The difference in accessibility between 
PCMBS and MTSET or MTSEA is most likely due to the difference in the location of the 
cysteine reactive moiety, and/or the probability that the PCMBS/cysteine conjugate is more 
likely to disrupt the local environment. However, an investigation examining the helix packing 
of EmrE suggests mercurial based compounds may be better probes for cysteines predicted to be 
located in low dielectric environments. EmrE is a small multidrug transporter in Escherichia 
coli, and cysteines substituted in the transmembrane domains were only accessible to organic 
mercurials and not sulfhydryl reagents such as maleimides and methanethiosulfonates [219]. 
Additionally, we observed that thimerosal, a mercurial based sulfhydryl reagent, added to the 
intracellular side of the membrane resulted in a left-shift in apparent Ca2+ affinity (Fig. A.1A and 
A.1B); like PCMBS, thimerosal-sensitivity was traced to modification of Cys276 (Fig. A.2). 
Therefore our results using PCMBS and thimerosal, would also indicate that mercurial 
compounds can access cysteines predicted to be in low dielectric environments. However, none 
of the endogenous cysteines in KCa3.1 were accessible with Et-Hg+ [111], suggesting the effect 
on the WT-channel is not related to the presence of mercury, but the unique size and chemistry 
of PCMBS and thimerosal. MTS reagents do not affect gating of the closely related channel 
KCa2.3 [197, 198], suggesting these compounds cannot bind to the endogenous cysteine(s). 
KCa2.3 has two endogenous cysteine residues in S6, Cys525 and Cys535, which are equivalent to 
Cys267 and Cys277 in KCa3.1. Therefore, I wanted to ask whether PCMBS could access and 
modify the endogenous cysteines in KCa2.3 as a way to determine whether mercurial 
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compounds are better at accessing cysteines in low dielectric environments. However, unlike 
KCa3.1, the addition of PCMBS to KCa2.3 had no effect on steady-state behavior (Fig. A.3A). 
KCa2.3 has a glycine (Gly534) at the position corresponding to Cys276 in KCa3.1. Therefore, we 
tested whether the mutation G534C could confer PCMBS sensitivity to KCa2.3. As we observed 
in the WT-channel, the addition of PCMBS did not affect steady-state behavior of the channel 
(A.3B). The inability of PCMBS to modify G534C can be explained by the inability of PCMBS 
to access G534C, or the mutation could mimic the phenotype from KCa3.1, masking any 
potential effect by the compound. As illustrated in Figs. (A.5A and A.5D) and (A.7A and A.7D), 
the mutation G534C influenced channel behavior in a manner similar to the effect of PCMBS on 
KCa3.1. That is, the mutation causes a left-shift in apparent Ca2+ affinity and a slight slowing in 
the deactivation process (see Table A.3 and A.5). Therefore, PCMBS may be able to access 
G534C, but the mutation affects channel gating; masking any potential effect the compound may 
have on the channel. In total, the results from experiments with thimerosal and PCMBS 
interpreted in context with the EmrE investigation argue for mercurial based compounds as 
better probes for cysteines in low dielectric environments. The discrepancy with the Et-Hg+ 
result may be due to the inability of this compound to act as a perturbing molecule rather than an 
accessibility problem. Et-Hg+ is smaller than MTSEA, with dimensions closer to the size of a 
dehydrated K+ ion [111]. Therefore, Et-Hg+ may access the endogenous cysteine(s) in S6, but 
because of the compound’s small size, it cannot disrupt channel gating. 
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3.2 S6 IS A DYNAMIC COMPONENT OF THE GATING MECHANISM 
The idea that S6 is critical for the gating mechanism is intrinsic to the chemomechanical gating 
model proposed for the activation of KCa3.1. In this model, the chemical energy of Ca2+-binding 
is transformed into a mechanical force enabling the channel to transition into the open state. S6, 
due to its relative location between the CaM/CaMBD and the pore, is a logical choice to couple 
the conformational change occurring in the CaMBD to the pore. Thus, S6, in addition to forming 
part of the pore, is also a dynamic component in the gating machinery. Considering this, it was 
no surprise that perturbation to this region modulated the gating of KCa3.1. However, it was 
interesting to note that while only a small number of the mutations from the tryptophan scan 
resulted in functional channels, the ones that did tended to shift the gating equilibrium toward the 
open conformation (see Table A.2). Furthermore, the addition of PCMBS and the V275A 
mutation also shifted the gating equilibrium toward the open conformation (see Table 1 and A.2). 
It is difficult to draw any generalizations about the nature of perturbations to S6 from such a 
small sample size, but these results are consistent with a previous investigation on the Kv 
channel [210]. Yifrach et al., made the observation that the majority of mutations along S6 
shifted the gating equilibrium toward the open conformation. This can occur in one of two ways: 
the mutations can stabilize the open or destabilize the closed conformation. Based solely upon 
theoretical reasoning, they proposed that the mutations destabilize the closed conformation for 
the following reasons. 1) Mutations are more likely to disrupt protein structure then to stabilize 
it. 2) The closed state is more stable compared to the open state due to a higher number of 
favorable protein interactions. Since there are more ways to disrupt an optimally packed protein, 
they suspect that the closed state is more susceptible to perturbations. Although we cannot 
determine if the shift in gating equilibrium is the result of stabilizing the open conformation or 
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destabilizing the closed conformation, interpreting our data in context with the Yifrach et al., 
investigation may provide insight into the nature of S6 in KCa3.1. By drawing an analogy to this 
investigation, we can infer that perturbation to S6 causes the gating equilibrium to shift toward 
the open conformation because the closed conformation of KCa3.1 is intrinsically more stable, 
thus the lowest energy state of the protein. Therefore, any perturbation to this region will 
destabilize the structure causing the gating equilibrium to shift toward the open conformation. 
Does this line of reasoning follow for S6 in all ion channels? Not all perturbations to S6 
shift the gating equilibrium toward the open conformation. There are many examples where 
mutations along this domain shift the gating equilibrium toward the closed state. For example, in 
KCa2.3 mutations along S6 tended to shift the gating equilibrium in both directions (see Table 
A.3). Following the line of reasoning discussed above, the tendency for perturbation to shift the 
gating equilibrium in both directions could be explained because the closed conformation of S6 
is not the most stable conformation, and therefore not the lowest energy conformation. 
Therefore, mutations in S6 may destabilize the closed conformation, pushing the gating 
equilibrium toward the open conformation; mutations may also stabilize the closed 
conformation, pushing the gating equilibrium toward the closed state. How mutations in S6 
disrupt the energetics of gating suggests a functional difference in this transmembrane domain 
that is at odds with the sequence similarity between these channels. Although this discrepancy 
may be explained by the four amino acid difference in S6 (Table A.1), it suggests that the 
coupling between CaM and the activation gate may account for the mutational phenotype. If the 
coupling pathway is different between these channels, it can be expected that mutations in S6 
will have a different effect on the energetics of channel gating. As discussed below, functional 
 119 
differences between these channels can be used as a tool to isolate the regions of the channel 
responsible for this behavior.  
3.3 KCa3.1 VERSUS KCa2.3 
KCa3.1 and KCa2.3 have a high degree of homology along the CaM/CaMBD, which is reflected 
by their apparent Ca2+ affinities being similar (Table A.2 and A.3). However, the activation rate 
for KCa2.3 is about 10-fold faster compared to KCa3.1 (Table A.4 and A.5). Additionally, the 
Po(max) values derived from variance analysis are 0.6 and 0.9 for KCa3.1 and KCa2.3, 
respectively (Fig. 13 and A.8). Since the apparent Ca2+ affinities are equivalent, the differences 
between Po(max) and the activation rates are quite interesting. The most logical explanation would 
be the differences in the gating machinery: S5, S6, and the CaMBD. However, S6 and the 
CaMBD, are highly homologous (Table A.1), which would argue for the discrepancy in behavior 
possibly originating from S5. A chimeric approach would be effective for determining whether 
S5 or specific regions of S5 are responsible for the difference in behavior. However, KCa2.2 
with the S5 from KCa3.1 does not express (Devor lab unpublished data). Therefore, a less 
invasive approach where only a few amino acids are swapped between channels at a time to 
avoid non-functional channels will be necessary. Furthermore, determining whether the chimeric 
channel adopts the behavior of the donor channel based on effects on binding or conformation 
change would be critical for understanding the coupling mechanism. However, one of the most 
fundamental problems in ligand-gated ion channels is making the distinction between effects on 
binding and effects on conformational change. Robert Stephenson first noted that the action of an 
agonist could not be described by just an affinity constant; there must be another quantity he 
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termed efficacy that describes the ability of the agonist to activate the receptor [220]. Therefore, 
two terms are used to describe the action of an agonist. Affinity is defined as the initial binding 
reaction and efficacy describes everything that occurs after the initial binding of the agonist. For 
ion channels, the equivalent terminology is binding and gating [221]. Therefore, all behavioral 
characteristics of ligand-gated ion channels can be reduced to differences in binding or gating. 
However, obtaining useful and accurate measurements of these quantities have been difficult. 
This is due in part to the fact that these terms are not independent of one another [221]. Binding 
affects gating, which means that gating must affect binding. This concept is a reflection of the 
basic physical principle of reciprocity, if A affects B then B must affect A [222, 223]. Therefore, 
for any ligand that produces a conformational change, the total amount of binding as measured in 
a ligand binding experiment depends not only on the affinity of the initial binding, but also on 
the extent to which the conformational change takes place once ligand had become bound [221]. 
In the case of KCa3.1 and KCa2.2, it would be nearly impossible to measure affinity and 
efficacy of Ca2+ without a detailed activation mechanism such as that described for the muscle 
nicotinic acetylcholine receptor [224, 225]. However, as explained in the next section, Li et al., 
[196] show that the trivalent lanthanide ion, terbium (Tb3+), can act as a substitute for Ca2+; 
binding to the same sites on KCa2.2 CaM but with a higher affinity. Characterizing the 
functional effects of Tb3+ on the activation of KCa3.1 and KCa2.2 will be a useful tool for 
understanding the coupling between CaM and the channel, which may provide insight into a 
mechanism for separately measuring affinity and efficacy. 
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3.4 CYSTEINE 276 AS AN IMPORTANT SITE FOR THE COUPLING OF Ca2+ 
BINDING TO CHANNEL GATING 
One of the more interesting effects of using PCMBS is its ability to increase Po(max) in saturating 
[Ca2+]i, suggesting that 10 μM Ca2+ is insufficient to saturate the activation of KCa3.1. However, 
increasing [Ca2+]i above 10 μM does not increase residual current (unrecorded observation). 
Compounds that potentiate the closely related channel, KCa2.2 are thought to stabilize the 
CaM/channel interaction. EBIO and NS309 increase the apparent Ca2+ affinity; EBIO slows the 
deactivation process; and NS309 increases current in saturating Ca2+. Stabilizing the 
CaM/channel interaction as a means to potentiate channel activation was confirmed by 
characterizing the effect of Tb3+ on the activation of KCa2.2. Tb3+ has been shown biochemically 
to bind to the same Ca2+ binding sites, activating the purified CaM protein, thus acting as a 
substitute for Ca2+. Investigating the effect of Tb3+ on a CaM-dependent ion channel, Li et al., 
[196] showed Tb3+ binds to the same sites as Ca2+, but with a higher affinity. The higher affinity 
causes a dramatic left-shift in the apparent Ca2+ affinity, in addition to a dramatic slowing in the 
deactivation process [196]. PCMBS binds to an amino acid (Cys276) in S6, but influences channel 
behavior in a manner similar to compounds that stabilize the CaM/channel interaction. This 
result can be explained if Cys276 is in a region of the channel associated with the coupling 
machinery. If coupling is a direct or indirect transfer of the energy from the CaM/CaMBD to the 
activation gate, than any perturbation to this pathway should mimic the effect of stabilizing the 
CaM/channel interaction. Therefore, Cys276 (or the neighboring residues; see section regarding 
the potential mechanism of PCMBS) functions to allosterically couple the energy of Ca2+ 
binding to the activation gate. The same conclusion also applies for Leu281, on account of the 
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L281W mutation mimicking the effects EBIO, NS309, and Tb3+. These results are not surprising 
considering the C-terminal linker between the CaMBD and S6 is the most likely pathway for the 
transfer of activation energy. This has been confirmed in the BK channel. Modifying the linker 
length inversely influences channel Po [129]. However, what is not obvious is how these domains 
function to transduce the chemical energy of Ca2+ binding into a mechanical force to open the 
channel. In the next section I will present two potential mechanisms based upon PCMBS and the 
L281W mutation that attempt to partially describe the coupling between CaM and KCa3.1. 
3.5 POTENTIAL COUPLING MECHANISM 
As previously explained in the review of the chemomechanical gating model, the binding of Ca2+ 
to CaM results in a conformational change in the CaMBD, which leads to a rotational movement 
of this domain that is transmitted to the activation gate through S6 [189, 192, 193]. However, 
what is not understood is how the conformational change in CaM/CaMBD is allosterically 
coupled to the activation gate. In this dissertation, I am proposing that the non-luminal face of 
the C-terminal portion of S6 forms an interaction surface that functions to allosterically couple 
conformational changes to the activation gate. Therefore, understanding the functional effects of 
PCMBS and the L281W mutation may provide insight into the coupling between CaM and the 
channel. I will propose two potential coupling pathways based upon these perturbations, and in 
the conclusion/future directions section I will propose how to go about testing for each of these 
models.  
My first hypothesis states that shifting the gating energetics toward the open 
conformation is due to a potential interaction between S6 transmembrane domains from adjacent 
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subunits. This idea flows from the homology model of the closed and open states of KCa3.1 
using the x-ray structures of KcsA and Kv1.2, respectively. The closed state model predicts a 
steric clash between Cys276 and Leu281 from the adjacent transmembrane domain (Fig. 26). From 
this model we can estimate that the distance between the β-carbon of Cys276 and the β-carbon of 
Leu281 is 7.0 Å, which is comparable to the distance between the corresponding β-carbons in 
KcsA (7 Å) and KirBac1.1 (9 Å). PCMBS is 6.5 Å from the mercury atom to the sulfur atom 
(inset Fig. 26), and this length increases to 9.0 Å when measured from the sulfur atom to the 
thiol group of the conjugated cysteine (inset Fig. 26). Therefore, I hypothesize that when 
PCMBS is conjugated to Cys276 it disrupts the closing transition by sterically clashing with 
Leu281. This mechanism would suggest that S6 would have to undergo a combined rotation and 
inward lateral movement to transition from the predicted orientation in the open state model to 
the orientation depicted in the closed state model (Fig. 26). This type of conformational change 
would suggest that the coupling mechanism occurs along the linkers between transmembrane 
domains, suggesting the C-terminal linker and the bottom end of S6 as a likely pathway for the 
transfer of energy to the activation gate. Therefore, the conformational change originating in the 
CaMBD would travel along the C-terminal linker to the bottom end of S6. If KCa3.1 has a 
similar gating mechanism as MthK, the presence of a glycine in S6 would enable the helix to 
bend in an outward lateral direction. Removing Ca2+ would reverse this process, causing the 
helix to move in an inward lateral direction, which would orient Cys276 and Leu281 from the 
adjacent helix into close approximation.  
My second hypothesis states that the shift in gating energetics toward the open 
conformation is due to a potential S5-S6 interaction. Leu281 is oriented toward S5 (inset Fig. 26). 
Increasing side-chain volume with the L281W mutation is expected to disrupt this interaction, 
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preventing the transition into the closed conformation. Mutations in transmembrane domains S5 
and S6 indicate this interaction is important for the opening and closing of K+ channels [128]. 
Therefore, based upon the L281W mutation, the coupling mechanism is expected to be 
dependent upon the interacting surfaces between transmembrane domains. In the spHCN1 pace 
maker channel, the S4-S5 linker and the C-terminal linker come in close approximation during 
gating. Utilizing this model in context with my hypothesis suggests a possible coupling pathway 
between CaM and the activation gate. The energy from Ca2+ binding could travel from the 
CaMBD to the activation gate via the C-terminal linker, which in the spHCN1 channel, interacts 
with the S4-S5 linker. From the S4-S5 linker the activation energy would be predicted to follow 
S5 and through a S5-S6 coupling finally end at the activation gate. Therefore, based upon the 
functional effects of PCMBS and the L281W mutation, I presented two possible coupling 
pathways that are mediated through either: 1) an intersubunit interaction or 2) an S5-S6 
interaction. In the next section I will propose a series of experiments to distinguish between these 
potential interactions. 
3.6 CONCLUSION/FUTURE DIRECTIONS 
The goal of this dissertation was to investigate the role of S6 in the activation mechanism of 
KCa3.1. In doing so, we learned that not only is S6 a structural component of the pore, but also a 
dynamic element participating in the activation mechanism. Previous investigations noted that 
the luminal surface of the C-terminal end of S6 participates in the activation mechanism [110, 
111, 113]. We furthered this model by showing that the non-luminal surface of this segment is 
important for allosterically coupling the conformational change in CaM to the activation gate. 
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Disrupting this region with PCMBS or the L281W mutation shifts the gating equilibrium toward 
the open state by disrupting the closing transition. Therefore, the updated chemomechanical 
model states that the activation energy from Ca2+ causes a conformational change in CaMBD, 
which through the luminal and non-luminal surfaces of the C-terminal end of S6 is allosterically 
coupled to the activation gate. Furthermore, the activation energy is potentially transmitted to the 
activation gate through either the linkers connecting transmembrane domains, or through the 
interacting surfaces between transmembrane domains.    
The overall importance of S6 to the activation mechanism was confirmed by 
investigating this domain in the closely related channel, KCa2.2. Similar to KCa3.1, mutations in 
S6 altered the energetics of channel gating. Although the functional effect of the mutations was 
quite similar (Tables A.2-A.5), important functional differences exist between these channels. 
Exploring these functional differences would be an effective strategy for furthering our 
understanding of the activation mechanism. To that end, I proposed two potential mechanisms 
for coupling between CaM and KCa3.1 based upon the functional effects of PCMBS and the 
L281W mutation. Although these mechanisms propose two different pathways for the transfer of 
energy to the activation gate, these mechanisms are not meant to be mutually exclusive. It is 
possible that the coupling mechanism incorporates a S5-S6 interaction in combination with an 
intersubuit interaction. Therefore, the next objective in this dissertation would be to investigate 
whether either of these mechanisms is associated with the activation of KCa3.1.  
The first hypothesis states that Cys276 and Leu281 come into close approximation in the 
closed conformation. We would attempt to cross-link these residues using cysteine cross-linkers 
as a means to test this hypothesis. Additionally, using variable length cross-linkers we could 
gauge the distance between these positions in the closed conformation. Since we are attempting 
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to crosslink residues on adjacent subunits, we would use tandem dimers to control subunit 
stoichiometry. This approach has been employed numerous times beginning in the early 90’s to 
look at subunit stoichiometry [226] and more recently to examine possible interacting sites 
within the channel [227, 228]. Following this approach would ensure that the channel assembles 
as ABAB rather than ABBA. This is a critical part of the experiment, as my objective is to 
crosslink residues from adjacent subunits rather then from diagonal subunits. Before attempting 
the cross-linking experiment, I would confirm that the WT and mutant tandem constructs are 
functional, and display gating behavior that is similar to the WT-monomer. The first subunit in 
the tandem construct used in the cross-linking experiments would be cysteine-less except for a 
cysteine at position 276. The second subunit would also be cysteine-less, but in this case, a 
cysteine would be engineered in position 281. The channels would be expressed in a 
heterologous expression system and crosslinking reagents would be applied to the intercellular 
surface of an excised membrane patch. Our model indicates the potential for steric clash between 
Cys276 and Leu281 from the adjacent subunit in the closed conformation. Therefore, to obtain an 
accurate estimate of the distance between these residues, the cross-linking reagent would be 
added after the channel entered the closed conformation. Since I am using a series of cross-
linking reagents with variable lengths, I would expect the majority of the reagents to cross-link 
the channel. However, the linker length that best describes the distance between these positions 
in the closed conformation would prevent the channel from transitioning into the open 
conformation upon the addition of Ca2+. For instance, there may be enough slack using the 
longest linkers that the channel may be able to fully transition into the open conformation. 
Medium length linkers may only allow for a partial opening; the just right length linker would 
lock the channel in the closed conformation. Recovery from the closed state would only occur 
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with the addition of a reducing agent. Since PCMBS is open-state dependent, the cross-linking 
reagents may not have access to Cys276 and Cys281 in the closed conformation. Therefore, I 
would like to add the caveat that cross-linking may not occur in the closed state. If this is the 
case, I would add the reagents to the open state in order to increase the probability of cross-
linking the channel. In an actively gating channel, I would expect the linker length that best 
describes the closed-state distance between these two positions to lock the channel in this state, 
even in the presence of Ca2+. Linkers that are longer than the closed-state distance may allow for 
full or even partial gating transitions. However, even in the open-state, MTS reagents did not 
have access to the non-luminal face of S6 [113]. Again, I would add the caveat that cross-linking 
may not occur in the open state. In which case, I would follow the protocol from Soskin et al., 
for cross-linking cysteines in low dielectric environments [219].  
The second hypothesis states that a S5-S6 interaction is important for the activation 
mechanism. Increasing the volume at position 281 may prevent the rotation of S6 that is thought 
to accompany the open to closed transition in KcsA [217]. To test this hypothesis, I would first 
determine whether substitution of large volume side-chain amino acids such as tyrosine and 
phenylalanine could reproduce the effect of the L281W mutation. If the phenotype is the result of 
an increase in side-chain volume at that position then substitution of amino acids with similar 
sized side-chains would be expected to reproduce the functional effect of the mutation. The 
endogenous amino acid is a leucine, therefore, substitution of amino acids with smaller or similar 
sized side-chains would not be expected to disrupt channel gating. Therefore, as an additional 
test of this hypothesis, I would locate the potential interacting amino acid in S5. To do this I 
would perform a tryptophan scan in this helix. Mutations that are expected to interact with S6 
would have a similar phenotype as the L281W mutation. To determine whether the two positions 
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interact, one would have to assess the independence of the two mutations; the mutation in S5 and 
the L281W mutation in S6. Two mutations can separately effect channel gating; when these 
positions are coupled, the combination of the two mutations will have an additive effect on 
gating energetics [210]. In a S5-S6 interaction, I expect the mutations to be close enough to 
directly interact. Therefore, as an assessment of this interaction, I would expect the mutation in 
S5 that interacts with S6 to have an additive effect on the energetics of gating. If the mutation in 
S5 does not interact with the mutation in S6, I would expect the effects of both mutations to 
cancel out. 
In conclusion, the work presented in this dissertation refines the current 
chemomechanical gating model to include the non-luminal surface of the C-terminal portion of 
S6 as a potential interacting site. This site functions to allosterically couple the conformational 
changes in the CaMBD to the pore, enabling the channel to transition from a non-conducting to a 
conducting configuration. Furthermore, from this work I developed two hypotheses that describe 
a potential coupling pathway between CaM and the activation gate. As an additional component 
of my dissertation, I investigated S6 in the activation mechanism of KCa2.3. Although the 
conclusions were not as definitive when compared to the KCa3.1 investigation, the results 
confirm the important of S6 in the activation mechanism. Furthermore, the important functional 
differences I outlined between these channels can be exploited to better understand the coupling 
mechanism and the specific regions that participate in this process. 
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4.0  APPENDIX 
4.1 INTRODUCTION: STRUCTURE-FUNCTION INVESTIGATION OF S6 IN 
KCa3.1 AND KCa2.3 
As previously described, PCMBS influences the steady-state and kinetic behavior of KCa3.1 by 
binding to Cys276. The closely related channel, KCa2.3 has a glycine residue at the equivalent 
position (Gly534), see Table (A.1). Therefore, we proposed that KCa2.3 would be insensitive to 
PCMBS. As illustrated in Fig. (A.3A), and consistent with our hypothesis, PCMBS had no effect 
on the steady-state current of this channel. Since Cys276 in KCa3.1 is required for PCMBS-
sensitivity, we proposed that the equivalent mutation (G534C) would confer PCMBS sensitivity 
to KCa2.3. However, and much to our surprise, PCMBS had no effect on the steady-state current 
of this channel (Fig. A.3B). The inability of PCMBS to modulate the gating of this channel may 
occur because PCMBS cannot bind to Cys534, or the G534C mutation modulated channel gating 
in a manner that may mask any potential effect by PCMBS. As shown in Figs. (A.5 and A.7) 
along with Tables (A.3 and A.5), the mutation influenced steady-state and kinetic behavior in 
manner similar to the observed effect of PCMBS on KCa3.1. This modulation in channel gating 
would mask any potential effects this compound may have on the gating of KCa2.3. This was a 
rather surprising result. The high degree of homology in S6 between KCa3.1 and KCa2.3 would 
suggest functional homogeneity for the corresponding residues located along this transmembrane 
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domain, see Table (A.1). Since our investigation into the molecular mechanism of PCMBS 
required a series of mutations along S6 in KCa3.1, we decided to make the corresponding 
mutations in KCa2.3 as a means to determine whether any other distinct functional domains exist 
between these channels. The segment of S6 we investigated begins at the proposed glycine-
gating hinge (Gly274 in KCa3.1 and Gly532 in KCa2.3) and extends C-terminally, five amino 
acids before the end of S6 (Val282 in KCa3.1 and Val540 in KCa2.3). We performed a tryptophan 
scan of this region, looking for mutations that disrupt the steady-state and/or kinetic behavior of 
the channel. Furthermore, we focused on the predicted binding site of PCMBS (Cys276) and the 
corresponding residue (Gly534) in KCa2.3, in addition to the residues neighboring these positions 
as they are conserved in both channels Cys277 and Cys535 in KCa3.1 and KCa2.3, respectively. 
Our results indicate that the segment of S6 we investigated is functionally equivalent between 
KCa3.1 and KCa2.3. However, KCa2.3 has more mutations that influence both the steady-state 
and kinetic behavior of the channel, suggesting this region of S6 may undergo a more 
complicated conformational change as the channel transitions from the closed to the open 
conformation. 
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4.2 RESULTS 
4.2.1 Results Table 1 
The mutations made along S6 in KCa3.1 and KCa2.3. The mutations are aligned according to the position along 
S6 and grouped based on the substituted amino acid or the corresponding amino acid present in the other channel. 
 
  KC3.1       KCa2.3  
Position      Position 
G274W      G532W 
V275A      A533V 
V275W      A533W 
C276A       
C276D       G534D 
C276F       G534F 
C276G       G534C 
C276W      G534W 
C276Y       G534Y 
C277A 
C277D       C535D 
C277F       C535F 
C277G       C535G 
C277W      C535W 
C277Y       C535Y 
 
T278W      T536W 
 
A279W      A537W 
 
L280W      L538W 
 
L281W      V539W 
 
V282W      V540W 
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4.2.2 Results Table 2 
The mutations that expressed macroscopic currents in KCa3.1 and KCa2.3. Constructs that expressed highly 
enough to produce macroscopic currents are demarcate from the constructs that do not express by a yes. It is 
interesting, with the exceptions of V275A and C277Y in KCa3.1 and C535F in KCa2.3, that all of the mutations in 
KCa3.1 with little to no channel expression corresponded to the mutations KCa2.3 having little to no channel 
expression. This result would suggest that the residues required for packing are equivalent in both channels. 
 
 
  KC3.1       KCa2.3 
 
Position macroscopic current   Position macroscopic current  
 
G274W      G532W  
V275A Yes     A533V  
V275W      A533W  
C276A  Yes     
C276D       G534D  
C276F  Yes     G534F  Yes 
C276G  Yes     G534C  Yes 
C276W Yes     G534W Yes  
C276Y       G534Y  
C277A  Yes 
C277D       C535D   
C277F       C535F  Yes 
C277G  Yes     C535G  Yes 
C277W Yes     C535W Yes  
C277Y  Yes     C535Y   
 
T278W      T536W  
 
A279W      A537W  
 
L280W      L538W  
 
L281W Yes     V539W Yes 
 
V282W Yes     V540W Yes 
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4.2.3 Results Table 3 
The mutations that mediated a left-shift in apparent Ca2+ affinity in KCa3.1 and KCa2.3. The strike-through 
represents the mutations with little to no channel expression. Mutations resulting in a left-shift in apparent affinity 
are grouped at the bottom two positions, Leu281 and Val282 in KCa3.1 and Val539 and Val540 in KCa2.3. This result is 
not surprising since a previous investigation showed that significant conformational change is expected to occur in 
the C-terminal segment of S6. Furthermore, our results would also suggest that gating sensitive residues are located 
one (Val275) and two (Gly534) amino acids down from the predicted gating hinge (Gly274) and (Gly532) in KCa3.1 and 
KCa2.3, respectively. Assuming KCa3.1 and KCa2.3 incorporate a glycine gating hinge in the mechanism for 
transitioning from the closed to the open conformation, it would follow that residues neighboring the gating hinge 
would also undergo a significant conformation change.  
 
 KC3.1       KCa2.3 
Position Phenotype    Position Phenotype  
 
G274W      G532W 
V275A  left-shift    A533V 
V275W      A533W 
C276A 
C276D       G534D 
C276F       G534F 
C276G       G534C  left shift  
C276W      G534W 
C276Y       G534Y 
C277A 
C277D       C535D 
C277F       C535F 
C277G       C535G 
C277W      C535W 
C277Y       C535Y 
 
T278W      T536W 
 
A279W      A537W 
 
L280W      L538W 
 
L281W  left-shift    V539W  left-shift  
 
V282W  left-shift    V540W  left-shift  
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4.2.4 Results Table 4 
The mutations that mediated a right-shift in apparent Ca2+ affinity in KCa3.1 and KCa2.3. As observed in the 
previous Table, the mutations causing a right-shift in apparent Ca2+ affinity are grouped around the same residue, 
Cys277 and Cys535 in KCa3.1 and KCa2.3, respectively. 
 
 KC3.1       KCa2.3 
 
 
Position Phenotype    Position Phenotype  
 
G274W      G532W 
 
V275A left-shift    A533V 
V275W      A533W 
 
C276A       
C276D       G534D 
C276F       G534F 
C276G       G534C  left-shift  
C276W      G534W right-shift  
C276Y       G534Y 
 
C277A 
C277D       C535D 
C277F       C535F  right-shift  
C277G       C535G   
C277W slight right-shift   C535W right-shift  
C277Y  slight right-shift   C535Y 
 
T278W      T536W 
 
A279W      A537W 
 
L280W      L538W 
 
L281W  left-shift    V539W left-shift   
 
V282W  left-shift    V540W left-shift  
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4.2.5 Results Table 5 
The mutations that alter activation or deactivation kinetics in KCa3.1 and KCa2.3. Unlike the previous results, 
the mutations that disrupt deactivation kinetics are randomly distributed along S6. The exception would be the 
mutation in KCa3.1 (C277F) and the corresponding position in KCa2.3 (G534C). It is interesting to note that none 
of the mutations disrupt activation kinetics. KCa2.3 has 3 mutations (to 1 mutation in KCa3.1) that disrupt both the 
steady-state and kinetic behavior of the channel, suggesting the channel may undergo a more complicated 
conformational change as it transitions from the closed to open conformation. 
 
KC3.1       KCa2.3 
Position Phenotype    Position Phenotype  
 
G274W      G532W 
V275A left-shift    A533V 
V275W      A533W 
C276A       
C276D       G534D 
C276F  deactivation is SLOWER  G534F 
C276G       G534C left-shift/deactivation is  
          SLOWER  
C276W      G534W  right-shift  
C276Y       G534Y 
C277A 
C277D       C535D 
C277F       C535F    right-shift/deactivation is  
          FASTER  
C277G       C535G 
C277W slight right-shift   C535W right shift  
C277Y  slight right-shift   C535Y 
 
T278W      T536W 
 
A279W      A537W 
 
L280W      L538W 
 
L281W     left-shift/deactivation is SLOWER V539W  left-shift   
 
V282W left-shift    V540W   left-shift/deactivation is  
          SLOWER  
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4.2.6 Results Table 6 
Summary of the effects that the mutations had on S6 residues in K Ca3.1 and KCa2.3. Mutations that had no 
effect on channel behavior are in italics. In summary, these results indicate that the residues required for channel 
expression are equivalent between KCa3.1 and KCa2.3. The mutations that cause a right-shift in apparent Ca2+ 
affinity are grouped in the middle of the search region, whereas the mutations that cause a left-shift in apparent Ca2+ 
affinity are grouped toward the C-terminal end of the search region. This result would indicate the basic architecture 
of the search region is equivalent between both channels. The only discrepancy from this investigation is that 
KCa2.3 has more mutations that disrupt both steady-state and kinetic behavior of the channel, suggesting this 
channel may undergo a more complicated conformational change(s) as it transitions from the closed to the open 
conformation.  
 
 KC3.1       KCa2.3 
Position Phenotype    Position Phenotype  
 
G274W      G532W 
V275A left-shift    A533V 
V275W      A533W 
C276A       
C276D       G534D 
C276F  deactivation is SLOWER  G534F 
C276G       G534C left-shift/deactivation is  
          SLOWER  
C276W      G534W right-shift 
C276Y       G534Y 
C277A 
C277D       C535D 
C277F           C535F    right-shift/deactivation is  
          FASTER  
C277G       C535G 
C277W slight right-shift   C535W right shift  
C277Y  slight right-shift   C535Y 
 
T278W      T536W 
 
A279W      A537W 
 
L280W      L538W 
 
L281W       left-shift/deactivation is SLOWER V539W left-shift   
 
V282W left-shift    V540W left-shift/deactivation is  
          SLOWER  
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4.3  DISCUSSION/CONCLUSIONS 
KCa3.1 and KCa2.3 are closely related channels with a high degree of homology, especially in 
S6 and the CaM/CaMBD region in the C-terminal domain. This homology is reflected by the 
similarity in the apparent Ca2+ affinity between these channels, see Table (A.2) and (A.3). 
However, this is where the similarity between channel function ends. KCa2.3 has a higher Po(max) 
(Fig. A.8) compared to KCa3.1 (Fig. 13). Although, both channels have a similar deactivation 
rate, the activation rate for KCa2.3 is 10-fold faster when compared to KCa3.1. Therefore, we 
asked whether any of these differences could be attributed to any potential functional differences 
existing along S6. Our results would indicate that the segment of S6 we investigated is similar 
between both channels, with the lone discrepancy being that there are more mutations that 
influence both the steady-state and kinetic behavior of KCa2.3, suggesting this region of the 
channel may undergo a more complex conformational change as the channel transitions from the 
closed to the open conformation. The functional similarity we reported between these channels is 
not surprising, since the region we investigated only differs by a couple of amino acids. 
Therefore, the observed differences in channel function must be explained by differences in other 
regions of the channel. Since we only investigated the region of S6 surrounding the PCMBS 
binding site, it is possible that functional differences exist either above or below this segment. 
Therefore, one possible avenue for investigation would be to complete the tryptophan scan of S6 
as a means to determine whether functionally different regions exist outside of the previously 
examined region. Another approach, and one more likely to find functional differences in the 
channel is to investigate how S5 contributes to the activation mechanism in both of these 
channels. Unlike S6, which is highly homologous between these channels, the S5 sequence is 
quite different (15 out of 23 amino acids). Therefore, another avenue of investigation would be 
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to swap S5 domains between these channels. However, the chimera does not express when the 
full S5 is switched between channels (DC Devor, unpublished observations). Therefore, an 
alternative approach would be to switch the non-conserved amino acids between channels. If S5 
significantly contributes to the activation mechanism, then the chimeric channel would display 
the functional properties of the donor channel. 
Although our investigation did not report any significant functional differences between 
these channels, we can conclude that S6 actively participates in the Ca2+-dependent activation 
mechanism. The wide disparity between Po and activation kinetics indicates these channels are 
functionally much different than their sequence suggests. These discrepancies cannot be 
explained by the existence of functionally different domains present along the S6 segment we 
investigated. However, the potential exists for these disparate channel properties to be explained 
by differences in the S5 transmembrane domain or the regions of S6 that were outside our area of 
investigation. 
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4.4 APPENDIX FIGURES 
Figure A.1A 
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Figure A.1B  
 
Figure A.1. Thimerosal shifts the apparent Ca 2+ affinity in KCa3.1. Complete Ca2+ concentration response 
experiments were performed to estimate EC50 and the Hill coefficient (h) in the absence and presence of thimerosal. 
(A) Representative macroscopic current record from an inside-out patch expressing KCa3.1 channels. The patch was 
excised in 10 μM Ca2+i followed by a series of Ca2+i concentrations beginning with 0, 0.1, 0.3, 0.6, 1.0, 3.0, and 10 
μM Ca2+i, all applied in 10 s intervals using a rapid solution exchanger. After the current reached a steady-state level, 
thimerosal (500 μM) was added and a 2nd Ca2+i concentration response experiment was performed using the above 
Ca2+i concentrations in the presence of thimerosal. (B) Plot of normalized <I> current against the corresponding 
Ca2+i for KCa3.1 (?) and KCa3.1+thimerosal (?) fit with a variation of the Hill equation (see methods). This 
analysis gave estimates for KCa3.1 (solid line, n=15) EC50=498±14 nM and h=2.4±0.04 and KCa3.1+thimerosal 
(dashed line, n=10) EC50=229±22 nM and h=3.3±0.04. All experiments were done in pairs, but an alternate set of 
Ca2+i concentrations (0.1, 0.15, 0.2, 0.25, 0.3, 0.6, 1.0 and 10 μM) were used when estimating EC50 and h for 
KCa3.1+thimerosal. Error bars represent standard error of the mean (SEM). The error bars for KCa3.1 are smaller 
than the symbols (?).  
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Figure A.2 
 
 
 
 
 
Figure A.2. C276A prevents the thimerosal-dependent increase in apparent Ca2+ affinity. Plot of normalized 
<I> current against the corresponding Ca2+i for KCa3.1 C276A (?) and KCa3.1 C276A+thimerosal (?). All 
analyses were performed following the protocol described in Fig. A.1 to give averages: KCa3.1 C276A (solid line, 
n=7) EC50=506±76 nM and h=2.5±0.2 and KCa3.1 C276A+thimerosal (dashed line, n=7) EC50=557±47 nM and 
h=2.1±0.1. Error bars represent standard error of the mean (SEM).  
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Figure A.3A 
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 Figure A.3B 
 
Figure A.3. PCMBS does not increase the steady-state current in (A) KCa2.3 or (B) KCa2.3 G534C. 
Macroscopic current records from KCa2.3 channels heterologously expressed in HEK cells to determine sensitivity 
to PCMBS. PCMBS (500 μM) was added to inside-out patches excised in 10 μM Ca2+i following the establishment 
of steady-state current level. PCMBS washout lasted at least 1 minute to ensure there were not any experimental 
artifacts associated with the addition of the compound. 
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Figure A.4A 
 
 
 
 
 
 
 
Figure A.4B 
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 Figure A.4C 
 
 
Figure A.4D 
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 Figure A.4E 
 
 
Figure A.4F 
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Figure A.4 KCa3.1 Ca2+ concentration response experiments. Complete Ca2+ concentration response 
experiments were performed to estimate the EC50 and the Hill coefficients (h) for KCa3.1 and the corresponding 
mutations along S6. The patch was excised in 10 μM Ca2+i followed by a series of Ca2+i concentrations beginning 
with 0, 0.1, 0.3, 0.6, 1.0, 3.0, and 10 μM Ca2+i, all applied in 10 sec intervals using a rapid solution exchanger. Plot 
of normalized <I> current against the corresponding Ca2+i for KCa3.1 S6 mutations fit with a variation of the Hill 
equation (see methods). The plots of KCa3.1 Ca2+ response curves are organized in two ways: the first is according 
to the position and type of mutation and the second is according to the effect of the mutation. (A) Mutations at 
position C276 - C276W, C276Y, C276F, C276G, and C276A. (B) Mutations at position C277 - C277W, C277Y, 
C277F, C277G, and C277A. (C) Tryptophan mutations – C276W, C277W, L281W, and V282W. (D) Left shift in 
apparent Ca2+ affinity - V275A, L281W, and V282W (E) Right shift in apparent Ca2+ affinity - C277W, C277Y, and 
C277F and (F) No effect on apparent Ca2+ affinity - C276W, C276Y, C276F, C276G, C276A, C277G, and C277A. 
The WT Ca2+ response curve is included in every figure as a means for comparing the mutations. Refer to table A.2 
for estimates of EC50 and h. Error bars represent standard error of the mean (SEM). 
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Figure A.5A 
 
 
 
 
 
Figure A.5B 
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Figure A.5C 
 
 
Figure A.5D 
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Figure A.5E 
 
Figure A.5F 
 
 
 151 
Figure A.5. KCa2.3 Ca2+ concentration response experiments. Complete Ca2+ concentration response 
experiments were performed to estimate the EC50 and the Hill coefficients (h) for KCa2.3 and the corresponding 
mutations along S6. The patch was excised in 10 μM Ca2+i followed by a series of Ca2+i concentrations beginning 
with 0, 0.1, 0.3, 0.6, 1.0, 3.0, and 10 μM Ca2+i, all applied in 10 sec intervals using a rapid solution exchanger. Plot 
of normalized <I> current against the corresponding Ca2+i for KCa2.3 S6 mutations fit with a variation of the Hill 
equation (see methods). The plots of KCa2.3 Ca2+ response curves are organized in two ways: the first is according 
to the position and type of mutation and the second is according to the effect of the mutation. (A) Mutations at 
position G534 – G534W, G534C, G534Y, and G534F. (B) Mutations at position C535 – C535W, C535F, C535G, 
and C535A. (C) Tryptophan mutations – G534W, C535W, V539W, and V540W. (D) Left shift in apparent Ca2+ 
affinity – V540W, G534C, and A533V/G534CV275A. (E) Right shift in apparent Ca2+ affinity – G534Y, C535W, 
and C535F. (F) No effect on apparent Ca2+ affinity – G534F, G534W, C535G, C535A, and V539W. The WT Ca2+ 
response curve is included in every figure as a means for comparing the mutations. Refer to table A.3 for estimates 
of EC50 and h. Error bars represent standard error of the mean (SEM). 
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Figure A.6A 
 
 
Figure A.6B 
 
 
Figure A.6C 
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Figure A.6D 
 
 
 
 
Figure A.6E 
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Figure A.6F 
 
 
Figure A.6. KCa3.1 activation and deactivation rates. Activation and deactivation kinetics were estimated with 
Ca2+-jump experiments for KCa3.1 and the corresponding mutations along S6. A rapid solution exchanger was 
utilized to quickly alternate between a Ca2+i-free solution and 1 of 4 Ca2+i solutions: 0.5, 0.7, 1.0, and 10 μM Ca2+i 
following the protocol illustrating one complete Ca2+ cycle shown in the inset of figure (5). 5-10 complete Ca2+ 
cycles were recorded from a single patch. Activation and deactivation sweeps were collected and averaged 
according to their respective Ca2+-concentration. The graphs illustrating the activation (left panel) and deactivation 
rates (right panel) were estimated by fitting activation and deactivation records with an exponential function and 
reported as a time constant (τ-on and τ-off), see also Table (A.4). (A) Activation and deactivation rates between WT 
and the mutation at position V275 - V275A. (B) Activation and deactivation rates between WT and the mutations at 
position C276 - C276A, C276G, and C276F. (C) Activation and deactivation rates between WT and the mutations at 
position C277 - C277A, C277G, and C277W. (D) Activation and deactivation rates between WT and the tryptophan 
mutations - C277W, L281W, and V282W. (E) Mutations that slowed the deactivation process - C276F and L281W. 
(F) Mutations that had no effect on the activation and/or deactivation process – V275A, C276A, C276G, C276F, 
C277A, C277G, C277W, L281W, V282W. 
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Figure A.7A 
 
 
Figure A.7B 
 
 
Figure A.7C 
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Figure A.7D 
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Figure A.7E 
 
 
 Figure A.7. KCa2.3 activation and deactivation rates. Activation and deactivation rates Activation and 
deactivation kinetics were estimated with Ca2+-jump experiments for KCa2.3 and the corresponding mutations along 
S6. A rapid solution exchanger was utilized to quickly alternate between a Ca2+i-free solution and 1 of 4 Ca2+i 
solutions: 0.5, 0.7, 1.0, and 10 μM Ca2+i following the protocol illustrating one complete Ca2+ cycle shown in the 
inset of figure (5). 5-10 complete Ca2+ cycles were recorded from a single patch. Activation and deactivation sweeps 
were collected and averaged according to their respective Ca2+-concentration. The graphs illustrating the activation 
(left panel) and deactivation rates (right panel) were estimated by fitting activation and deactivation records with an 
exponential function and reported as a time constant (τ-on and τ-off), see also Table (A.5). (A) Activation and 
deactivation rates between WT and the mutations at position G534 - G534F, G534Y, G534W, and G534C. (B) 
Activation and deactivation rates between WT and the mutations at position C535 - C535G, C535F, and C535W. 
(C) Activation and deactivation rates between WT and the tryptophan mutations - G534W, C535W, V539W, and 
V540W. (D) Top panel – mutations that slowed the deactivation process - G534C and V540W. Bottom panel – 
mutation that increase the rate of deactivation - C535F. (E) Mutations that had no effect on the activation and/or 
deactivation process – G534F, G534Y, G534W, G534C, C535F, C535G, C535W, V539W, and V540W. 
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Figure A.8 
 
 
Figure A.8. Estimate of  KCa2.3 P o(max). Variance analysis of KCa2.3 channel current was utilized to estimate 
Po(max). Plot of variance (σ2), against mean current <I> as fit with Eq. 1 (solid line) and Po(max) was calculated using 
Eq. 2: Po(max) = 0.89, N=680, and i=0.9 pA, n=1. 
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4.5 APPENDIX TABLES 
Table A.1. Sequence alignment between KCa3.1 and KCa2.3. The clustal program was used to align the full-
length sequences for KCa3.1 and KCa2.3. The highlighted area in S6 represents the region in KCa3.1 and KCa2.3 
examined by site-directed mutagenesis. The regions of the channel comprising transmembrane domains 1-6 are 
underlined, in addition to the segment of the C-terminus representing the CaMBD. 
 
      Sequence Alignment 
 
KCa3.1    ------------------------------------------------------------ 
 KCa2.3    MSSCRYNGGVMRPLSNLSSSRRNLHEMDSEAQPLQPPASVVGGGGGASSPSAAAAASSSA 60 
 
                                                                            
 
KCa3.1    --------------------MGGDLVLGLG------------------------------ 10 
 KCa2.3    PEIVVSKPEHNNSNNLALYGTGGGGSTGGGGGGGGGGGGSGHGSSSGTKSSKKKNQNIGY 120 
                                    **.   * *     
                                                                                    
                     ______S1__________                 ________ 
 KCa3.1    ALRRRKRLLEQEKSLAGWALVLAGTGIGLMVLHAEMLWFGGCSWALYLFLVKCTISISTF 70 
 KCa2.3    KLGHRRALFEKRKRLSDYALIFGMFGIVVMVIETELSWGAYDKASLYSLALKCLISLSTI 180 
     * :*: *:*:.* *:.:**::.  ** :**:.:*: * .  . :** : :** **:**: 
 
    ___S2____                         _________S3_______ 
 KCa3.1    LLLCLIVAFHAKEVQLFMTDNGLRDWRVALTGRQAAQIVLELVVCGLHPAPVRGPPCVQD 130 
 KCa2.3    ILLGLIIVYHAREIQLFMVDNGADDWRIAMTYERIFFICLEILVCAIHPIPGN---YTFT 237 
    :** **:.:**:*:****.***  ***:*:* .:   * **::**.:** * .    . 
   
                                  ________S4________ 
 KCa3.1    LGAPLTSPQPWPGFLGQGEALLSLAMLLRLYLVPRAVLLRSGVLLNASYRSIGALNQVRF 190 
 KCa2.3    WTARLAFSYAPSTTTADVDIILSIPMFLRLYLIARVMLLHSKLFTDASSRSIGALNKINF 297 
      * *: . . .   .: : :**:.*:*****:.*.:**:* :: :** *******::.* 
 
              _________S5____________                    _______ 
 KCa3.1    RHWFVAKLYMNTHPGRLLLGLTLGLWLTTAWVLSVAER--QAVNATGHLSDTLWLIPITF 248 
 KCa2.3    NTRFVMKTLMTICPGTVLLVFSISLWIIAAWTVRACERYHDQQDVTSNFLGAMWLISITF 357 
    .  ** *  *.  ** :** :::.**: :**.: ..**  :  :.*.:: .::***.*** 
 
    ____P-Loop_____    ________S6_________ _____________________ 
 KCa3.1    LTIGYGDVVPGTMWGKIVCLCTGVMGVCCTALLVAVVARKLEFNKAEKHVHNFMMDIQYT 308 
 KCa2.3    LSIGYGDMVPNTYCGKGVCLLTGIMGAGCTALVVAVVARKLELTKAEKHVHNFMMDTQLT 417 
    *:*****:**.*  ** *** **:**. ****:*********:.************ * * 
 
    ______________________CaMBD_________________________________ 
 KCa3.1    KEMKESAARVLQEAWMFYKHTR--RKESHA-ARRHQRKLLAAINAFRQVRLKHRKLREQV 365 
 KCa2.3    KRVKNAAANVLRETWLIYKNTKLVKKIDHAKVRKHQRKFLQAIHQLRSVKMEQRKLNDQA 477 
    *.:*::**.**:*:*::**:*:  :* .** .*:****:* **: :*.*::::***.:*. 
 
    _____________ 
 KCa3.1    NSMVDISKMHMILYDLQQNLSSSHR-------ALEKQIDTLAGKLDALTELLSTALGPRQ 418 
 KCa2.3    NTLVDLAKTQNIMYDMISDLNERSEDFEKRIVTLETKLETLIGSIHALPGLISQTIRQQQ 537 
    *::**::* : *:**: .:*..  .       :**.:::** *.:.**. *:* ::  :* 
 
 
 KCa3.1    ----------------------------------LPEPSQQSK 427 
 KCa2.3    RDFIETQMENYDKHVTYNAERSRSSSRRRRSSSTAPPTSSESS 580 
                                       * .*.:*. 
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Table A.2 
 
Table A.2. KCa3.1 Ca2+ concentration experiments. Results from Ca2+ concentration response 
experiments on KCa3.1 and all of the corresponding mutations that were capable of expressing 
macroscopic currents. EC50 and Hill coefficients (h) were calculated by fitting the plot of the 
normalized <I> current against the corresponding Ca2+i with a variation of the Hill equation 
as described in the Materials and Methods section. The number of times the experiment 
was performed is represented by (n).  
 
Construct  EC50   h  n 
WT   508±13 nM  2.0±0.1 57 
V275A  377±28 nM  2.4±0.1 11 
C276A   460±27 nM  1.7±0.04 18 
C276F   482±31 nM  2.3±0.2 10 
C276G   570±51 nM  1.7±0.1 5 
C276W  565±48 nM  1.9±0.05 7 
C276Y   631±286 nM  1.4±0.2 2 
C277A   566±24 nM  1.9±0.1 15 
C277F   1048±258 nM  1.9±0.1 2 
C277G   542±44 nM  2.5±0.1 4 
C277W  761±53 nM  1.5±0.1 6 
C277Y   753±51 nM  2.0±0.1 8 
L281W  54±6 nM  3.2±0.2 12 
V282W  296±14 nM  1.6±0.1 12 
 
 
 
 
  162
Table A.3 
 
Table A.3. KCa2.3 Ca2+ concentration experiments. Results from Ca2+ concentration response 
experiments on KCa2.3 and all of the corresponding mutations capable of expressing 
macroscopic currents. EC50 and Hill coefficients (h) were calculated by fitting the plot of the 
normalized <I> current against the corresponding Ca2+i with a variation of the Hill equation 
as described in the Materials and Methods section. The number of times the experiment 
was performed is represented by (n).  
 
 
Construct  EC50   h  n 
KCa2.3  411±14 nM  4.0±0.1 30 
A533V/G534C 284±6 nM  5.2±0.3 9 
G534C   165±14 nM  3.6±0.1 12 
G534F   418±17 nM  5.1±0.2 6 
G534W  530±77 nM  4.2±0.3 6  
C535A   375±24 nM  3.8±0.2 7 
C535F   891±19 nM  4.0±0.2 13 
C535G   450±27 nM  4.5±0.2 12 
C535W  737±28 nM  4.0±0.1 16 
V539W  318±15 nM  3.8±0.1 14 
V540W  164±6 nM  3.6±0.2 10 
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Table A.4 
 
Table A.4 KCa3.1 activation and deactivation rates. Activation and deactivation time 
constants from Ca2+ jump experiments on KCa3.1 and all of the corresponding mutations capable 
of expressing macroscopic currents. Activation (tau (τ) on) and deactivation (tau (τ) off) time 
constants were estimated by fitting activation and deactivation records with an exponential 
function as reported in the Materials and Methods section. The number of times the 
experiment was performed is represented by (n). 
 
Construct  Ca2+ (µM) τ on (ms)  τ off (ms)  n 
KCa3.1  0.5  209±9   57±2   51 
   0.7  170±5   57±2   51 
   1.0  141±5   59±2   51 
   10  114±5   56±2   51 
V275A  0.5  236±24  53±4   9 
   0.7  173±21  55±3   9 
   1.0  141±12  47±2   9 
   10  104±5   49±3   9 
C276A   0.5  211±20  48±4   7 
   0.7  186±15  46±4   7 
   1.0  142±15  56±3   7 
   10  120±11  43±3   7 
C276F   10  111±12  77±14   5 
C276G   10  89±6   47±4   2 
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C277A   0.5  244±10  54±6   6 
   0.7  186±9   59±6   6 
   1.0  152±8   59±5   6 
   10  129±12  59±7   6 
C277G   0.5  227±49  53±5   3 
   0.7  130±15  62±6   3 
   1.0  135±14  54±5   3 
   10  99±8   50±7   3 
C277W  10  146±14  53±8   7 
L281W  0.5  149±12  186±11  23 
   0.7  130±9   202±11  23 
   1.0  119±10  198±9   23 
   10  92±7   197±8   23 
V282W  0.5  161±11  59±3   13 
   0.7  131±8   59±2   13 
   1.0  113±8   59±3   13 
   10  84±5   58±3   13 
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Table A.5 
Table A.5 KCa2.3 activation and deactivation rates. Activation and deactivation time 
constants from Ca2+ jump experiments on KCa2.3 and all of the corresponding mutation capable 
of expressing macroscopic currents. Activation (tau (τ) on) and deactivation (tau (τ) off) time 
constants were estimated by fitting activation and deactivation records with an exponential 
function as reported in the Materials and Methods section. The number of times the 
experiment was performed is represented by (n). In a couple of constructs the apparent Ca2+ 
affinity was right shifted and as a result macroscopic currents could only be observed and 
recorded in high [Ca2+].     
 
Construct  Ca2+ (µM) τ on (ms)  τ off (ms)  n 
KCa2.3  0.4  204±19  54±3   8 
   0.6  91±9   54±3   8 
   1.0  32±2   55±2   8 
   10  17±1   55±3   8 
G534C   0.4  127±12  103±7   13 
   0.6  64±6   106±7   13 
   1.0  28±3   104±7   13 
   10  18±2   130±3   13 
G534F   0.4  152±15  78±8   5 
   0.6  70±8   72±4   5 
   1.0  28±1   65±3   5 
   10  20±3   70±5   5 
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G534W  0.4  138±12  73±9   4 
   0.6  49±2   63±4   4 
   1.0  22±2   57±1   4 
   10  17±2   58±3   4 
G534Y  0.4  111±17  63±5   6 
   0.6  62±9   59±7   6 
   1.0  43±5   52±7   6 
   10  30±5   48±4   6 
C277G   0.5  227±49  53±5   3 
   0.7  130±15  62±6   3 
   1.0  135±14  54±5   3 
   10  99±8   50±7   3 
C535F   0.4  -   -   - 
   0.6  -   -   - 
   1.0  33±3   35±3   8 
   10  15±2   30±2   8 
C535G   0.4  292±30  52±2   8 
   0.6  163±12  56±1   8 
   1.0  29±5   56±1   8 
   10  13±1   54±2   8 
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C535W  0.4  -   -   - 
   0.6  137±14  56±3   12 
   1.0  53±4   54±2   12 
   10  19±2   43±2   12 
V539W  0.4  140±10  64±3   9 
   0.6  65±4   64±4   9 
   1.0  30±3   64±3   9 
   10  16±2   64±3   9 
V540W  0.4  88±7   91±3   7 
   0.6  39±3   91±4   7 
   1.0  18±1   95±3   7 
   10  10±1   92±3   7 
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Table A.6A Table A.6. Primers. Primers used for site directed mutagenesis in KCa3.1 (6A)  
  and KCa2.3 (6B). Bold indicates the amino acid mutation and the corresponding  
  nucleotide change. 
 
KCa3.1 
 
 
V275W  F 5′ ACTGGAGTCATGGGTTGGTGCTGCACAGCCCTGCTG 3′ 
  R 5′ CAGGGCTGTGCAGCACCAACCCATGACTCCAGTGCA 3′ 
 
C276A  F 5′ GGAGTCATGGGTGTCGCCTGCACAGCCCTGCTG 3′ 
  R 5′ CAGCAGGGCTGTGCAGGCGACACCCATGACTCC 3′ 
 
C276D  F 5′ GGAGTCATGGGTGTCGACTGCACAGCCCTGCTG 3′ 
  R 5′ CAGCAGGGCTGTGCAGTCGACACCCATGACTCC 3′ 
 
C276F  F 5′ GGAGTCATGGGTGTCTTCTGCACAGCCCTGCTG 3′ 
  R 5′ CAGCAGGGCTGTGCAGAAGACACCCATGACTCC 3′ 
 
C276G  F 5′ GGAGTCATGGGTGTCGGCTGCACAGCCCTGCTG 3′ 
  R 5′ CAGCAGGGCTGTGCAGCCGACACCCATGACTCC 3′ 
 
C276W  F 5′ GGAGTCATGGGTGTCTGGTGCACAGCCCTGCTG 3′ 
  R 5′ CAGCAGGGCTGTGCACCAGACACCCATGACTCC 3′ 
 
C276Y  F 5′ GGAGTCATGGGTGTCTACTGCACAGCCCTGCTG 3′ 
  R 5′ CAGCAGGGCTGTGCAGTAGACACCCATGACTCC 3′ 
 
C277A  F 5′ GTCATGGGTGTCTGCGCCACAGCCCTGCTGGTG 3′ 
  F 5′ CACCAGCAGGGCTGTGGCGCAGACACCCATGAC 3′ 
 
C277D  F 5′ GTCATGGGTGTCTGCGACACAGCCCTGCTGGTG 3′ 
  R 5′ CACCAGCAGGGCTGTGTCGCAGACACCCATGAC 3′ 
 
C277F  F 5′ GTCATGGGTGTCTGCTTCACAGCCCTGCTGGTG 3′ 
  R 5′ CACCAGCAGGGCTGTGAAGCAGACACCCATGAC 3′ 
 
C277G  F 5′ GTCATGGGTGTCTGCGGCACAGCCCTGCTGGTG 3′ 
  R 5′ CACCAGCAGGGCTGTGCCGCAGACACCCATGAC 3′ 
 
C277W  F 5′ GTCATGGGTGTCTGCTGGACAGCCCTGCTGGTG 3′ 
  R 5′ CACCAGCAGGGCTGTCCAGCAGACACCCATGAC 3′ 
 
C277Y  F 5′ GTCATGGGTGTCTGCTACACAGCCCTGCTGGTG 3′ 
  R 5′ CACCAGCAGGGCTGTGTAGCAGACACCCATGAC 3′ 
 
T278W  F 5′ ATGGGTGTCTGCTGCTGGGCCCTGCTGGTGGCC 3′ 
  R 5′ GGCCACCAGCAGGGCCCAGCAGCAGACACCCAT 3′ 
 
A279W  F 5′ GGTGTCTGCTGCACATGGCTGCTGGTGGCCGTG 3′ 
  R 5′ CACGCCCACCAGCAGCCATGTGCAGCAGACACC 3′ 
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L280W  F 5′ GTCTGCTGCACAGCCTGGCTGGTGGCCGTGGTG 3′ 
  R 5′ CACCACGCCCACCAGCCAGGCTGTGCAGCAGAC 3′ 
 
L281W  F 5′ TGCTGCACAGCCCTGTGGGTGGCCGTGGTGGCC 3′ 
  R 5′ GGCCACCACGGCCACCCACAGGGCTGTGCAGCA 3′ 
 
 
V282W  F 5′ TGCACAGCCCTGCTGTGGGCCGTGGTGGCCCGG 3′ 
  R 5′ CCGGGCCACCACGCCCCACAGCAGGGCTGTGCA 3′ 
 
V275A/C276G F 5′ ACTGGAGTCATGGGTGCCGGCTGCACAGCCCTG 3′ 
  F 5′ CAGGGCTGTGCAGCCGGCACCCATGACTCCAGT 3′ 
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Table A.6B      
     KCa2.3 
 
 
G532W  F 5′ CTCACTGGCATCATGTGGGCAGGCTGCACTGCC 3′ 
  R 5′ GGCAGTGCAGCCTGCCCACATGATGCCAGTGAG 3′ 
 
A533V  F 5′ ACTGGCATCATGGGTGTAGGCTGCACTGCCCTC 3′ 
  R 5′ GAGGGCAGTGCAGCCTACACCCATGATGCCAGT 3′ 
 
A533W  F 5′ CTCACTGGCATCATGGGTTGGGGCTGCACTGCCCTC 3′ 
  R 5′ GAGGGCAGTGCAGCCCCAACCCATGATGCCAGTGAG 3′ 
 
G534C  F 5′ GGCATCATGGGTGCATGCTGCACTGCCCTCGTG 3′ 
  R 5′ CACGAGGGCAGTGCAGCATGCACCCATGATGCC 3′ 
 
G534D  F 5′ GGCATCATGGGTGCAGACTGCACTGCCCTCGTG 3′ 
  R 5′ CACGAGGGCAGTGCAGTCTGCACCCATGATGCC 3′ 
 
G534F  F 5′ GGCATCATGGGTGCATTCTGCACTGCCCTCGTG 3′ 
  R 5′ CACGAGGCCAGTGCAGAATGCACCCATGATGCC 3′ 
 
G534W  F 5′ GGCATCATGGGTGCATGGTGCACTGCCCTCGTG 3′ 
  R 5′ CACGAGGGCAGTGCACCATGCACCCATGATGCC 3′ 
 
G534Y  F 5′ GGCATCATGGGTGCATACTGCACTGCCCTCGTG 3′ 
  R 5′ CACGAGGGCAGTGCAGTATGCACCCATGATGCC 3′ 
 
C535D  F 5′ GGCATCATGGGTGCAGGCGACACTGCCCTCGTGGTAGCT 3′ 
  R 5′ AGCTACCACGAGGGCAGTGTCGCCTGCACCCATGATGCC 3′ 
 
C535F  F 5′ GGCATCATGGGTGCAGGCTTCACTGCCCTCGTGGTAGCT 3′ 
  R 5′ AGCTACCACGAGGGCAGTGAAGCCTGCACCACTGATGCC 3′ 
 
C535G  F 5′ GGCATCATGGGTGCAGGCGGCACTGCCCTCGTGGTAGCT 3′ 
  R 5′ AGCTACCACGAGGGCAGTGCCGCCTGCACCCATGATGCC 3′ 
 
C535W  F 5′ GGCATCATGGGTGCAGGCTGGACTGCCCTCGTGGTAGCT 3′ 
  R 5′ AGCTACCACGAGGGCAGTCCAGCCTGCACCCATGATGCC 3′ 
 
C535Y  F 5′ GGCATCATGGGTGCAGGCTACACTGCCCTCGTGGTAGCT 3′ 
  R 5′ AGCTACCACGAGGGCAGTGTAGCCTGCACCCATGATGCC 3′ 
 
T536W  F 5′ ATGGGTGCAGGCTGCTGGGCCCTCGTGGTAGCT 3′ 
  R 5′ AGCTACCACGAGGGCCCAGCAGCCTGCACCCAT 3′ 
 
A537W  F 5′ GGTGCAGGCTGCACTTGGCTCGTGGTAGCTGTGGTTGCC 3′ 
  R 5′ GGCAACCACAGCTACCACGAGCCAAGTGCAACCTGCACC 3′ 
 
L538W  F 5′ GCAGGCTGCACTGCCTGGGTGGTAGCTGTGGTTGCC 3′ 
  R 5′ GGCAACCACAGCTACCACCCAGGCAGTGCAGCCTGC 3′ 
 
V539W  F 5′ GGCTGCACTGCCCTCTGGGTAGCTGTGGTTGCC 3′ 
  R 5′ GGCAACCACAGCTACCCAGAGGGCAGTGCAGCC 3′ 
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V540W  F 5′ TGCACTGCCCTCGTGTGGGCTGTGGTTGCCCGG 3′ 
  R 5′ CCGGGCAACCACAGCCCACACGAGGGCAGTGCA 3′ 
 
 
 
A533V/G534C F 5′ GGCATCATGGGTGTATGCTGCACTGCCCTCGTGGTAGCT 3′ 
  R 5′ AGCTACCACGAGGGCAGTGCAGCATACACCCATGATGCC 3′ 
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Table A.7A 
Sensitivity Analysis 
 
Sensitivity Analysis KCa3.1: linear dependence on Ca2+ concentration, k=A⋅[Ca]. Data set #1 
Kinetic Rate Constant   Change in Error  Change in Error 
Transition     +10% rate constant  -10% rate constant 
_________________________________________________________________________________________________________ 
12      7 µM‐1 s‐1      14%        17% 
21      36 s‐1        10%        12% 
23      1200 µM‐1 s‐1      13%        16% 
32      230 s‐1       13%        16% 
34      *        *        * 
43      *        *        * 
35      35 s‐1        51%        58% 
53      16 s‐1        50%        61% 
46      *        *        *     
64      *        *        *   
   
total error = 31 
________________________________________________________________________________________________________ 
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Table A.7B 
 
Sensitivity Analysis KCa3.1: non-linear dependence on Ca2+ concentration, k=A⋅[Ca]/(B+[Ca]). 
Data set #1 
Kinetic Rate Constant   Change in Error  Change in Error 
Transition     +10% rate constant  -10% rate constant 
________________________________________________________________________________________________________ 
12      30 µM‐1 s‐1      10%        5% 
21      26 s‐1        4%        7% 
23      2700 µM‐1 s‐1      10%        9% 
32      230 s‐1       8%        12% 
34      *        *        * 
43      *        *        * 
35      27 s‐1        37%        35% 
53      15 s‐1        30%        45% 
46      *        *        * 
64      *        *        *   
   
total error = 38 
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Table A.7C 
 
 
Sensitivity Analysis KCa3.1: linear-dependence on Ca2+ concentration, k=A⋅[Ca]. Data set #2 
(paired) 
Kinetic Rate Constant   Change in Error  Change in Error 
Transition     +10% rate constant  -10% rate constant 
_________________________________________________________________________________________________________ 
12      5 µM‐1 s‐1      8%        10% 
21      21 s‐1        4%        6% 
23      1740 µM‐1 s‐1      6%        8% 
32      280 s‐1       7%        8% 
34      *        *        * 
43      *        *        * 
35      32 s‐1        37%        44% 
53      21 s‐1        38%        43% 
46      *        *        * 
64      *        *        * 
total error = 38 
_________________________________________________________________________________________________________ 
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Table A.7D 
 
Sensitivity Analysis KCa3.1: non-linear dependence on Ca2+ concentration, k=A⋅[Ca]/(B+[Ca]). 
Data set #2 (paired) 
Kinetic Rate Constant   Change in Error  Change in Error 
Transition     +10% rate constant  -10% rate constant 
_________________________________________________________________________________________________________ 
12      24 µM‐1 s‐1      8%        11% 
21      42 s‐1        6%        6% 
23      8150 µM‐1 s‐1      6%        9% 
32      150 s‐1       7%        7% 
34      *        *        * 
43      *        *        * 
35      39 s‐1        34%        42% 
53      24 s‐1        36%        40% 
46      *        *        * 
64      *        *        *   
   
total error = 38 
_________________________________________________________________________________________________________ 
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Table A.7E 
Sensitivity Analysis KCa3.1+PCMBS: linear dependence on Ca2+ concentration, k=A⋅[Ca]. Data 
set #2 (paired) 
Kinetic Rate Constant   Change in Error  Change in Error 
Transition     +10% rate constant  -10% rate constant 
_________________________________________________________________________________________________________ 
12      5 µM‐1 s‐1      1%        2% 
21      23 s‐1        1%        1% 
23      550 µM‐1 s‐1      1%        2% 
32      660 s‐1       1%        1% 
34      *        *        * 
43      *        *        * 
35      290 s‐1       1%        2% 
53      4 s‐1        2%        2% 
46      *        *        * 
64      *        *        * 
total error = 64 
_________________________________________________________________________________________________________ 
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Table A.7F 
Sensitivity Analysis KCa3.1+PCMBS: non-linear dependence on Ca2+ concentration, 
k=A⋅[Ca]/(B+[Ca]). 
Data set #2 (paired) 
Kinetic Rate Constant   Change in Error  Change in Error 
Transition     +10% rate constant  -10% rate constant 
_________________________________________________________________________________________________________ 
12      10 µM‐1 s‐1      4%        3% 
21      76 s‐1        3%        3% 
23      2900 µM‐1 s‐1      3%        4% 
32      2980 s‐1      3%        4% 
34      *        *        *     
43      *        *        *     
35      290 s‐1       3%        4% 
53      3 s‐1        5%        4% 
46      *        *        * 
64      *        *        * 
total error = 45 
_________________________________________________________________________________________________________ 
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Table A.7G 
Sensitivity Analysis KCa3.1+PCMBS constrained: non-linear dependence on Ca+ concentration, 
k=A⋅[Ca]/(B+[Ca]). 
Kinetic Rate Constant   Change in Error  Change in Error 
Transition     +10% rate constant  -10% rate constant 
_________________________________________________________________________________________________________ 
12      *27 µM‐1 s‐1      2%        2% 
21      *34 s‐1       1%        1% 
23      *5425 µM‐1 s‐1    1%        2% 
32      *190 s‐1      2%        2% 
34      *        *        *     
43      *        *        *     
35      *34 s‐1       3%        5% 
53      3 s‐1        5%        4% 
46      *        *        * 
64      *        *        * 
total error = 43 
_________________________________________________________________________________________________________ 
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Table A.7H 
 
Sensitivity Analysis KCa3.1 L281W: non-linear dependence on Ca+ concentration, 
k=A⋅[Ca]/(B+[Ca]). 
Kinetic Rate Constant   Change in Error  Change in Error 
Transition     +10% rate constant  -10% rate constant 
_________________________________________________________________________________________________________ 
12      11 µM‐1 s‐1      0.3%        0.3% 
21      76 s‐1        0.2%        0.2% 
23      12380 µM‐1 s‐1    0.2%        0.2% 
32      192 s‐1       0.2%        0.2% 
34      *        *        *     
43      *        *        *     
35      53 s‐1        2%        3% 
53      5 s‐1        3%        3% 
46      *        *        * 
64      *        *        * 
total error = 8 
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Table A.7I 
 
Sensitivity Analysis KCa3.1 L281W constrained: non-linear dependence on Ca+ concentration, 
k=A⋅[Ca]/(B+[Ca]). 
Kinetic Rate Constant   Change in Error  Change in Error 
Transition     +10% rate constant  -10% rate constant 
_________________________________________________________________________________________________________ 
12      *27 µM‐1 s‐1      0.2%        0.2% 
21      *34 s‐1       0.2%        0.1% 
23      *5425 µM‐1 s‐1    0.2%        0.3% 
32      *190 s‐1      0.0%        0.2% 
34      *        *        *     
43      *        *        *     
35      *34 s‐1       2%        2% 
53      4 s‐1        1%        3% 
46      *        *        * 
64      *        *        * 
total error = 13 
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Table A.7. Sensitivity analysis. Rate constants and values from the sensitivity analysis. 
Sensitivity analysis was performed to determine whether the rate constants obtained from the 
kinetic modeling were the best estimates for the corresponding parameter. (A) Rate constants and 
sensitivity analysis values derived from the kinetic modeling of KCa3.1 assuming a linear 
dependence on Ca2+ concentration. Current recordings were taken from data set #1. (B) KCa3.1 
assuming a non-linear dependence on Ca2+ concentration, recording were taken from data set #1. 
(C) KCa3.1 assuming a linear dependence on Ca2+ concentration, recordings were taken from 
data set #2. (D) KCa3.1 assuming a non-linear dependence on Ca2+ concentration, recordings 
were taken from data set #2. (E) KCa3.1+PCMBS assuming a linear dependence on Ca2+ 
concentration, recordings were taken from data set #2. (F) KCa3.1+PCMBS assuming a non-
linear dependence on Ca2+ concentration, recordings were taken from data set #2. (G) 
KCa3.1+PCMBS constrained model, assuming a non-linear dependence on Ca2+ concentration. 
Transitions 12, 21, 23, 32, 35 are fixed to the average value from KCa3.1 (without PCMBS) 
data sets #1 and #2. (H) KCa3.1 L281W assuming a non-linear dependence on Ca2+ 
concentration. (I) KCa3.1 L281W constrained model assuming a non-linear dependence on Ca2+ 
concentration. Transitions 12, 21, 23, 32, 35 are fixed to the average value from KCa3.1 
(without PCMBS) data sets #1 and #2. 
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Table A.8 
 
 
 
 
 
Table A.8. Sequence alignment. Sequence alignment of S6 between KCa3.1, KcsA, and Shaker 
illustrating a correspondence between residues Val275 and Thr278 to the known pore lining 
residues Ile100 and Phe103 in KcsA, and residues Thr278 and Val282 to the known pore lining 
residues Ile402 and Val406 in Shaker. 
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